
<html lang="en"     class="pb-page"  data-request-id="0efc0703-0893-4af9-b870-301bdfa7d007"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01379;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor" /></meta><meta name="dc.Creator" content="Kunal  Kumar" /></meta><meta name="dc.Creator" content="Peng  Wang" /></meta><meta name="dc.Creator" content="Jessica  Wilson" /></meta><meta name="dc.Creator" content="Viktor  Zlatanic" /></meta><meta name="dc.Creator" content="Cecilia  Berrouet" /></meta><meta name="dc.Creator" content="Susmita  Khamrui" /></meta><meta name="dc.Creator" content="Cody  Secor" /></meta><meta name="dc.Creator" content="Ethan A.  Swartz" /></meta><meta name="dc.Creator" content="Michael  Lazarus" /></meta><meta name="dc.Creator" content="Roberto  Sanchez" /></meta><meta name="dc.Creator" content="Andrew F.  Stewart" /></meta><meta name="dc.Creator" content="Adolfo  Garcia-Ocana" /></meta><meta name="dc.Creator" content="Robert J.  DeVita" /></meta><meta name="dc.Description" content="Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of selectivity..." /></meta><meta name="Description" content="Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of selectivity..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 31, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01379" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01379" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01379" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01379" /></link>
        
    
    

<title>Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01379" /></meta><meta property="og:title" content="Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0003.jpeg" /></meta><meta property="og:description" content="Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of selectivity, both against other kinases and CNS off-targets, we therefore sought to expand structure–activity relationships for harmine’s DYRK1A activity, to enhance selectivity for off-targets while retaining human β-cell proliferation activity. We carried out optimization of the 9-N-position of harmine to synthesize 29 harmine-based analogs. Several novel inhibitors showed excellent DYRK1A inhibition and human β-cell proliferation capability. An optimized DYRK1A inhibitor, 2-2c, was identified as a novel, efficacious in vivo lead candidate. 2-2c also demonstrates improved selectivity for kinases and CNS off-targets, as well as in vivo efficacy for β-cell proliferation and regeneration at lower doses than harmine. Collectively, these findings demonstrate that 2-2c is a much improved in vivo lead candidate as compared to harmine for the treatment of diabetes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01379"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01379">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01379&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01379&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01379&amp;href=/doi/10.1021/acs.jmedchem.9b01379" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2986-3003</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01536" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01689" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kunal Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kunal Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kunal++Kumar">Kunal Kumar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peng Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peng Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Wang">Peng Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Wilson">Jessica Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Viktor Zlatanic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Viktor Zlatanic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Viktor++Zlatanic">Viktor Zlatanic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cecilia Berrouet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cecilia Berrouet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cecilia++Berrouet">Cecilia Berrouet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susmita Khamrui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susmita Khamrui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susmita++Khamrui">Susmita Khamrui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cody Secor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cody Secor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cody++Secor">Cody Secor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ethan A. Swartz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ethan A. Swartz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ethan+A.++Swartz">Ethan A. Swartz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Lazarus</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Lazarus</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Lazarus">Michael Lazarus</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6738-2563" title="Orcid link">http://orcid.org/0000-0002-6738-2563</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roberto Sanchez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roberto Sanchez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Sanchez">Roberto Sanchez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew F. Stewart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew F. Stewart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+F.++Stewart">Andrew F. Stewart</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adolfo Garcia-Ocana</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adolfo Garcia-Ocana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8cede8e3e0eae3a2ebedfeefe5eda1e3efede2edcce1ffffe1a2e9e8f9ed"><span class="__cf_email__" data-cfemail="0c6d6863606a63226b6d7e6f656d21636f6d626d4c617f7f61226968796d">[email protected]</span></a> (A.G.-O.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adolfo++Garcia-Ocana">Adolfo Garcia-Ocana</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Robert J. DeVita</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert J. DeVita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div><div class="loa-info-affiliations-info">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#fb8994999e898fd59f9e8d928f9abb96888896d59e9f8e"><span class="__cf_email__" data-cfemail="3f4d505d5a4d4b115b5a49564b5e7f524c4c52115a5b4a">[email protected]</span></a>. Phone: 212-659-5542 (R.J.D.V.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++DeVita">Robert J. DeVita</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2671-8497" title="Orcid link">http://orcid.org/0000-0002-2671-8497</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01379&amp;href=/doi/10.1021%2Facs.jmedchem.9b01379" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2986–3003</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 31, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 October 2019</li><li><span class="item_label"><b>Published</b> online</span>31 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01379" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01379</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2986%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKunal%2BKumar%252C%2BPeng%2BWang%252C%2BJessica%2BWilson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D6%26contentID%3Dacs.jmedchem.9b01379%26title%3DSynthesis%2Band%2BBiological%2BValidation%2Bof%2Ba%2BHarmine-Based%252C%2BCentral%2BNervous%2BSystem%2B%2528CNS%2529-Avoidant%252C%2BSelective%252C%2BHuman%2B%25CE%25B2-Cell%2BRegenerative%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinase%2BA%2B%2528DYRK1A%2529%2BInhibitor%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3003%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01379"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2135</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01379" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kunal&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Wilson&quot;},{&quot;first_name&quot;:&quot;Viktor&quot;,&quot;last_name&quot;:&quot;Zlatanic&quot;},{&quot;first_name&quot;:&quot;Cecilia&quot;,&quot;last_name&quot;:&quot;Berrouet&quot;},{&quot;first_name&quot;:&quot;Susmita&quot;,&quot;last_name&quot;:&quot;Khamrui&quot;},{&quot;first_name&quot;:&quot;Cody&quot;,&quot;last_name&quot;:&quot;Secor&quot;},{&quot;first_name&quot;:&quot;Ethan&quot;,&quot;last_name&quot;:&quot;A. Swartz&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Lazarus&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Sanchez&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;F. Stewart&quot;},{&quot;first_name&quot;:&quot;Adolfo&quot;,&quot;last_name&quot;:&quot;Garcia-Ocana&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. DeVita&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2986-3003&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01379&quot;},&quot;abstract&quot;:&quot;Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of selectivity, both against other kinases and CNS off-targets, we therefore sought to expand structure–activity relationships for harmine’s DYRK1A activity, to enhance selectivity for off-targets while retaining human β-cell proliferation activity. We carried out optimization of the 9-N-position of harmine to synthesize 29 harmine-based analogs. Several novel inhibitors showed excellent DYRK1A inhibition and human β-cell proliferation capability. An optimized DYRK1A inhibitor, 2-2c, was identified as a novel, efficacious in vivo lead candidate. 2-2c also demonstrates improved selectivity for kinases and CNS off-targets, as well as in vivo efficacy for β-cell proliferation and regeneration at lower doses than harmine. Collectively, these findings demonstrate that 2-2c is a much improved in vivo lead candidate as compared to harmi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01379&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01379" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01379&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01379" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01379&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01379" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01379&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01379&amp;href=/doi/10.1021/acs.jmedchem.9b01379" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01379" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01379" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01379%26sid%3Dliteratum%253Aachs%26pmid%3D32003560%26genre%3Darticle%26aulast%3DKumar%26date%3D2020%26atitle%3DSynthesis%2Band%2BBiological%2BValidation%2Bof%2Ba%2BHarmine-Based%252C%2BCentral%2BNervous%2BSystem%2B%2528CNS%2529-Avoidant%252C%2BSelective%252C%2BHuman%2B%25CE%25B2-Cell%2BRegenerative%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinase%2BA%2B%2528DYRK1A%2529%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D6%26spage%3D2986%26epage%3D3003%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (17)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/jmcmar.2020.63.issue-6/20200326/jmcmar.2020.63.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. Since, harmine suffers from a lack of selectivity, both against other kinases and CNS off-targets, we therefore sought to expand structure–activity relationships for harmine’s DYRK1A activity, to enhance selectivity for off-targets while retaining human β-cell proliferation activity. We carried out optimization of the 9-<i>N</i>-position of harmine to synthesize 29 harmine-based analogs. Several novel inhibitors showed excellent DYRK1A inhibition and human β-cell proliferation capability. An optimized DYRK1A inhibitor, <b>2-2c</b>, was identified as a novel, efficacious in vivo lead candidate. <b>2-2c</b> also demonstrates improved selectivity for kinases and CNS off-targets, as well as in vivo efficacy for β-cell proliferation and regeneration at lower doses than harmine. Collectively, these findings demonstrate that <b>2-2c</b> is a much improved in vivo lead candidate as compared to harmine for the treatment of diabetes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dual-specificity tyrosine phosphorylation-regulated kinase A (DYRK1A) belongs to the CMGC (CDK, MAPK, CDC-like kinases, GSK3 kinase) family of eukaryotic protein kinases that have been shown to play important roles in neurodegenerative diseases,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> tumorigenesis and apoptosis.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> More recently, DYRK1A was identified as a regulator of regenerative pathways relevant to human insulin-producing pancreatic β-cells.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Numerous studies have explored development of DYRK1A inhibitor scaffolds in view of the involvement of DYRK1A in these diseases.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref8 ref9 ref10">(2−6,8−10)</a> Several DYRK1A inhibitors, from natural sources like harmine, as well as from small molecule drug discovery programs, have been identified and characterized.<a onclick="showRef(event, 'ref8 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(8,11−33)</a> Among all the DYRK1A inhibitors, harmine and its analogs (β-carbolines) are the most commonly studied and remain one of the most potent and orally bioavailable class of inhibitors known.<a onclick="showRef(event, 'ref2 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref10">(2,10)</a> In addition to its kinase inhibitory activity, harmine has been suggested to be a hallucinogen due to its presence in the hallucinogenic infusion ayahuasca and its affinity for serotonin, tryptamine, and other receptors in the central nervous system (CNS).<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> Harmine and several related analogs have also been found to inhibit DYRK1A-mediated phosphorylation of tau proteins in the CNS<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and to have anti-proliferative cancer activity, including inhibition of topoisomerase I,<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> inhibition of CDKs,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> induction of cell apoptosis,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and DNA intercalation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">Recently, our group found that harmine is able to induce human β-cell proliferation using a luciferase reporter phenotypic small-molecule high-throughput screen (HTS). Subsequently, we identified the DYRK1A-NFAT pathway as being the major pathway for this cell proliferation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These results have been confirmed in other labs with DYRK1A inhibitors unrelated to the harmine scaffold, including from our own lab.<a onclick="showRef(event, 'ref6 ref8 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref43 ref44 ref45">(6,8,43−45)</a> DYRK1A is expressed ubiquitously; accordingly, DYRK1A inhibitors including harmine, developed for other therapeutic purposes, are predicted to have adverse effects on multiple tissues, thereby limiting their therapeutic potential. Thus, there is an urgent need to develop strategies to generate more selective harmine analogs as pharmacological lead candidates with limited CNS activities yet retaining human β-cell proliferative effects, with an improved pharmacological profile for therapeutic development.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In addition, optimized, tissue-specific β-cell-targeted harmine analogs may also be useful for treatment of diabetes. One such prototype technology, for example, reported by DiMarchi and colleagues, conjugated estrogen derivatives to GLP-1 analog peptides to effectively target cells that highly express the GLP1 receptor, including β-cells.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a></div><div class="NLM_p">With knowledge of this previous work, we developed a systematic medicinal chemistry strategy to investigate structure–activity relationships of harmine analogs for both DYRK1A activity and β-cell proliferation, with the intention of identifying a kinase and CNS off-target selective as well as linkable harmine analogs for targeted therapy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In our previous work, we recently reported the optimization of the 1-position of harmine, which led to two compounds that exhibited robust human β-cell proliferation at doses of 3–30 μM with one compound <b>I</b> (R = CH<sub>2</sub>OH) showing improved kinase selectivity as compared to harmine.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Herein, we report our subsequent efforts for medicinal chemistry optimization of harmine’s 9-<i>N-</i>position. We describe the identification of an improved, harmine-based in vivo DYRK1A inhibitor molecular probe with excellent in vitro human β-cell proliferation potency, improved kinase and CNS receptor selectivity, and enhanced efficacy in three in vivo models of β-cell proliferation and regeneration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization of the 1-position of harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Synthesis of 9-<i>N</i>-Substituted Harmine Analogs</h4><div class="NLM_p">Modification at the 9-<i>N</i>-position of harmine was carried out by the reaction sequences outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Alkylation of harmine with various alkyl bromides in the presence of sodium hydride as the base generated harmine analogs <b>2-1a–2-1j</b>, <b>2-1k</b>, and <b>2-1l</b> having a terminal methyl ester or <i>t</i>-butyl ester group with carbon chain lengths of 1–5 carbons in 40–68% yield.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> Harmine analogs <b>2-1a</b>–<b>2-1e</b> and <b>2-1k</b> with terminal methyl esters were refluxed in excess methanolic ammonia solution to provide the corresponding terminal carboxamide analogs <b>2-2a</b>–<b>2-2e</b> and <b>2-2f</b> in 84–95% yield. <i>t</i>-Butyl ester harmine analogs <b>2-1f</b>–<b>2-1j</b> were treated with hydrochloric acid at room temperature to give corresponding acids <b>2-3a</b>–<b>2-3e</b> in excellent yield.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Harmine α-methyl carboxylic acid analogs <b>2-3f</b> and <b>2-3g</b> were synthesized from their corresponding benzyl esters by hydrogenolysis using palladium on carbon and triethyl silane.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> 9-<i>N</i>-substituted analogs with terminal amino groups <b>2-5a</b> and <b>2-5b</b> were synthesized in 34 and 36% yield, respectively, by phthalimide deprotection of intermediates <b>1-2m</b> and <b>1-2n</b> using hydrazine monohydrate.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Acylation of amines <b>2-5a</b> and <b>2-5b</b> with acetic anhydride and trimethylamine afforded harmine acetamide analogs <b>2-6a</b> and <b>2-6b</b> in 44 and 63% yield, respectively. <i>N</i>-Methylations of compounds <b>2-5a</b>,<b>b</b> were carried out first by formylation using ethyl formate followed by LiAlH<sub>4</sub> reduction to generate mono <i>N</i>-methylamino analogs <b>2-7a</b> and <b>2-7b</b> in 27 and 41% yield, respectively. Acetylation of these <i>N</i>-methylated harmine analogs using acetic anhydride and trimethylamine similarly afforded acetamides <b>2-8a</b> and <b>2-8b</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 9-<i>N-</i>Substituted Harmine Analog<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH (2 equiv), Br(CH<sub>2</sub>)<i><sub>n</sub></i>CO<sub>2</sub>R (2 equiv), DMF, 50 °C, 12 h, 21–82%; (b) 7 N NH<sub>3</sub> in MeOH (20 equiv), 90 °C, 12 h, 40–100%; (c) 4 N HCl in dioxane, rt, 12 h, 60–100%; (d) Et<sub>3</sub>SiH (8 equiv), Pd-C, MeOH, rt, 1 h, 6–64% (2 steps); (e) NaH (2 equiv), Br(CH<sub>2</sub>)<i><sub>n</sub></i>NHPhth (2 equiv) (for <b>2-1m</b> and <b>2-1n</b>) and Br(CH<sub>2</sub>)<sub>3</sub>NHBoc (2 equiv) (for <b>2-1o</b>), DMF, 50 °C, 12 h, 60–84%; (f) hydrazine monohydrate (20 equiv), MeOH, reflux, 3 h, 34–36%; (g) acetic anhydride (1 equiv), Et<sub>3</sub>N (2.2 equiv), DCM, rt, 12 h, 38–63%; (h) (i) ethylformate (0.5 equiv), EtOH, microwave, 150 °C, 30 min; (ii) LiAlH<sub>4</sub> (3 equiv), THF, reflux, 4 h, 27–41%.</p></p></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationship Studies of Harmine Analogs</h3><div class="NLM_p">Harmine is considered as a type-I DYRK1A inhibitor that binds to the canonical ATP binding pocket. The compound forms two hydrogen bonding interactions with both the side chain of Lys188 and backbone Leu241 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Based on the known binding pose of harmine, we surmised that there are three positions, 1-methyl, 7-methoxy, and 9-<i>N</i> indole where rational modifications of harmine can be carried out (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We sought to identify novel harmine-based DYRK1A inhibitors with equal or improved DYRK1A activity and human β-cell proliferation while also increasing kinase and other off-target selectivity as compared to harmine. Such optimized harmine analogs are expected to serve as more selective in vivo chemical probe DYRK1A inhibitors for β-cell proliferation. A DYRK1A inhibitor optimized for this type of diabetes application would also have potential for conjugation to prototype carriers, such as GLP1 analogs, for β-cell-targeted therapy. In our earlier work,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> modifications of the 1-position in harmine was explored (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) to provide compounds with an improved β-cell proliferation ability. However, opportunities for further improvements to provide more advanced in vivo chemical probes were limited. Similarly, 7-position optimization of harmine was carried out but the majority of 7-substituted analogs demonstrate that these harmine modifications do not result in DYRK1A inhibitors superior in potency to harmine.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Subsequently, we continued the harmine SAR studies for optimization through additional systematic structural modifications at its 9-<i>N-</i>positions while retaining the 1-position methyl and 7-position methoxy groups as shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Substituents explored for optimization of the 9-<i>N-</i>position of harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> SAR Studies of 9-<i>N</i>-Harmine Analogs</h3><div class="NLM_p">Modifications of the 9-<i>N</i>-position of harmine were studied by introducing substituents bearing terminal methyl ester (<b>2-1a</b> to <b>2-1l</b>), carboxamide (<b>2-2a</b> to <b>2-2f</b>), carboxylic acid (<b>2-3a</b> to <b>2-3g</b>), and amino/substituted amino (<b>2-1q</b>, <b>2-5</b>, <b>2-6</b>, <b>2-7</b>, and <b>2-8</b>) functional groups with varying chain lengths of 1–5 carbons (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Gratifyingly, modifications at the 9-<i>N-</i>position nitrogen were generally more well tolerated to retain potent DYRK1A inhibition as compared to changes at harmine’s 7-position.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Several analogs were found to show similar or occasionally better DYRK1A inhibitory activity as compared to harmine (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Among all the analogs with terminal methyl esters (<b>2-1a</b> to <b>2-1e</b>, <b>2-1k</b>, and <b>2-1l</b>), compounds <b>2-1c</b>, <b>2-1k</b>, and <b>2-1l</b> containing a 3-carbon chain length exhibited the most potent DYRK1A inhibition with IC<sub>50</sub> in the range of 13–27 nM. The carbon chain length significantly impacted DYRK1A binding; decreasing to 1 or 2 carbon atom linkers or increasing to 4 and 5 carbon atom linkers reduced the DYRK1A inhibitory activity. These data suggest that a 3-carbon atom chain length is optimal for added pharmacophores to retain DYRK1A inhibition activity at the 9-<i>N</i>-position. Compounds bearing terminal carboxylic acids (<b>2-3a</b> to <b>2-3g</b>) at the 9-<i>N</i>-position were detrimental to DYRK1A activity regardless of the carbon chain length. The docking studies of these novel harmine analogs <b>2-3a</b> to <b>2-3g</b> to the crystal structure of DYRK1A bound to harmine analog <b>2-2c</b> (vide infra) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>) suggest that a carboxylic acid functional group is disfavored because of the highly negative electrostatic environment in the ATP binding site (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Figure S1B</a>). In contrast, harmine analogs with carboxamide functional groups behaved similarly to those analogs bearing terminal methyl esters. For example, compounds <b>2-2c</b> and <b>2-2f</b> with a 3-carbon chain length to this pharmacophore exhibited potent DYRK1A inhibitory activity with IC<sub>50</sub> values in the range of 14–25 nM, comparable or better than that of the parent harmine. This further confirmed that a 3-carbon chain length to new pharmacophores at the 9-<i>N</i>-position is optimal for the DYRK1A binding activity. With the knowledge that a 3-carbon chain length is critical to DYRK1A activity, we synthesized several harmine analogs with terminal amino/substituted amino moieties to investigate the effect of these groups on DYRK1A activity. Comparison of the two harmine analogs <b>2-5a</b> and <b>2-5b</b> bearing a terminal amino group, with <b>2-5b</b> having a 3-carbon chain length, demonstrated better IC<sub>50</sub> = 152 nM (as compared to <b>2-5a</b>) although it is ∼5-fold less active than harmine. When the basic amino group was replaced with an <i>N</i>-BOC amino group (<b>2-1o</b>), the activity improved ∼4-fold, comparable to that of harmine, in spite of the sterically demanding <i>t</i>-butyl group. A similar trend in activity was observed wherein methylamino-substituted harmine analogs <b>2-7a</b> and <b>2-7b</b> had poor activity as compared to those bearing an acetamido group (<b>2-6a</b> and <b>2-6b</b>). The DYRK1A inhibitory activity of these compounds (<b>2-7a</b> and <b>2-7b</b>) is partially or fully recovered for the related acetylated analogs <b>2-8a</b> and <b>2-8b</b>. These results indicate that non-basic substituted <i>N</i>-BOC-amino or acetamido groups have improved DYRK1A binding activity as compared to their basic amino analogs. For example, primary amine and methylamine-substituted harmine analogs (with the exception of <b>2-1o</b>) were inferior to analogs <b>2-1c</b>, <b>2-1k</b>, and <b>2-1l</b> (3-carbon methyl ester) and <b>2-2c</b>, <b>2-2f</b>, and <b>2-2g</b> (3-carbon carboxamide) harmine analogs. Based on the docking studies of these 9-<i>N</i>-harmine analogs, which is later confirmed by the co-crystal structure of <b>2-2c</b> bound to DYRK1A (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), we can safely conclude that the activity of these compounds is due to their ability to effectively hydrogen-bond to the side chain of Asn 244 and the backbone of Glu 291 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Figure S1A</a>). It appears that the hydrogen bonding to Asn 244 is the stronger interaction.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. DYRK1A Inhibition of 9-<i>N</i>-Harmine Analogs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0004.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0001.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are determined using 10 serial three-fold dilutions (<i>N</i> = 2 independent experiments)</p></div></div><div></div></div><div class="NLM_p last">These results demonstrate that modifications at the indole nitrogen are well tolerated for non-ionizable H-bonding pharmacophores and consistent with the following considerations: (1) the available space as indicated by the crystal structure of harmine bound to DYRK1A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>) and (2) the new hydrogen bond(s) made by several analogs (i.e., <b>2-2c</b>) to the side chain of Asn 244 and/or the backbone of Glu 291. In addition, harmine analogs bearing terminal methyl ester or carboxamide with a 3-carbon chain exhibit the best DYRK1A inhibitory activity among these 9-<i>N</i>-harmine analogs with several analogs comparable to harmine. We next explored the structure–activity relationships of identified potent DYRK1A inhibitor harmine analogs for in vitro β-cell proliferation activity. Those with significant β-cell proliferation were then studied for selectivity against kinase and known harmine CNS off-targets.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effects of Harmine Analogs on Human β-Cell Proliferation</h3><div class="NLM_p">We next explored the structure–activity relationships of the most potent DYRK1A inhibitor 9-<i>N</i>-harmine analogs for in vitro β-cell proliferation activity. Twenty compounds with DYRK1A inhibitory activity (IC<sub>50</sub> < 200 nM) were studied for their ability to induce human β-cell proliferation in vitro as assessed by Ki67–insulin co-immunolabeling<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Among these new harmine analogs, <b>2-2c</b>, <b>2-2d</b>, <b>2-2f</b>, <b>2-1k</b>, and <b>2-1l</b> exhibited in vitro human β-cell proliferation at a single screening concentration of 10 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,</a>B). Dose–response experiments for these active analogs indicated that <b>2-2c</b>, <b>2-2f</b>, and <b>2-1k</b> were found to be more potent than harmine, exhibiting maximal proliferation rates at 3 μM. This is ∼3-fold lower than that of harmine’s maximal proliferative dose (10 μM).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, these analogs inhibited proliferation at 30 μM. It should be noted that the harmine dose–response curve is identical to that of <b>2-2d.</b><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Compounds <b>2-2d</b> and <b>2-1k</b> behaved identically to harmine, with maximal proliferation at 10 μM, and, like harmine, inhibited proliferation at higher doses.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Since DYRK1A inhibitors mediate β-cell proliferation in part via induction of cytoplasmic-to-nuclear translocation of the NFAT transcription factor family,<a onclick="showRef(event, 'ref5 ref49'); return false;" href="javascript:void(0);" class="ref ref5 ref49">(5,49)</a> we also explored NFaT translocation for this new series of compounds. Notably, compounds <b>2-2c</b>, <b>2-2d</b>, <b>2-2f</b>, <b>2-1k</b>, and <b>2-1l</b> induced NFAT2-GFP nuclear translocation in the mouse R7T1 insulinoma cell line, as had been observed for harmine (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D,</a>E).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of harmine and new analogs on human β-cell proliferation. (A) Initial screening of harmine analogs on human β-cell proliferation at 10 μM. DMSO was used as a negative control, and harmine was used as a positive control (<i>N</i> = 3 independent experiments with different human islet donors for each compound). (B) Representative example from (A) of Ki67–insulin double-positive cells induced by <b>2-2c.</b> (C) Dose–response curves for human β-cell proliferation for <b>1-2b</b>, <b>2-2c</b>, <b>2-2d</b>, <b>2-2f</b>, <b>2-1k</b>, and <b>2-1l</b> in human β cells (<i>N</i> = 3 independent experiments with different human islet donors for each dose); harmine (10 μM) is the positive control. Dosage: 1, 3, 10, and 30 μM. Abbreviation H = harmine, D = DMSO. (D) Quantitation of nuclear frequency of NFATC1-GFP in the R7T1 mouse insulinoma cell line treated with the compounds that showed proliferation in human islets. DMSO was used as a negative control, and harmine was used as a positive control (10 μM, 24 h; <i>N</i> = 3 independent experiments for each compound). (E) Representative example of <b>2-2c</b> (10 μM, 24 h), increasing the nuclear frequency of NFATC1-GFP in R7T1 rodent β-cells. (F) Effects in human islets of DMSO or <b>2-2c</b> treatment as in (A) on mRNA expression of four canonical markers of β-cell differentiation, <i>INS, PDX1</i>, <i>NKX6.1</i>, and <i>MAFA</i>, in three different human islet preparations (<i>N</i> = 3 independent experiments). Error bars indicate SEM and * indicates <i>P</i> < 0.05. A minimum of 1000 β-cells was counted for each graph. In all relevant panels, error bars indicate SEM and * indicates <i>P</i> < 0.05. A minimum of 1000 β-cells was counted for each graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Harmine Analog <b>2-2c</b> Enhances β-Cell Proliferation as Well as Differentiation</h3><div class="NLM_p">Analog <b>2-2c</b>, which contains an optimal 3-carbon linker to a carboxamide, was selected for detailed study since it displayed the best combination of potent DYRK1A kinase inhibition and cell-based bioactivity (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S2</a>). <b>2-2c</b> induced proliferation at ∼2 to 3 fold lower concentration (3–5 μM) in both rat and human β-cells, achieving proliferation rates similar to that of harmine at 10 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Figure S2A–D</a>).</div><div class="NLM_p last">To address the theoretical concern that the activation of mitogenic pathways might lead to de-differentiation of β-cells, we next examined the expression of four canonical markers of β-cell differentiation: the insulin gene (<i>INS</i>) and three essential β-cell transcription factors, <i>PDX1</i>, <i>NKX6.1</i>, and <i>MAFA</i> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F). Reassuringly, <b>2-2c</b> not only failed to induce de-differentiation at 5 μM, it actually enhanced expression of all four key β-cell differentiation markers, as had been observed for harmine itself at 10 μM.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Collectively, these findings indicate that <b>2-2c</b> is a potent DYRK1A inhibitor with <i>K</i><sub>d</sub> comparable to harmine for this kinase, which can induce human β-cell proliferation at 3-fold lower concentrations while maintaining or improving β-cell differentiation.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Harmine Analog <b>2-2c</b> Extends into the Far Side of the Active Site Where the Ribose Binds</h3><div class="NLM_p">In order to understand the binding mode of <b>2-2c</b> to DYRK1A, we obtained an X-ray crystal structure of <b>2-2c</b> bound to DYRK1A <b>(</b><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S1</a><b>)</b>. The compound co-crystallized with DYRK1A yielding a clear density for the inhibitor upon refinement. The refined structure contains four copies of DYRK1A in the asymmetric unit. As seen in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Figure S3</a>, the electron density from the <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> omit map shows unambiguously the alkyl chain of <b>2-2c</b> extending out from the harmine scaffold. The compound makes several polar contacts to the kinase, as seen in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B. Compound <b>2-2c</b> makes the previously described contacts for the harmine scaffold to the Leu241 backbone in the hinge and the Lys188 side chain. In addition, it was observed that the carboxamide moiety of <b>2-2c</b> makes two new additional contacts at the end of the alkyl chain with the DYRK1A protein. In chain D (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), the density suggests bidentate contacts of the <b>2-2c</b> carboxamide to the Glu291 backbone and Asn244 side chain not previously observed for harmine. In chain A, it is likely making contact with the Asn244 side chain alone, suggesting some flexibility in the <b>2-2c</b> carboxamide moiety. Interestingly, this part of the pocket is normally unoccupied in the harmine structure but overlays with the ATP binding pocket. When the structure of ATP bound to PKA is overlaid (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), it is clear that the displaced water and the alkyl chain line up with the ribose of ATP. Therefore, this binding mode indicates that the carboxamide could make similar contacts to that of the ATP ribose, which is stabilized by a contact to the side chain and backbone carbonyl of Glu291 in the PKA structure. This suggests that <b>2-2c</b> is taking advantage of the ribose binding pocket that is previously occupied by water molecules when harmine is bound. Based on the X-ray crystal structure of <b>2-2c</b> bound to DYRK1A, one can conclude that some of the greater DYRK1A inhibitory activity of this and related compounds is due to their ability to make new hydrogen bonds to the side chain of Asn244 and the backbone of Glu291.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of compound <b>2-2c</b> bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>). (A) Overlay of harmine (cyan) with the crystal structure of <b>2-2c</b> (yellow) bound to DYRK1A. The previously published harmine structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>) was superimposed on the new <b>2-2c</b> structure. (B) Contacts of <b>2-2c</b> are shown, including the new contacts of the amide of <b>2-2c</b> to the Glu291 backbone and the Asn244 side chain of chain D, along with the hinge binding and Lys188 previously seen in harmine. (C) Overlay of the <b>2-2c</b> structure and ATP. Using the structure of ATP bound to PKA (4DH3),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> the ATP position was superimposed onto DYRK1A, showing the overlapping areas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Kinome Scan Profile</h3><div class="NLM_p">Since harmine is known to exhibit varying degrees of inhibition for kinases other than DYRK1A,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we explored the full kinome profile (468 kinases) of compounds <b>2-2c,</b> harmine, and compound <b>I</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> at 10 μM to understand their kinome selectivity profiles (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Note that for <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, results are shown only for kinases for which activities <20% remain of the 468 kinases screened (full data sets in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S2</a>). Harmine inhibited 17 kinases at 10 μM (<20% activity remaining) in addition to DYRK1A, similar to earlier reports.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In comparison, compound <b>2-2c</b> exhibited a cleaner kinome profile, with <20% activity remaining against only 12 kinases in addition to DYRK1A. Importantly, compound <b>2-2c</b> showed reduced inhibition against CSNK1A1, CSNK1D, CSNK1E, CSNK1G2, CSNK2A1, IRAK1, and VPS3 as compared to harmine and showed inhibition greater than harmine only for PIK3CG (13 vs 49% for <b>2-2c</b> and harmine, respectively). Interestingly, the kinome profile of compound <b>2-2c</b> showed similar degrees of selectivity when compared to the previously reported 1-C harmine analog <b>I</b>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> albeit against different kinases. Furthermore, unlike harmine and <b>2-2c</b>, compound <b>I</b> showed lower activity against DYRK1B at 10 μM, supporting the notion that DYRK1B is less important than DYRK1A for human β-cell proliferation. Similarly, in contrast to harmine and compound <b>I</b>, <b>2-2c</b> was a poor inhibitor of the casein kinase family, suggesting that casein kinases are not required for induction of β-cell proliferation by harmine analogs. Collectively, the kinome profile data indicate that compound <b>2-2c</b> has ∼20% improved selectivity (12 vs 17 hits), as compared to harmine, equivalent DYRK1A inhibition, and 3-fold greater potency in vitro for human β-cell proliferation activity. For these reasons, we selected <b>2-2c</b> as the lead compound for further characterization.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome scan data of compound <b>2-2c</b>, harmine, and compound <b>I</b>. (A) Compounds were screened at 10 μM against 468 kinases using Discoverx kinome scan (<i>N</i> = 2 independent experiments). Results for primary screen binding interactions are reported as “% DMSO Ctrl” where lower values indicate stronger affinity (see the Supporting Information for details). (B) TreeSpot interaction map for harmine and compound <b>2-2c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Improved in Vitro CNS off-Target Activity</h3><div class="NLM_p">As noted above, harmine-containing plant extracts are psychoactive, an effect that has been attributed to interactions with CNS receptors for serotonin, tryptamine, and related targets. These effects limit the utility of harmine for therapeutic use in chronic diseases such as diabetes. Therefore, we next explored the CNS off-target profile of <b>2-2c</b> at 10 μM against a panel of known harmine and closely related CNS off-targets (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S3</a>). In comparison to harmine, <b>2-2c</b> was far more selective, showing no binding activity against any of these receptors, with activity observed only against monoamine oxidase A (MAO-A) at the testing concentration. Collectively, these data, together with the kinome scan data, illustrate that systematic modification of harmine permits retention of its positive attributes and separation from its translational liabilities. Compound <b>2-2c</b> displays both improved kinase and superior CNS off-target profiles as compared to harmine while maintaining potent DYRK1A inhibition and β-cell proliferative activity.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro and in vivo CNS off-target activity of compound <b>2-2c</b>. (A) Percent inhibition of a selected panel of CNS off-targets (known for harmine) at 10 μM of compound <b>2-2c</b> and harmine. <i>N</i> = 2 independent experiments. (B) Brain plasma ratio of compound <b>2-2c</b> in CD-1 mice after oral dosing at 30 mg/kg. (C) Effects of compound <b>2-2c</b> and harmine in the induction of tremor in mice. Representatives of snapshots from the video of 12 week-old C57BL6/N male mice that received i.p. injections of either (a) saline, (b) harmine 10 mg/kg, and (c) compound <b>2-2c</b> 30 mg/kg. Mice were analyzed for 15 min after injection (video attached as supplementary material).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo CNS Effects of Harmine and <b>2-2c</b></h3><div class="NLM_p">Tremor and hyperactivity are hallmarks of CNS hyperexcitability in murine models. Therefore, we next analyzed whether tremor and mouse movement were different following intraperitoneal (i.p.) administration of saline, harmine, and compound <b>2-2c</b> in 12 week-old male C57BL6N mice. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>Ca and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_003.mov" class="ext-link">Movie S1</a>, mice injected with saline showed normal exploratory and grooming activity and frequent normal alterations in cage position. As previously reported,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> i.p. administration of harmine at 10 mg/kg produced tremor and hyperactivity that lasted 5–15 min (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>Cb, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov" class="ext-link">Movie S2</a>). The tremor was present both at rest and during movement and was accompanied by the Straub tail phenomenon and hunched-back posture, both CNS excitatory signs,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> but mice were able to ambulate normally (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>Cb, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov" class="ext-link">Movie S2</a>). Gratifyingly, despite i.p. administration of large doses, 10 or even 30 mg/Kg, <b>2-2c</b> did not produce tremor, motor alterations, or Straub tail phenomenon and their overall behavior was indistinguishable from the saline-treated mice during the 15 min observation period (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>Cc, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_005.mov" class="ext-link">Movie S3</a>). Thus, compound <b>2-2c</b> eliminated off-target CNS behavioral effects as compared to harmine, both at equal and a three-fold higher dose.</div><div class="NLM_p last">Compound <b>2-2c</b> was next tested for brain penetration in CD-1 mice after oral dosing at 30 mg/kg. Compound <b>2-2c</b> displayed a low brain/plasma ratio of 0.2–0.4 (at 15–30 min, respectively) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Figure S4, and Tables S4–S6</a>), far lower than the brain/plasma ratio of 9 to 10 for harmine, at the same 30 mg/kg i.p. dose.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Thus, <b>2-2c</b> avoids the off-target CNS activity exhibited by harmine in two ways: by reducing activity at relevant CNS targets and by its decreased brain penetration in vivo.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Administration of Compound <b>2-2c</b> Enhances Mouse and Human β-Cell Replication and β-Cell Mass Expansion</h3><div class="NLM_p">The in vitro Ki67 assays described thus far may or may not translate into actual increases in β-cell numbers. To assess the ability of compound <b>2-2c</b> to unequivocally enhance mouse and human β-cell proliferation and augment β-cell mass, we used three different in vivo animal models.<a onclick="showRef(event, 'ref5 ref58'); return false;" href="javascript:void(0);" class="ref ref5 ref58">(5,58)</a></div><div class="NLM_p">In the first model, we explored whether compound <b>2-2c</b> increases β-cell Ki67 immunolabeling in vivo. We used progressively increasing daily i.p. doses of compound <b>2-2c</b> or harmine over 7 days in C57BL6N mice and measured Ki67 labeling of pancreatic β-cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, increasing doses of compound <b>2-2c</b> robustly enhanced Ki67 β-cell labeling, with maximally effective doses at 1 and 3 mg/kg. In the same experiments, as reported previously,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> harmine also increased mouse β-cell replication comparably, but required higher doses of 6 and 10 mg/kg i.p., respectively (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). These results indicate that compound <b>2-2c</b> is more potent than harmine in inducing mouse β-cell replication in vivo.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compound <b>2-2c</b> in three in vivo models of β-cell replication and regeneration. (A) Representative images (<i>n</i> = 10–20 images per animal) of Ki67 immunolabeling of β-cells in 12 week-old C57BL6N male mice receiving daily i.p. injections of either saline or different doses of compound <b>2-2c</b> and harmine for 7 days. (B) Quantification of Ki67 labeling of β-cells in saline and compound <b>2-2c</b>-treated mice, with 6 to 12 mice in each group. *<i>P</i> < 0.05 vs saline. (C) Quantification of Ki67 labeling of β-cells in saline- and harmine-treated mice, with four mice in each group. *<i>P</i> < 0.05 vs saline. (D) Quantification of Ki67 labeling of β-cells in 12 week-old C57BL6N male mice receiving sham operation or partial pancreatectomy (PPx) and treated daily i.p. injections of either saline or compound <b>2-2c</b> for 7 days, with five to six mice in each group. *<i>P</i> < 0.05. (E) Quantification of β-cell mass in saline- and compound <b>2-2c</b>-treated mice receiving sham operation or PPx and either saline or compound <b>2-2c</b> for 7 days, with five to six mice in each group. *<i>P</i> < 0.05. (F) Representative images of Ki67 immunolabeling of human β-cells in islet grafts transplanted under the kidney capsule of immunodeficient mice receiving daily injections of either saline, <b>2-2c</b>, or harmine for 7 days. (G) Quantification of Ki67 labeling of human β-cells in saline-, <b>2-2c</b>-, and harmine-treated mice, with four different human islet preparations in four mice per treatment. *<i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The studies in the first model do not unequivocally prove that increases in Ki67 labeling translate into increases in actual β-cell numbers. Accordingly, we turned to a second in vivo model, a standard partial pancreatectomy (PPX) mouse model, which not only permits assessment of β-cell proliferation markers but also quantifies actual changes in β-cell mass. In this model, mice undergo a 60% PPX or a sham-PPX treatment and are then treated with a drug of interest or control vehicle for seven days at which point the pancreas remnant in the PPX mice is harvested and total β-cell mass measured. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D, treatment with compound <b>2-2c</b> (1 mg/kg) again induced β-cell Ki67 labeling in C57BL6N mice, in both sham-operated mice and mice subjected to PPX. The most robust proliferation occurred in the β-cells of compound <b>2-2c</b>-treated PPX mice. Most importantly, restoration of β-cell mass following PPX was substantially more rapid in compound <b>2-2c</b>-treated mice than in the controls, reaching near-normal values in only 7 days (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). It should also be noted that, as expected and reported previously,<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> lower rates of proliferation occurred in the sham-PPX animals but did not translate into an increase in β-cell mass, reflecting the fact that mouse β-cell mass only increases in the presence of PPX, hyperglycemia, or insulin resistance, none of which occurred in the sham animals.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> β-cell mass and glucose homeostasis were normal at the baseline. Taken together, these studies indicate that compound <b>2-2c</b> unequivocally increases mammalian β-cell mass in vivo. Moreover, at the 1 mg/kg dose, it is substantially more effective than the 10-fold higher dose required for efficacy of harmine in this animal model.</div><div class="NLM_p">The first two models used murine β-cells as their endpoint but do not address whether compound <b>2-2c</b> can increase human β-cell proliferation in vivo. Thus, we turned to a third in vivo model in which human islets are transplanted into the renal capsule of immunodeficient mice so that they cannot be rejected. This model permits in vivo assessment of human β-cell proliferation within the human islet grafts in response to drugs of interest. We used the standard euglycemic non-obese diabetic, severe combined immunodeficient (NOD-SCID) mouse model.<a onclick="showRef(event, 'ref5 ref58'); return false;" href="javascript:void(0);" class="ref ref5 ref58">(5,58)</a> As observed previously,<a onclick="showRef(event, 'ref5 ref58'); return false;" href="javascript:void(0);" class="ref ref5 ref58">(5,58)</a> harmine (10 mg/kg) administered i.p. daily for 7 days increased human β-cell Ki67 labeling in the grafts by 2- to 3-fold compared to saline-treated mice (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F,G). Importantly, administration of a 10-fold lower dose of compound <b>2-2c</b> (1 mg/kg) produced an identical increase in human β-cell Ki67 labeling (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F,G).</div><div class="NLM_p last">Collectively, these results indicate that compound <b>2-2c</b> can induce both human and mouse β-cell proliferation in vivo, increases not only markers of β-cell proliferation but also actual β-cell mass, and is 3- to 10-fold more potent than harmine in vivo.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While harmine analogs offer promise in β-cell regenerative approaches to type 1 and type 2 diabetes, they confront two major translational hurdles: (1) suboptimal pharmacological properties, most notably poor selectivity both against other kinases and CNS off-targets, and (2) the widespread tissue distribution of DYRK1A, predicting adverse effects in other tissues of next-generation DYRK1A inhibitors. In the current studies, we have addressed both of these challenges. First, we have overcome kinase and off-target selectivity issues through optimization of the 9-<i>N</i>-position, synthesizing compound <b>2-2c</b>, a novel harmine-based DYRK1A inhibitor with improved kinase and CNS receptor selectivity, and enhanced human β-cell mitogenic efficacy. We note that <b>2-2c</b> likely remains a MAO-A inhibitor. Since MAO-A is present in peripheral tissues, it remains possible in theory that <b>2-2c</b> may elicit undesirable effects outside the CNS via inhibition of MAO-A in peripheral tissues. We also note that although harmine and <b>2-2c</b> display similar DYRK1A IC<sub>50</sub> values, this cannot explain the superior efficacy of <b>2-2c</b> on human β-cell proliferation. We speculate that this may reflect improvement in the off-target profile against uncertain antikinases or other molecules, superior β-cell permeability, longer on-time in DYRK1A, or other as yet uncertain beneficial features.</div><div class="NLM_p">Second, selective harmine analogs such as <b>2-2c</b> demonstrate linkers that may permit attachment to β-cell-specific delivery molecules, which can be chemically linked to the harmine scaffold without diminishing—or even enhancing—human β-cell mitogenic activity and other drug-like properties.</div><div class="NLM_p">With regard to the first challenge, we extensively studied structure–activity relationships of the 9-<i>N</i>-position of harmine. Modifications at the harmine 9-<i>N</i>-position were generally well tolerated. Several 9-<i>N</i>-harmine analogs showed comparable or better DYRK1A inhibitory activity than harmine. Among the 62 compounds synthesized, compound <b>2-2c</b> was the best compound identified in this series. It induced human β-cell proliferation at a 2- to 3-fold lower dosage than harmine in both rat and human islets while maintaining or improving β-cell differentiation. This bodes well for both type 1 and type 2 diabetes therapy where β-cell de-differentiation is known to occur.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> Further, selectivity profiles of <b>2-2c</b>, for both the full kinome panels, indicate that compound <b>2-2c</b> has ∼20% improved kinase selectivity over harmine (with activity at only 12 other kinases in addition to DYRK1A) while retaining similar in vitro β-cell proliferation activity and DYRK1A inhibition and improved β-cell mitogenic potency. Furthermore, the kinome scan selectivity data also support the notion that inhibition of casein kinases is not required for induction of human β-cell proliferation by harmine analogs. Since silencing DYRK1A in human β-cells mimics the proliferative effect of harmine and 5-IT,<a onclick="showRef(event, 'ref5 ref8 ref64'); return false;" href="javascript:void(0);" class="ref ref5 ref8 ref64">(5,8,64)</a> it is presumed that DYRK1A is the principal mitogenic target of harmine and other DYRK1A inhibitors. The kinome scan for compound <b>I</b> also suggests that inhibition of DYRK1B is less important than DYRK1A, but it remains uncertain whether harmine- or <b>2-2c</b>-mediated inhibition of DYRK1B and/or DYRK2 may also contribute to human β-cell proliferation of this class of molecules.</div><div class="NLM_p">When tested in CNS off-target assays, compound <b>2-2c</b> was further selective than harmine, showing no binding activity to eight of the nine CNS-targets for which harmine shows activity, with the sole exception being monoamine oxidase A. This enhanced in vitro CNS selectivity was recapitulated in vivo<i>:</i> supraefficacious doses of <b>2-2c</b> at 10 or even 30 mg/kg in 12 week-old male C57BL6N mice did not produce tremor, motor alterations, or other signs of psychoactivity as observed for harmine at 10 mg/Kg, further confirming the improved CNS tolerability in vivo. In addition, compound <b>2-2c</b> also showed low brain penetration in mice, which may have been influenced by the addition of the polar carboxamide <i>N</i>-pharmacophore. These data indicate improved CNS safety and tolerability for compound <b>2-2c</b> as compared to harmine due to both reduced activity on CNS targets and higher peripheral vs brain exposure of the compound.</div><div class="NLM_p">Three different in vivo animal models were used to assess the ability of compound <b>2-2c</b> to enhance mouse and human β-cell proliferation and augment β-cell mass. In each model, compound <b>2-2c</b> was significantly superior to harmine. In the first model, this was demonstrated by enhanced Ki67 mouse and human β-cell labeling despite lower, maximally effective doses of 1 and 3 mg/kg for <b>2-2c</b>. In comparison, harmine achieved similar rates of mouse β-cell replication although it required 3- to 10-fold higher doses: 6 and 10 mg/kg. In the second model, a partial pancreatectomy (PPX) model, regeneration of β-cell mass was substantially more rapid in the <b>2-2c</b>-treated mice and occurred at a 10-fold lower dose than harmine. In the third model, a standard NOD-SCID immunodeficient mouse model transplanted with human islets, compound <b>2-2c</b> (1 mg/kg) yielded significant human β-cell Ki67 labeling at a 10-fold lower dose than required for harmine. These data collectively point to an approximate 30-fold safety margin (no CNS effects observed at 30 mg/Kg) for behavioral effects in mice as compared to harmine where these are seen at efficacious doses for β-cell proliferation.</div><div class="NLM_p last">In summary, we describe a novel potential lead candidate for in vivo rodent and human β-cell proliferation with improved properties as compared to harmine. Harmine suffers from sub-optimal kinase selectivity and adverse CNS effects in vivo, limiting the ability to become a long-term dosing regimen in animals and a chronic therapeutic indication in humans with diabetes. We have demonstrated that compound <b>2-2c</b>, as compared to harmine, has similar in vitro DYRK1A inhibition activity, with enhanced in vitro selectivity both at CNS targets as well as a full 468 member kinome panel. In addition and importantly, compound <b>2-2c</b> has potent in vitro human β-cell proliferation activity and in vivo efficacy for β-cell proliferation in three different models of diabetes at 10-fold lower doses than harmine. These occur without any observed in vivo behavioral adverse effects, even at 30-fold higher doses than harmine. In a recent study,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> we showed that a combination of harmine with TGF-β inhibitors not only increases Ki67 indices but also increases actual β-cell numbers after only 4 or 7 days of treatment. Like harmine, we expect that this new, non-CNS active compound <b>2-2c</b> will provide an additional advantage for increasing β-cell number and β-cell mass for long-term treatment. In conclusion, through extensive SAR studies and biological characterization, we have identified promising in vivo lead candidate <b>2-2c</b>, which retains the positive attributes of harmine, potent DYRK1A inhibition and in vitro and in vivo β-cell proliferation, while separating its negative liabilities of poor kinase selectivity and untoward in vitro and in vivo CNS effects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthetic Procedure</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Materials and Methods</h4><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were acquired on a Bruker DRX-600 spectrometer at 600 MHz for <sup>1</sup>H and 150 MHz for <sup>13</sup>C. TLC was performed on silica-coated aluminum sheets (thickness of 200 μm) or alumina-coated (thickness of 200 μm) aluminum sheets supplied by Sorbent Technologies, and column chromatography was carried out on a Teledyne ISCO combiflash equipped with a variable wavelength detector and a fraction collector using a RediSep Rf high-performance silica flash column by Teledyne ISCO.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Purity Analysis</h4><div class="NLM_p">LCMS/HPLC analysis for purity and HRMS were conducted on an Agilent Technologies G1969A high-resolution API-TOF mass spectrometer attached to an Agilent Technologies 1200 HPLC system. Samples were ionized by electrospray ionization (ESI) in positive mode. Chromatography was performed on a 2.1 × 150 mm Zorbax 300SB-C18 5-μm column with water containing 0.1% formic acid as solvent A and acetonitrile containing 0.1% formic acid as solvent B at a flow rate of 0.4 mL/min. The gradient program was as follows: 1% B (0–1 min), 1–99% B (1–4 min), and 99% B (4–8 min). The temperature of the column was held at 50 °C for the entire analysis. Purity of the compounds was determined to be >95%.</div><div class="NLM_p last">The chemicals and reagents were purchased from Aldrich Co., Alfa Aesar, Enamine, TCI USA. All solvents were purchased in an anhydrous form from Acros Organics and used without further purification.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for the Synthesis of <b>2-1</b></h3><div class="NLM_p">To a solution of harmine (1 mmol) in DMF (7 mL) was added NaH (2 equiv) and stirred at room temperature for 1 h. To this solution was added alkyl bromide (1.5 equiv) at 50 °C and stirred at that temperature for 12 h. After completion of the reaction confirmed by TLC, the reaction mixture was diluted with water, transferred to a separatory funnel, and extracted with ethyl acetate (50 mL × 2). The organic layer was washed with water, dried over magnesium sulfate, filtered, evaporated, and purified by flash column chromatography using DCM/MeOH (9/1) as the eluent to yield the desired product <b>2-1</b> as a white solid.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(7-Methoxy-1-methyl-β-carbolin-9-yl)acetic Acid Methyl Ester (<b>2-1a</b>)</h4><div class="NLM_p last">White solid. Yield 67%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 4.8 Hz, 1H), 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.86 (d, <i>J</i> = 5.4 Hz, 1H), 7.03 (d, <i>J</i> = 1.2 Hz, 1H), 6.91 (m, 1H), 5.41 (s, 2H), 3.91 (s, 3H), 3.77 (s, 3H), 2.86 (s, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 285.1234, found: 285.1251; purity >95%.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propionic Acid Methyl Ester (<b>2-1b</b>)</h4><div class="NLM_p last">White solid. Yield 81%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 5.4 Hz, 1H), 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.84 (d, <i>J</i> = 4.2 Hz, 1H), 7.10 (s, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 1H), 4.91 (m, 2H), 3.94 (s, 3H), 3.55 (s, 3H), 2.99 (s, 3H), 2.82 (t, <i>J</i> = 7.2 Hz, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 299.1390, found: 299.1384; purity >95%.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butyric Acid Methyl Ester (<b>2-1c</b>)</h4><div class="NLM_p last">White solid. Yield 74%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.11 (d, <i>J</i> = 5.4 Hz, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 1H), 7.84 (d, <i>J</i> = 5.4 Hz, 1H), 7.18 (s, 1H), 6.90 (m, 1H), 4.61 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.64 (s, 3H), 3.00 (s, 3H), 2.47 (t, <i>J</i> = 6.6 Hz, 2H), 2.10 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 313.1547, found: 313.1556; purity >95%.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-(7-Methoxy-1-methyl-β-carbolin-9-yl)pentanoic Acid Methyl Ester (<b>2-1d</b>)</h4><div class="NLM_p last">White solid. Yield 79%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.08 (d, <i>J</i> = 5.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.81 (d, <i>J</i> = 5.4 Hz, 1H), 7.03 (d, <i>J</i> = 1.8 Hz, 1H), 6.85 (m, 1H), 4.52 (t, <i>J</i> = 8.4 Hz, 2H), 3.93 (s, 3H), 3.60 (s, 3H), 2.96 (s, 3H), 2.37 (t, <i>J</i> = 7.2 Hz, 2H), 1.80 (m, 2H), 1.70 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 327.1703, found: 327.1715; purity >95%.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-(7-Methoxy-1-methyl-β-carbolin-9-yl)hexanoic Acid Methyl Ester (<b>2-1e</b>)</h4><div class="NLM_p last">White solid. Yield 82%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.08 (d, <i>J</i> = 5.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.81 (d, <i>J</i> = 5.4 Hz, 1H), 7.00 (d, <i>J</i> = 1.8 Hz, 1H), 6.87 (m, 1H), 4.50 (t, <i>J</i> = 7.8 Hz, 2H), 3.92 (s, 3H), 3.59 (s, 3H), 2.94 (s, 3H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 1.78 (m, 2H), 1.64 (m, 2H), 1.40 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 341.1860, found: 341.1841; purity >95%.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(7-Methoxy-1-methyl-β-carbolin-9-yl)acetic Acid <i>t</i>-Butyl Ester (<b>2-1f</b>)</h4><div class="NLM_p last">White solid. Yield 100%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.13 (d, <i>J</i> = 5.4 Hz, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 1H), 7.86 (d, <i>J</i> = 4.8 Hz, 1H), 7.03 (bs, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 5.30 (s, 2H), 3.92 (s, 3H), 2.89 (s, 3H), 1.42 (s, 9H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 327.1703, found: 327.1715; purity >95%.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propionic Acid <i>t</i>-Butyl Ester (<b>2-1g</b>)</h4><div class="NLM_p last">White solid. Yield 21%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.17 (d, <i>J</i> = 4.8 Hz, 1H), 8.09 (d, <i>J</i> = 9 Hz, 1H), 7.88 (d, <i>J</i> = 5.4 Hz, 1H), 7.23 (d, <i>J</i> = 2.4 Hz, 1H), 6.88 (m, 1H), 4.84 (t, <i>J</i> = 7.8 Hz, 2H), 3.90 (s, 3H), 2.95 (s, 3H), 2.71 (t, <i>J</i> = 7.2 Hz, 2H), 1.23 (s, 9H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]+ calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 341.1860, found: 341.1886; purity >95%.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butyric Acid <i>t</i>-Butyl Ester (<b>2-1h</b>)</h4><div class="NLM_p last">White solid. Yield 82%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 5.4 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 5.4 Hz, 1H), 7.24 (d, <i>J</i> = 2.4 Hz, 1H), 6.88 (m, 1H), 4.55 (t, <i>J</i> = 7.8 Hz, 2H), 3.91 (s, 3H), 2.94 (s, 3H), 2.35 (t, <i>J</i> = 6.6 Hz, 2H), 1.94 (m, 2H), 1.38 (s, 9H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 355.2016, found: 355.2016; purity >95%.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-(7-Methoxy-1-methyl-β-carbolin-9-yl)pentanoic Acid <i>t</i>-Butyl Ester (<b>2-1i</b>)</h4><div class="NLM_p last">White solid. Yield 80%. <sup>1</sup>H-NMR (600 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J</i> = 5.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (d, <i>J</i> = 5.4 Hz, 1H), 6.89 (d, <i>J</i> = 1.8 Hz, 1H), 6.87 (m, 1H), 4.48 (t, <i>J</i> = 7.8 Hz, 2H), 3.96 (s, 3H), 3.02 (s, 3H), 2.28 (t, <i>J</i> = 7.2 Hz, 2H), 1.86 (m, 2H), 1.72 (m, 2H), 1.41 (s, 9H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>+: 369.2173, found: 369.2173; purity >95%.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-(7-Methoxy-1-methyl-β-carbolin-9-yl)hexanoic Acid <i>t</i>-Butyl Ester (<b>2-1j</b>)</h4><div class="NLM_p last">White solid. Yield 76%. <sup>1</sup>H-NMR (600 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J</i> = 5.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (d, <i>J</i> = 5.4 Hz, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 1H), 6.84 (d, <i>J</i> = 1.8 Hz, 1H), 4.46 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.01 (s, 3H), 2.21 (t, <i>J</i> = 7.2 Hz, 2H), 1.84 (m, 2H), 1.64 (m, 2H), 1.41 (m, 11H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 383.2329, found: 383.2329; purity >95%.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Methyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butyric Acid Methyl Ester (<b>2-1k</b>)</h4><div class="NLM_p last">White solid. Yield 72%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.09 (d, <i>J</i> = 4.8 Hz, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.81 (d, <i>J</i> = 5.4 Hz, 1H), 7.06 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (m, 1H), 4.50 (m, 2H), 3.94 (s, 3H), 3.66 (s, 3H), 2.95 (s, 3H), 2.65 (m, 1H), 2.12 (m, 1H), 1.87 (m, 1H), 1.23 (d, <i>J</i> = 7.2 Hz, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 327.1703, found: 327.1703; purity >95%.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2,2-Dimethyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butyric Acid Methyl Ester (<b>2-1l</b>)</h4><div class="NLM_p last">White solid. Yield 68%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 4.8 Hz, 1H), 8.11 (d, <i>J</i> = 9 Hz, 1H), 7.88 (d, <i>J</i> = 4.8 Hz, 1H), 7.04 (s, 1H), 6.90 (d, <i>J</i> = 9 Hz, 1H), 4.49 (t, <i>J</i> = 8.4 Hz, 2H), 3.92 (s, 3H), 3.72 (s, 3H), 2.95 (s, 3H), 1.92 (t, <i>J</i> = 8.4 Hz, 1H), 1.30 (s, 6H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 341.1860, found: 341.1860; purity >95%.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propyl)phthalimide (<b>2-1m</b>)</h4><div class="NLM_p last">White solid. Yield 60%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.08 (d, <i>J</i> = 5.4 Hz, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 1H), 7.83–7.78 (m, 5H), 7.02 (d, <i>J</i> = 2.4 Hz, 1H), 6.85 (m, 1H), 4.64 (t, <i>J</i> = 7.8 Hz, 2H), 3.88 (s, 3H), 3.84 (t, <i>J</i> = 7.8 Hz, 2H), 2.92 (s, 3H), 2.24 (m, 2H); MS (ESI) <i>m/z</i> 400.71 (M + H)<sup>+</sup> .</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butyl)phthalimide (<b>2-1n</b>)</h4><div class="NLM_p last">White solid. Yield 84%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.09 (d, <i>J</i> = 5.4 Hz, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.83 (m, 6H), 7.11 (s, 1H), 6.86 (d, <i>J</i> = 9.6 Hz, 1H), 4.64 (m, 2H), 3.95 (s, 3H), 3.73 (m, 2H), 2.97 (s, 3H), 1.87 (m, 4H); MS (ESI) <i>m/z</i> 414.23 (M + H)<sup>+</sup> .</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propyl <i>tert-</i>Butyl Carbamate (<b>2-1o</b>)</h4><div class="NLM_p last">White solid. Yield 60%. <sup>1</sup>H-NMR (600 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J</i> = 5.4 Hz, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (d, <i>J</i> = 4.8 Hz, 1H), 6.90 (m, 2H), 4.54 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.22 (m, 2H), 3.04 (s, 3H), 2.02 (t, <i>J</i> = 7.8 Hz, 2H), 1.44 (s, 9H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>: 370.2125, found: 370.2130; purity >95%.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure for the Synthesis of <b>2-2</b></h3><div class="NLM_p">A solution of <b>2-1a</b> to <b>2-1e</b> and <b>2-1k</b> (0.175 mmol) and 7 N ammonia in methanol (4 mL) in a sealed pressure vessel was stirred at 90 °C for 12 h. After the completion of the reaction, the mixture was evaporated and purified by flash column chromatography using DCM/MeOH/ammonia (90/9/1) as the eluent to give the desired final compound <b>2-2</b> as a white solid.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(7-Methoxy-1-methyl-β-carbolin-9-yl)acetamide (<b>2-2a</b>)</h4><div class="NLM_p last">White solid. Yield 100%. <sup>1</sup>H-NMR (600 MHz, <i>d<sub>6</sub></i>-DMSO): δ 8.15 (d, <i>J</i> = 5.4 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 4.8 Hz, 1H), 7.71 (s, 1H), 7.35 (s, 1H), 7.15 (d, <i>J</i> = 1.8 Hz, 1H), 6.87 (m, 1H), 5.18 (s, 2H), 3.88 (s, 3H), 2.85 (s, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 270.1237, found: 270.1246; purity >95%.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propionamide (<b>2-2b</b>)</h4><div class="NLM_p last">White solid. Yield 100%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 4.8 Hz, 1H), 8.08 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 5.4 Hz, 1H), 7.41 (s, 1H), 7.23 (d, <i>J</i> = 1.8 Hz, 1H), 6.96 (s, 1H), 6.87 (m, 1H), 4.78 (t, <i>J</i> = 7.2 Hz, 2H), 3.90 (s, 3H), 2.97 (s, 3H), 2.57 (t, <i>J</i> = 7.8 Hz, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 284.1394, found: 284.1403; purity >95%.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butanamide (<b>2-2c</b>)</h4><div class="NLM_p last">White solid. Yield 99%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 4.8 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 4.8 Hz, 1H), 7.36 (s, 1H), 7.28 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (s, 1H), 6.86 (m, 1H), 4.53 (t, <i>J</i> = 7.8 Hz, 2H), 3.91 (s, 3H), 2.95 (s, 3H), 2.19 (t, <i>J</i> = 7.2 Hz, 2H), 1.94 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 298.1550, found: 298.1559; purity >95%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(7-Methoxy-1-methyl-β-carbolin-9-yl)pentanamide (<b>2-2d</b>)</h4><div class="NLM_p last">White solid. Yield 99%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 4.8 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 4.8 Hz, 1H), 7.26 (s, 1H), 7.19 (d, <i>J</i> = 1.8 Hz, 1H), 6.87 (m, 1H), 6.73 (s, 1H), 4.54 (t, <i>J</i> = 7.8 Hz, 2H), 3.90 (s, 3H), 2.94 (s, 3H), 2.10 (t, <i>J</i> = 7.2 Hz, 2H), 1.70 (m, 2H), 1.59 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 312.1707, found: 312.1709; purity >95%.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-(7-Methoxy-1-methyl-β-carbolin-9-yl)hexanamide (<b>2-2e</b>)</h4><div class="NLM_p last">White solid. Yield 80%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 5.4 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 4.8 Hz, 1H), 7.22 (s, 1H), 7.17 (d, <i>J</i> = 1.8 Hz, 1H), 6.87 (m, 1H), 6.70 (s, 1H), 4.53 (t, <i>J</i> = 7.8 Hz, 2H), 3.90 (s, 3H), 2.94 (s, 3H), 2.02 (t, <i>J</i> = 7.2 Hz, 2H), 1.72 (m, 2H), 1.53 (m, 2H), 1.36 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 326.1863, found: 326.1867; purity >95%.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Methyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butanamide (<b>2-2f</b>)</h4><div class="NLM_p last">White solid. Yield 40%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.17 (d, <i>J</i> = 4.8 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (bs, 1H), 7.46 (s, 1H), 7.19 (s, 1H), 6.99 (s, 1H), 6.89 (d, <i>J</i> = 7.8 Hz, 1H), 4.52 (m, 1H), 4.40 (m, 1H), 3.91 (s, 3H), 2.96 (s, 3H), 2.46 (m, 1H), 1.96 (m, 1H), 1.72 (m, 1H), 1.11 (d, <i>J</i> = 7.2 Hz, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 312.1707, found: 312.1710; purity >95%.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure for the Synthesis of <b>2-3</b></h3><div class="NLM_p">A solution of <b>2-1f</b> to <b>20-1j</b> (0.18 mmol) and 4 N HCl in dioxane (4 mL) was stirred at room temperature for 24 h. The reaction mixture was evaporated and triturated with diethyl ether to get the desired acid <b>2-3</b> as a white solid.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(7-Methoxy-1-methyl-β-carbolin-9-yl)acetic Acid (<b>2-3a</b>)</h4><div class="NLM_p last">White solid. Yield 91%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.54 (d, <i>J</i> = 6.6 Hz, 1H), 8.41 (d, <i>J</i> = 6.6 Hz, 1H), 8.38 (d, <i>J</i> = 9 Hz, 1H), 7.50 (d, <i>J</i> = 2.4 Hz, 1H), 7.07 (m, 1H), 5.60 (s, 2H), 3.94 (s, 3H), 3.10 (s, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 271.1077, found: 271.1082; purity >95%.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propionic Acid Hydrochloride (<b>2-3b</b>)</h4><div class="NLM_p last">White solid. Yield 60%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.31 (d, <i>J</i> = 6 Hz, 1H), 8.25 (d, <i>J</i> = 9 Hz, 2H), 7.37 (s, 1H), 6.99 (m, 1H), 4.88 (t, <i>J</i> = 7.2 Hz, 2H), 3.95 (s, 3H), 3.10 (s, 3H), 2.82 (t, <i>J</i> = 7.8 Hz, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 285.1234, found: 285.1240; Purity >95%.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butyric Acid Hydrochloride (<b>2-3c</b>)</h4><div class="NLM_p last">White solid. Yield 100%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.53 (d, <i>J</i> = 6.6 Hz, 1H), 8.44 (d, <i>J</i> = 6.6 Hz, 1H), 8.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (s, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 1H), 4.66 (t, <i>J</i> = 7.8 Hz, 2H), 3.98 (s, 3H), 3.18 (s, 3H), 2.44 (t, <i>J</i> = 6.6 Hz, 2H), 2.00 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 299.1390, found: 299.1392; purity >95%.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-(7-Methoxy-1-methyl-β-carbolin-9-yl)pentanoic Acid Hydrochloride (<b>2-3d</b>)</h4><div class="NLM_p last">White solid. Yield 99%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.53 (d, <i>J</i> = 6 Hz, 1H), 8.43 (d, <i>J</i> = 6 Hz, 1H), 8.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (s, 1H), 7.08 (d, <i>J</i> = 7.8 Hz, 1H), 4.68 (t, <i>J</i> = 7.8 Hz, 2H), 3.97 (s, 3H), 3.16 (s, 3H), 2.30 (t, <i>J</i> = 7.2 Hz, 2H), 1.81 (m, 2H), 1.63 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 313.1547, found: 313.1559; purity >95%.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-(7-Methoxy-1-methyl-β-carbolin-9-yl)hexanoic Acid Hydrochloride (<b>2-3e</b>)</h4><div class="NLM_p last">White solid. Yield 100%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.53 (d, <i>J</i> = 6 Hz, 1H), 8.43 (d, <i>J</i> = 6.6 Hz, 1H), 8.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.39 (s, 1H), 7.08 (d, <i>J</i> = 9 Hz, 1H), 4.66 (t, <i>J</i> = 7.8 Hz, 2H), 3.97 (s, 3H), 3.16 (s, 3H), 2.20 (t, <i>J</i> = 7.2 Hz, 2H), 1.79 (m, 2H), 1.56 (m, 2H), 1.41 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 327.1703, found: 327.1714; purity >95%.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-Methyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butyric Acid (<b>2-3f</b>)</h4><div class="NLM_p last">To a solution of harmine (666 mg, 3.14 mmol) in DMF (10 mL) was added NaH (188 mg, 4.71 mmol) and stirred at room temperature for 1 h. To this solution was added benzyl 2-methyl-4-bromobutyrate (1.343 g, 4.71 mmol) at 50 °C and stirred at that temperature for 12 h. After completion of the reaction confirmed by TLC, the reaction mixture was diluted with water, transferred to a separatory funnel, and extracted with ethyl acetate (50 mL × 2). The organic layer was washed with water, dried over magnesium sulfate, filtered, and evaporated to get an off-white solid. To this compound was added 10% palladium on carbon, and the mixture was suspended in methanol (10 mL). Slowly, triethylsilane (10 equiv) was added to the above solution at room temperature. After the addition, the reaction was stirred at room temperature for 1 h. Upon completion of the reaction, the catalyst was filtered over Celite, the filtrate was rotary-evaporated, and the crude was purified by flash column chromatography using DCM/MeOH (9/1) as the eluent to get the desired acid <b>2-3f</b> as a white solid. Yield 64%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.17 (d, <i>J</i> = 4.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (bs, 1H), 7.19 (s, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 1H), 4.55 (t, <i>J</i> = 4.8 Hz, 2H), 3.90 (s, 3H), 2.95 (s, 3H), 2.59 (m, 1H), 2.00 (m, 1H), 1.79 (m, 1H), 1.19 (d, <i>J</i> = 7.2 Hz, 3H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 313.1547, found: 313.1572; purity >95%.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2,2-Dimethyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butyric Acid (<b>2-3g</b>)</h4><div class="NLM_p last">Similar to compound <b>2-3f</b>, 2,2-dimethyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butyric acid <b>(2-3g)</b> was obtained as a white solid. Yield 60%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 5.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 4.8 Hz, 1H), 7.11 (d, <i>J</i> = 1.2 Hz, 1H), 6.89 (m, 1H), 4.51 (t, <i>J</i> = 8.4 Hz, 2H), 3.90 (s, 3H), 2.96 (s, 3H), 1.90 (m, 2H), 1.27 (s, 6H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 327.1703, found: 327.1732; purity >95%.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Synthesis of <b>2-5</b></h3><div class="NLM_p">A solution of <b>2-1m</b> or <b>2-1n</b> (0.12 mmol) and hydrazine monohydrate (20 equiv) in methanol (4 mL) was refluxed for 4 h. After completion of the reaction, the solvent was evaporated and the crude was purified by flash column chromatography using DCM/MeOH/Et<sub>3</sub>N (9:1:0.1) as the eluent to get the desired product <b>2-5</b> as a white solid.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(7-Methoxy-1-methyl-β-carbolin-9-yl)propylamine (<b>2-5a</b>)</h4><div class="NLM_p last">White solid. Yield 36%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.11 (d, <i>J</i> = 5.4 Hz, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 1H), 7.84 (d, <i>J</i> = 5.4 Hz, 1H), 7.10 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (m, 1H), 4.61 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.00 (s, 3H), 2.75 (m, 2H), 1.97 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>O<sup>+</sup>: 270.1601, found: 270.1604; purity >95%.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(7-Methoxy-1-methyl-β-carbolin-9-yl)butylamine (<b>2-5b</b>)</h4><div class="NLM_p last">White solid. Yield 34%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.11 (d, <i>J</i> = 5.4 Hz, 1H), 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.86 (d, <i>J</i> = 5.4 Hz, 1H), 7.08 (d, <i>J</i> = 1.8 Hz, 1H), 6.90 (m, 1H), 4.60 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.00 (s, 3H), 2.67 (t, <i>J</i> = 7.8 Hz, 2H), 1.86 (m, 2H), 1.56 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sup>+</sup>: 284.1757, found: 284.1778; purity >95%.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedure for the Synthesis of <b>2-6</b></h3><div class="NLM_p">To a solution of <b>2-5</b> (0.21 mmol) and DIPEA (1.2 equiv) in methylene chloride (2 mL) was added acetic anhydride (1.1 equiv) at 0 °C and stirred at room temperature for 1 h. The reaction mixture was evaporated and purified by column chromatography using DCM/MeOH (9:1) as the eluent to get the desired product <b>2-6</b> as a white solid.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-Acetyl-3-(7-methoxy-1-methyl-β-carbolin-9-yl)propylamine (<b>2-6a</b>)</h4><div class="NLM_p last">White solid. Yield 47%. <sup>1</sup>H-NMR (600 MHz,CDCl<sub>3</sub>): δ 8.20 (t, <i>J</i> = 6 Hz, 1H), 8.06 (m, 2H), 7.40 (m, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 6.96 (s, 1H), 4.67 (t, <i>J</i> = 8.4 Hz, 2H), 4.01 (s, 3H), 3.52 (m, 5H), 2.16 (m, 2H), 2.08 (s, 3H); HRMS (ESI): m/z [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 312.1707, found: 312.1711; purity >95%.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-Acetyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butylamine (<b>2-6b</b>)</h4><div class="NLM_p last">White solid. Yield 63%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 5.4 Hz, 1H), 8.05 (d, <i>J</i> = 9 Hz, 1H), 7.91 (d, <i>J</i> = 5.4 Hz, 1H), 7.09 (m, 1H), 6.92 (s, 1H), 4.61 (m, 2H), 3.95 (s, 3H), 3.19 (t, <i>J</i> = 7.2 Hz, 2H), 3.00 (s, 3H), 1.95 (s, 3H), 1.84 (m, 2H), 1.58 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 326.1863, found: 326.1881; purity >95%.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure for the Synthesis of <b>2-7</b></h3><div class="NLM_p">A solution of <b>2-5</b> (0.35 mmol) and ethyl formate (0.5 equiv) in ethanol (1 mL) was heated in a CEM microwave at 150 °C for 30 min. After the completion of the reaction, the solvent was evaporated, the crude reaction mixture was dissolved in THF (2 mL), and LiAlH<sub>4</sub> (3 equiv) was added in portions at room temperature. After the addition, the reaction mixture was refluxed for 4 h. The solvent was evaporated and the crude reaction mixture was purified by flash column chromatography using DCM/MeOH (9:1) as the eluent to get the desired product <b>2-7</b> as a white solid.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-Methyl-3-(7-methoxy-1-methyl-β-carbolin-9-yl)propylamine (<b>2-7a</b>)</h4><div class="NLM_p last">White solid. Yield 41%. <sup>1</sup>H-NMR (600 MHz, <i>d</i><sub>6</sub>-DMSO): δ 8.16 (d, <i>J</i> = 6.6 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 5.4 Hz, 1H), 7.24 (d, <i>J</i> = 2.4 Hz, 1H), 6.86 (m, 1H), 4.62 (t, <i>J</i> = 7.8 Hz, 2H), 3.90 (s, 3H), 2.96 (s, 3H), 2.62 (t, <i>J</i> = 7.2 Hz, 2H), 2.34 (s, 3H), 1.90 (t, <i>J</i> = 7.2 Hz, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sup>+</sup>: 284.1757, found: 284.1760; purity >95%.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-Methyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butylamine (<b>2-7b</b>)</h4><div class="NLM_p last">White solid. Yield 27%. <sup>1</sup>H-NMR (600 MHz, CD<sub>3</sub>OD): δ 8.07 (d, <i>J</i> = 5.4 Hz, 1H), 7.96 (d, <i>J</i> = 9 Hz, 1H), 7.78 (d, <i>J</i> = 5.4 Hz, 1H), 6.98 (m, 1H), 6.86 (m, 1H), 4.46 (t, <i>J</i> = 7.8 Hz, 2H), 3.91 (s, 3H), 2.92 (s, 3H), 2.53 (t, <i>J</i> = 7.2 Hz, 2H), 2.31 (s, 3H), 1.78 (s, 2H), 1.54 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>O<sup>+</sup>: 298.1914, found: 298.1912; purity >95%.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> General Procedure for the Synthesis of <b>2-8</b></h3><div class="NLM_p">To a solution of <b>2-7</b> (0.03 mmol) and DIPEA (1.2 equiv) in methylene chloride (1 mL) was added acetic anhydride (1.1 equiv) at 0 °C and stirred at room temperature for 1 h. The reaction mixture was evaporated and purified by column chromatography using DCM/MeOH (9:1) as the eluent to get the desired product <b>2-8</b> as a white solid.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-Acetyl-<i>N</i>-methyl-3-(7-methoxy-1-methyl-β-carbolin-9-yl)propylamine (<b>2-8a</b>)</h4><div class="NLM_p last">White solid. Yield 41%. <sup>1</sup>H-NMR (600 MHz,CDCl<sub>3</sub>): δ 8.27 (d, <i>J</i> = 5.4 Hz, 1H), 7.97 (d, <i>J</i> = 9 Hz, 1H), 7.77 (d, <i>J</i> = 5.4 Hz, 1H), 6.91 (m, 1H), 6.86 (m, 1H), 4.51 (t, <i>J</i> = 7.8 Hz, 2H), 3.95 (s, 3H), 3.52 (t, <i>J</i> = 6.6 Hz, 2H), 3.05 (s, 3H), 2.97 (s, 3H), 2.09 (s, 3H), 2.02 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 326.1863, found: 326.1857; purity >95%.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-Acetyl-<i>N</i>-methyl-4-(7-methoxy-1-methyl-β-carbolin-9-yl)butylamine (<b>2-8b</b>)</h4><div class="NLM_p last">White solid. Yield 38%. <sup>1</sup>H-NMR (600 MHz, CDCl<sub>3</sub>): δ 8.27 (d, <i>J</i> = 5.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 4.8 Hz, 1H), 6.97 (m, 1H), 6.89 (m, 1H), 4.54 (t, <i>J</i> = 7.8 Hz, 2H), 3.98 (s, 3H), 3.43 (t, <i>J</i> = 7.2 Hz, 2H), 3.06 (s, 3H), 2.91 (s, 3H), 2.06 (s, 3H), 1.79 (m, 2H), 1.62 (m, 2H); HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup>: 340.2020, found: 340.2013; purity >95%.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> DYRK1A Binding Assays</h3><div class="NLM_p last">Compounds were tested for DYRK1A binding activity by a commercial kinase profiling services, Life Technologies, which uses the FRET-based LanthaScreen Eu kinase binding assay.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compounds were screened for DYRK1A activity at concentrations of 1000 and 300 nM. The IC<sub>50</sub> was determined by the 10-point LanthaScreen Eu kinase binding assay<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> with <i>N</i> = 2 independent experiments.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> β-Cell Proliferation Assay</h3><div class="NLM_p last">Human pancreatic islets were obtained from the NIH/NIDDK-supported Integrated Islet Distribution Program (IIDP) (<a href="https://iidp.coh.org" class="extLink">https://iidp.coh.org</a>) and studied using protocols that have been published in detail.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Briefly, islets were first dispersed with Accutase (Sigma, St. Louis, MO) onto coverslips and treated with a vehicle (0.1% DMSO) or with harmine-related compounds in RPMI1640 complete medium for 96 h. Then, the cells were fixed with formaldehyde and immunolabeled for insulin and Ki67 as described below. Total insulin-positive cells and double-positive Ki67 and insulin-positive cells were imaged and counted. Islets from 3–5 different adult donors were tested as described in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. At least 1000 β-cells were counted for a human islet donor. Rat islets were isolated from 8 to 10 week-old male Wistar rats (Charles River Laboratories, Wilmington, MA) as described previously<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and treated with harmine-related compounds in the same manner described for human islets with <i>N</i> = 3 independent experiments with different human islet donors for each dose.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> NFAT2 Translocation Assay</h3><div class="NLM_p last">The immortalized R7T1 mouse insulinoma cell line was infected with an adenovirus expressing NFAT2-GFP in 50 μL of serum-free DMEM medium in a poly-<span class="smallcaps smallerCapital">d</span>-lysine thin glass bottom 96 well plate (BioCoat, Cat#356640) for 2 h, and after 2 h of infection, 150 μL of complete medium was added to stop the virus infection for 24 h, and then the medium was replaced with medium containing different compounds at 10 μM after another 24 hours, all as described previously.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The cells were imaged and counted for the NFAT2-GFP nuclear translocation. At least 1000 cells were counted for each data point with <i>N</i> = 3 independent experiments for each compound.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Immunocytochemistry</h3><div class="NLM_p last">Cells on coverslips were fixed in fresh 4% paraformaldehyde for 15 min at 25 °C, washed with PBS, and incubated in blocking buffer (1.0% BSA, 0.5% Triton, and 5% normal goat serum (NGS) in PBS) for 1 h at 25 °C. Cells on coverslips were incubated with primary antisera overnight at 4 °C in blocking buffer. Then, the cells were washed three times with PBST. Secondary antisera were added for 1 h at 25 °C in a secondary buffer (1% BSA, 0.5% Triton in PBS, 5% NGS). Primary antisera were as follows: Ki67 (RM-9106-s1, Thermo Scientific, 1:300) and insulin (DAKO A0564). Secondary antisera were as follows: goat anti-guinea pig Alexa Fluor 488 (Life Technologies A11073) and goat anti-rabbit Alexa Fluor 594 (Life Technologies A11037).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Gene Expression Studies</h3><div class="NLM_p">RNA was isolated from three different islet sources and quantitative RT-PCR was performed as described previously.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> CYPA was used as the reference gene to normalize the gene expression. Gene expression in dispersed islets or cell lines was analyzed by real-time PCR performed on an ABI 7500 System. Primer sequences are the same as described earlier<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and sequence are as follows with <i>N</i> = 3 human islet donors for each dose.</div><div class="NLM_p">PDX1: forward, TGATGTGTCTCTCGGTCAAGTT; reverse, ACCAAAGCTCACGCGTGGAAA</div><div class="NLM_p">MAFA: forward, GAGCGGCTACCAGCATCAC; reverse, CTCTGGAGTTGGCACTTCTCG</div><div class="NLM_p">INS: forward, TCACACCTGGTGGAAGCTCTCTA; reverse, ACAATGCCACGCTTCTGCAGGGAC</div><div class="NLM_p">NKX6.1: forward, ACACGAGACCCACTTTTTCCG; reverse, TGCTGGACTTGTGCTTCTTCAAC</div><div class="NLM_p last">CYPA: forward, CACCGTGTTCTTCGACATTG; reverse, TGAAGTCACCACCCTGACAC</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Kinome Scan Profile</h3><div class="NLM_p last">Compounds were screened against 468 kinases at a single concentration of 10 μM at DiscoverX using their proprietary KINOMEscan assay (<i>N</i> = 2 independent experiments).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The results for primary screen binding interactions are reported as % DMSO Ctrl where lower values indicate stronger affinity; see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S3</a> for the full kinome profile.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Protein Purification and X-ray Crystallography</h3><div class="NLM_p last">DYRK1A was a gift from Nicola Burgess-Brown (Addgene plasmid # 38913; <a href="http://n2t.net/addgene:38913" class="extLink">http://n2t.net/addgene:38913</a> ; RRID:Addgene_38913). The plasmid was transformed into BL21 LOBSTR cells and expressed and purified according to previous SGC conditions.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> After gel filtration, the protein was concentrated to ∼18 mg/mL and frozen in aliquots. The protein was mixed with inhibitors to a final concentration of 1 mM. Crystals were then obtained by a hanging drop method by mixing the protein inhibitor complex with a reservoir containing 30–40% PEG 400, 0.2 M lithium sulfate, and Tris pH 8.5–9.0 at 4 °C. Crystals appeared after 3 days and were flash-frozen in liquid nitrogen. Data was collected at NSLS II on the AMX beamline (17-ID-1) using a wavelength of 0.920126 Å. The data was then processed using autoPROC<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and scaled with Aimless<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> in CCP4.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The structure was solved by molecular replacement in Phaser<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> using 4YLJ as a search model.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The structures were refined using Phenix<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> and BUSTER<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> with positional, ADP, and TLS refinements (obtained from the TLSMD server<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a>), along with interspersed manual adjustments in Coot.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The ligand restraints were generated using Phenix eLBOW.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Figures from the structure were generated with PyMOL. The structure has been deposited to PDB (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>) and the coordinates will be released upon publication of the manuscript.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> In Vitro CNS Off-Target Activity</h3><div class="NLM_p last">Compound <b>2-2c</b> and harmine were screened against a selected panel of nine CNS off-targets at 10 μM concentration (<i>N</i> = 2 independent experiments) in Eurofins Panlabs biochemical radiometric enzymatic assay; please see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S3</a> for the detailed protocol.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Brain Penetration Determination of Compound <b>2-2c</b></h3><div class="NLM_p">Brain plasma exposure of compound <b>2-2c</b> in male CD-1 mice was carried out at BioDuro following oral dosage of 30 mg/kg. A total of 21 male CD-1 mice were randomly divided into seven groups (3 mice per time point) and dosed with <b>2-2c</b> following single oral administration in formulations. The in-life phases were conducted at BioDuro (Shanghai) Co., Ltd. under BioDuro study no. MTI-FFS-PK-20181117-03 with IACUC protocol no. BD-201812274 (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2">Table 2<div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>strain:</b></td><td class="colsep0 rowsep0" align="left">CD-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>age:</b></td><td class="colsep0 rowsep0" align="left">7−9 weeks</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>sex:</b></td><td class="colsep0 rowsep0" align="left">male</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>source of animals:</b></td><td class="colsep0 rowsep0" align="left">Lingchang</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>initial body weight:</b></td><td class="colsep0 rowsep0" align="left">25−27 g</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>experimental unit:</b></td><td class="colsep0 rowsep0" align="left">individual animal</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>replicates per time point:</b></td><td class="colsep0 rowsep0" align="left"><i>N</i> = 3 per time point</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>inclusion criteria:</b></td><td class="colsep0 rowsep0" align="left">animals will be healthy at the start of the trial</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>exclusion:</b></td><td class="colsep0 rowsep0" align="left">any of the above inclusion criteria out of specification</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>randomization:</b></td><td class="colsep0 rowsep0" align="left">animals will be assigned randomly to treatment groups</td></tr></tbody></table></div></div><div class="NLM_p last">Blood was collected from a cardiac puncture into EDTA-K<sub>2</sub> tubes, plasma and brain with the time points were 0.25, 0.5, 1, 2, 4, 8, and 24 h post-dose. Immediately following blood collection, the samples were inverted several times and put on wet ice pending centrifugation. Within 30 min of collection, plasma was separated by centrifugation at 4600 rpm for 5 min at 4 °C. A 20 μL aliquot of plasma sample and 2 μL of MeOH were mixed with 200 μL methanol/acetonitrile (1:1, v/v) containing an internal standard (50 ng/mL terfenadine). The samples were mixed and vortexed for 1 min and centrifuged at 4000 rpm at 4 °C for 15 min and then transferred. The supernatant was diluted (10× dilution) with water (with 0.1%FA) prior to injection. A 50 μL aliquot of brain homogenate sample and 5 μL of MeOH were mixed with 200 μL of methanol/acetonitrile (1:1, v/v) containing an internal standard (50 ng/mL terfenadine). The samples were mixed and vortexed for 1 min and centrifuged at 4000 rpm at 4 °C for 15 min and then transferred. The supernatant was diluted (10× dilution) with water (with 0.1%FA) prior to injection. For <b>2-2c</b>, all chromatographic separations were performed on a Shimadzu LC-30AD at room temperature with a flow rate of 0.7 mL/min. A Kinetex 2.6u C18 100A column (50 mm × 3.00 mm) was used. Mobile phase A consisted of 5 mM NH<sub>4</sub>OAC in water with 0.05% formic acid, and mobile phase B consisted of acetonitrile with 0.1% formic acid. The chromatographic time program started maintaining 15% mobile phase B for 0.4 min, 15 to 95% mobile phase B over 2.3 min, followed by a 95% mobile phase B wash for 0.1 min, and then down to 35% mobile phase B within 0.01 min and a re-equilibration for 0.69 min. The mass spectrometer (API-5500+, Applied Biosystems/MDS SCIEX Instruments, Foster City, CA) was operated in positive-ion multiple reaction monitoring mode (MRM), and the column temperature was room temperature during all the run times. The MRM channels of <b>2-2c</b> and internal standard (terfenadine) were <i>m</i>/<i>z</i> 298.21/213.20 and <i>m</i>/<i>z</i> 472.40/436.40, respectively. Data collection was performed using Analyst Software version 1.6.3 including linear regression with weighting (1/X2) being performed using the same software. The retention time for <b>2-2c</b> was 1.35 min. The retention time for the internal standard was 2.0 min. Individual and mean plasma/brain concentrations (μM) of <b>2-2c</b> are outlined in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Tables S4 and S5</a>. The brain plasma ratio of <b>2-2c</b> is outlined in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">Table S6</a>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Animal Studies</h3><div class="NLM_p last">All studies were approved in advance by and performed in compliance with the Icahn School of Medicine at Mount Sinai Institutional Animal Care and Use Committee. The mouse protocol number that covers the animal studies done at Mount Sinai is IACUC-2015-0107. Mice used in these studies were purchased from Charles River (C57BL6/N) and Jackson Labs (NOD.SCID).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Mouse Pancreas Studies</h3><div class="NLM_p last">Male C57BL/6 N mice (12 week-old) received the vehicle (saline), harmine HCl, or compound <b>2-2c</b> by intraperitoneal injection daily for 7 days. Mice were sacrificed on day 7, and their pancreata was harvested, fixed in 10% neutral buffered formalin, paraffin-embedded, and sectioned. Sections were stained for Ki67 and insulin as previously reported.<a onclick="showRef(event, 'ref5 ref58'); return false;" href="javascript:void(0);" class="ref ref5 ref58">(5,58)</a> A minimum of 2000 β-cells per pancreas was counted. For mouse partial pancreatectomy (PPX) studies, the model has been described in detail.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Briefly, 2 to 3 month-old male C57BL/6 mice were randomized into two groups (PPX or sham PPX), and a 60% PPX (splenic portion) or sham PPX (laparotomy only) was performed. Following PPX, mice were allowed to recover for 24 h and then further randomized to receive the vehicle (saline), 10 mg/kg harmine HCl, or 1 mg/kg compound <b>2-2c</b> by intraperitoneal injection daily for 7 days. They were killed on day 7 for Ki67 labeling and β-cell mass determination. β-cell mass and islet number were measured in four insulin-stained pancreas sections per mouse using ImageJ software (National Institutes of Health, Bethesda, MD).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Sections were also stained for Ki67 and insulin. A minimum of 2000 β-cells per pancreas was counted. Investigators were blinded as to group assignments. For NOD-SCID mouse Studies, male NOD diabetic mice (12 week old) were transplanted with human cadaveric islets in the left renal subcapsular space as described previously.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> On postoperative day 7, they were randomized to receive the vehicle (saline), 10 mg/kg harmine HCl, or 1 mg/kg compound <b>2-2c</b> by intraperitoneal injection daily for 7 days. The renal grafts then were harvested, fixed, sectioned, immunolabeled for insulin and Ki67, and counted as described above and as reported.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Four human islet donors were used in each of four sets of three NOD-SCID mice. A minimum of 2000 human β-cells was counted per graft. Investigators were blinded as to group assignments in all studies.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Docking</h3><div class="NLM_p last">All docking calculations and molecule preparations were carried out using tools in the Schrödinger Small Molecule Drug Discovery suite release 2018-4. The crystal structure of DYRK1A in complex with compound <b>2-2c</b> was used as the target for all docking calculation and was prepared using the Protein Preparation wizard in Maestro to add missing atoms, optimize hydrogen bonds, and minimize the structure (heavy atom convergence to RMSD 0.3 Å), with default parameters. Structures of ligands were prepared using ligprep with the OPLS3e force field and Epik ionization. The docking grid was generated centered on the compound <b>2-2c</b> location in the prepared DYRK1A crystal structure. Compounds were docked into the docking grid using Glide with XP precision using a core constraint restricting the harmine core to its reference position in the <b>2-2c</b> complex with a tolerance of 0.1 Å.<a onclick="showRef(event, 'ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84">(82−84)</a> In each case, the top pose (best docking score) was selected as the docking solution.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Electrostatic Potential</h3><div class="NLM_p last">Electrostatic potential calculation was carried out on the DYRK1A crystal structure in complex with compound <b>2-2c</b> using the Poisson–Boltzmann method as implemented in APBS within Maestro (Schrödinger, LLC) with default parameters. The potential was mapped on the protein surface.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01379" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01379?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01379</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figure S1: Docking of selected 9-<i>N</i>-substituted harmine analogs; Figure S2: effects of harmine analogs on human and rat β-cell proliferation; Figure S3: electron density of <b>2-2c</b> bound to DYRK1A; Figure S4: brain penetration determination of compound <b>2-2c</b> in male CD-1 mice; Table S1: data collection and refinement statistics; Table S2: kinome scan data of compounds <b>2-2c</b>, <b>I</b>, and harmine; Table S3: in vitro CNS off-target assay protocol; Table S4: individual and mean plasma concentrations (μM) of <b>2-2c</b>; Table S5: individual and mean brain concentrations (μM) of <b>2-2c</b>; Table S6: individual and mean concentration ratio of brain to plasma of <b>2-2c</b>; HPLC purity analysis; and NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of saline (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_003.mov" class="ext-link">MOV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of harmine (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov" class="ext-link">MOV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of <b>2-2c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_005.mov" class="ext-link">MOV</a>)</p></li><li><p class="inline">PDB file of <b>2-1c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-1k</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-1l</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_008.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-2c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_009.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-2f</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_010.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-3a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_011.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-3b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_012.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-5a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_013.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-5b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_014.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-6a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_015.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-7a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_016.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-8a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_017.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf">jm9b01379_si_001.pdf (4.21 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_002.csv">jm9b01379_si_002.csv (1.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_003.mov">jm9b01379_si_003.mov (4.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov">jm9b01379_si_004.mov (6.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_005.mov">jm9b01379_si_005.mov (3.89 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_006.pdb">jm9b01379_si_006.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_007.pdb">jm9b01379_si_007.pdb (457.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_008.pdb">jm9b01379_si_008.pdb (458.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_009.pdb">jm9b01379_si_009.pdb (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_010.pdb">jm9b01379_si_010.pdb (457.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_011.pdb">jm9b01379_si_011.pdb (456.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_012.pdb">jm9b01379_si_012.pdb (456.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_013.pdb">jm9b01379_si_013.pdb (457.17 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_014.pdb">jm9b01379_si_014.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_015.pdb">jm9b01379_si_015.pdb (457.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_016.pdb">jm9b01379_si_016.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_017.pdb">jm9b01379_si_017.pdb (457.87 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for the X-ray structures of compound <b>2-2c</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>) bound to DYRK1A are available from the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>). Authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01379" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adolfo Garcia-Ocana</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbbabfb4b7bdb4f5bcbaa9b8b2baf6b4b8bab5ba9bb6a8a8b6f5bebfaeba"><span class="__cf_email__" data-cfemail="f495909b98929bda939586979d95d99b97959a95b499878799da91908195">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. DeVita</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Institute, Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2671-8497" title="Orcid link">http://orcid.org/0000-0002-2671-8497</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3d4f525f584f491359584b54495c7d504e4e5013585948"><span class="__cf_email__" data-cfemail="582a373a3d2a2c763c3d2e312c3918352b2b35763d3c2d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kunal Kumar</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Institute, Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Wang</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Wilson</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viktor Zlatanic</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cecilia Berrouet</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susmita Khamrui</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cody Secor</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ethan A. Swartz</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Lazarus</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Institute, Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6738-2563" title="Orcid link">http://orcid.org/0000-0002-6738-2563</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Sanchez</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Institute, Icahn School of Medicine
at Mount Sinai, New York, New York 10029, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew F. Stewart</span> - <span class="hlFld-Affiliation affiliation">Diabetes,
Obesity, and Metabolism Institute, Icahn
School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.K. and P.W. are co-first authors.</p><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. K.K. designed and synthesized harmine analogs. P.W. designed experiments and performed β-cell proliferation assay, immunocytochemistry, and gene expression studies. E.A.S. carried out the NFAT translocation assay. S.K. and C.S. expressed DYRK1A proteins and carried out crystallography studies. M.L. designed crystallographic experiments and supervised and processed crystallographic data. J.W., V.Z., and C.B. performed behavioral studies and in vivo efficacy studies of harmine and 2-2c. R.S. carried out computational modeling studies. A.G.O. designed and supervised behavioral and in vivo efficacy studies in three models of β-cell replication and regeneration. A.F.S. and R.J.D. conceived the project, designed translational strategy: biology (A.F.S.); medicinal chemistry, drug discovery (R.J.D.), and supervised the project.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This research was supported by grants DK015015 and DK116904 (R.J.D., K.K., P.W., A.F.S., E.A.S.), UC4 DK104211, P-30 DK020541, and JDRF 2-SRA-2017 514-S-B (A.F.S., P.W., E.A.S.), DK020541, DK105015, and DK113079 (A.G.O., J.W., V.Z., C.B.), and GM124838 (M.L., C.S., S.K.). This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai, the Human Islet and Adenoviral Core of the Einstein-Sinai Diabetes Research Center, and the NIDDK Human Islet Research Network (HIRN). This research used beamline 17-ID-1 (AMX) of the National Synchrotron Light Source II, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract no. DE-SC0012704.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Patent Applications have been filed by Mt. Sinai on the subject chemical matter of this manuscript. Patent applications on drug combinations have been filed by Mt. Sinai.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">DYRK1A</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine phosphorylation-regulated kinase 1A</p></td></tr><tr><td class="NLM_term">NFAT</td><td class="NLM_def"><p class="first last">nuclear factor of activated T cells</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 86 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.-X.+Gongauthor=Y.-W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lgPLO7Fib0YxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of alzheimer’s?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+A+new+avenue+for+a+disease+modifying+treatment+of+alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lgPLO7Fib0YxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520A%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ionescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbcke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span> <span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0lgQFwWcQ2tXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Martínez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Gómez, P.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span>. <i>Mol. Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e970048</span> <span class="refDoi"> DOI: 10.4161/23723548.2014.970048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.4161%2F23723548.2014.970048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27308401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=P.+Fern%C3%A1ndez-Mart%C3%ADnezauthor=C.+Zahoneroauthor=P.+S%C3%A1nchez-G%C3%B3mez&title=DYRK1A%3A+the+double-edged+kinase+as+a+protagonist+in+cell+growth+and+tumorigenesis&doi=10.4161%2F23723548.2014.970048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span></div><div class="casAuthors">Fernandez-Martinez, P.; Zahonero, C.; Sanchez-Gomez, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e970048/1-e970048/11</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">DYRK1A (dual-specificity tyrosine-regulated kinase 1A) is a kinase with multiple implications for embryonic development, esp. in the nervous system where it regulates the balance between proliferation and differentiation of neural progenitors.  The DYRK1A gene is located in the Down syndrome crit. region and may play a significant role in the developmental brain defects, early neurodegeneration, and cancer susceptibility of individuals with this syndrome.  DYRK1A is also expressed in adults, where it might participate in the regulation of cell cycle, survival, and tumorigenesis, thus representing a potential therapeutic target for certain types of cancer.  However, the final readout of DYRK1A overexpression or inhibition depends strongly on the cellular context, as it has both tumor suppressor and oncogenic activities.  Here, we will discuss the functions and substrates of DYRK1A assocd. with the control of cell growth and tumorigenesis with a focus on the potential use of DYRK1A inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OUDGl-nB87Vg90H21EOLACvtfcHk0lgQFwWcQ2tXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D&md5=27153f30af11f2572ba271ee09dd9939</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.970048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.970048%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Mart%25C3%25ADnez%26aufirst%3DP.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DS%25C3%25A1nchez-G%25C3%25B3mez%26aufirst%3DP.%26atitle%3DDYRK1A%253A%2520the%2520double-edged%2520kinase%2520as%2520a%2520protagonist%2520in%2520cell%2520growth%2520and%2520tumorigenesis%26jtitle%3DMol.%2520Cell.%2520Oncol.%26date%3D2015%26volume%3D2%26doi%3D10.4161%2F23723548.2014.970048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.-C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0lgQFwWcQ2tXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.-C.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swafford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursalaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pinzon, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8372</span>, <span class="refDoi"> DOI: 10.1038/ncomms9372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms9372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26496802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8372&author=W.+Shenauthor=B.+Taylorauthor=Q.+Jinauthor=V.+Nguyen-Tranauthor=S.+Meeusenauthor=Y.-Q.+Zhangauthor=A.+Kamireddyauthor=A.+Swaffordauthor=A.+F.+Powersauthor=J.+Walkerauthor=J.+Lambauthor=B.+Bursalayaauthor=M.+DiDonatoauthor=G.+Harbauthor=M.+Qiuauthor=C.+M.+Filippiauthor=L.+Deatonauthor=C.+N.+Turkauthor=W.+L.+Suarez-Pinzonauthor=Y.+Liuauthor=X.+Haoauthor=T.+Moauthor=S.+Yanauthor=J.+Liauthor=A.+E.+Hermanauthor=B.+J.+Heringauthor=T.+Wuauthor=H.+M.+Seidelauthor=P.+McNamaraauthor=R.+Glynneauthor=B.+Laffitte&title=Inhibition+of+DYRK1A+and+GSK3B+induces+human+%CE%B2-cell+proliferation&doi=10.1038%2Fncomms9372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span></div><div class="casAuthors">Shen, Weijun; Taylor, Brandon; Jin, Qihui; Nguyen-Tran, Van; Meeusen, Shelly; Zhang, You-Qing; Kamireddy, Anwesh; Swafford, Austin; Powers, Andrew F.; Walker, John; Lamb, John; Bursalaya, Badry; DiDonato, Michael; Harb, George; Qiu, Minhua; Filippi, Christophe M.; Deaton, Lisa; Turk, Carolina N.; Suarez-Pinzon, Wilma L.; Liu, Yahu; Hao, Xueshi; Mo, Tingting; Yan, Shanshan; Li, Jing; Herman, Ann E.; Hering, Bernhard J.; Wu, Tom; Seidel, H. Martin; McNamara, Peter; Glynne, Richard; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8372</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insufficient pancreatic β-cell mass or function results in diabetes mellitus.  While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacol. agents have been described that increase β-cell replication in humans.  Here we report aminopyrazine compds. that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B.  Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice.  Oral dosing of these compds. in diabetic mice induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycemic control.  Biochem., genetic and cell biol. data point to Dyrk1a as the key mol. target.  This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVHzP-VkH5nrVg90H21EOLACvtfcHk0ljnsCMez30Ayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK&md5=5ef960af3bfd2795b9fdce52876e5d59</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncomms9372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9372%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DNguyen-Tran%26aufirst%3DV.%26aulast%3DMeeusen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DKamireddy%26aufirst%3DA.%26aulast%3DSwafford%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DBursalaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DFilippi%26aufirst%3DC.%2BM.%26aulast%3DDeaton%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DSuarez-Pinzon%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DA.%2BE.%26aulast%3DHering%26aufirst%3DB.%2BJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520DYRK1A%2520and%2520GSK3B%2520induces%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8372%26doi%3D10.1038%2Fncomms9372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachdi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kariyawasam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aïello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharfmann, R.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2229</span>, <span class="refDoi"> DOI: 10.4161/cc.29250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.4161%2Fcc.29250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24870561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WisLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2221-2229&author=L.+Rachdiauthor=D.+Kariyawasamauthor=V.+A%C3%AFelloauthor=Y.+Heraultauthor=N.+Janelauthor=J.-M.+Delabarauthor=M.+Polakauthor=R.+Scharfmann&title=Dyrk1A+induces+pancreatic+%CE%B2+cell+mass+expansion+and+improves+glucose+tolerance&doi=10.4161%2Fcc.29250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance</span></div><div class="casAuthors">Rachdi, Latif; Kariyawasam, Dulanjalee; Aiello, Virginie; Herault, Yann; Janel, Nathalie; Delabar, Jean-Maurice; Polak, Michel; Scharfmann, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2221-2229</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Type 2 diabetes is caused by a limited capacity of insulin-producing pancreatic β cells to increase their mass and function in response to insulin resistance.  The signaling pathways that pos. regulate functional β cell mass have not been fully elucidated.  DYRK1A (also called minibrain/MNB) is a member of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family.  A significant amt. of data implicates DYRK1A in brain growth and Down syndrome, and recent data indicate that Dyrk1A haploinsufficient mice have a low functional β cell mass.  Here we ask whether Dyrk1A upregulation could be a way to increase functional β cell mass.  We used mice overexpressing Dyrk1A under the control of its own regulatory sequences (mBACTgDyrk1A).  These mice exhibit decreased glucose levels and hyperinsulinemia in the fasting state.  Improved glucose tolerance is obsd. in these mice as early as 4 wk of age.  Upregulation of Dyrk1A in β cells induces expansion of β cell mass through increased proliferation and cell size.  Importantly, mBACTgDyrk1A mice are protected against high-fat-diet-induced β cell failure through increase in β cell mass and insulin sensitivity.  These studies show the crucial role of the DYRK1A pathway in the regulation of β cell mass and carbohydrate metab. in vivo.  Activating the DYRK1A pathway could thus represent an innovative way to increase functional β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre5nXGBuindrVg90H21EOLACvtfcHk0ljnsCMez30Ayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WisLzP&md5=92dc7241ee0f258a91351b6bffd941d8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4161%2Fcc.29250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.29250%26sid%3Dliteratum%253Aachs%26aulast%3DRachdi%26aufirst%3DL.%26aulast%3DKariyawasam%26aufirst%3DD.%26aulast%3DA%25C3%25AFello%26aufirst%3DV.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.-M.%26aulast%3DPolak%26aufirst%3DM.%26aulast%3DScharfmann%26aufirst%3DR.%26atitle%3DDyrk1A%2520induces%2520pancreatic%2520%25CE%25B2%2520cell%2520mass%2520expansion%2520and%2520improves%2520glucose%2520tolerance%26jtitle%3DCell%2520Cycle%26date%3D2014%26volume%3D13%26spage%3D2221%26epage%3D2229%26doi%3D10.4161%2Fcc.29250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dančik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human β-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26953159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8Dikauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A stimulates human beta-cell proliferation</span></div><div class="casAuthors">Dirice, Ercument; Walpita, Deepika; Vetere, Amedeo; Meier, Bennett C.; Kahraman, Sevim; Hu, Jiang; Dancik, Vlado; Burns, Sean M.; Gilbert, Tamara J.; Olson, David E.; Clemons, Paul A.; Kulkarni, Rohit N.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1660-1671</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1).  While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle applies to humans, as human β-cells are remarkably resistant to stimulation of division (3,4).  Here, we show that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increase proliferation in rodent and porcine islets (5), strongly and selectively increases human β-cell proliferation in vitro and in vivo.  Remarkably, 5-IT also increased glucose-dependent insulin secretion after prolonged treatment.  Kinome profiling revealed 5-IT to be a potent and selective inhibitor of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) and cell division cycle-like kinase families.  Induction of β-cell proliferation by either 5-IT or harmine, another natural product DYRK1A inhibitor, was suppressed by coincubation with the calcineurin inhibitor FK506, suggesting involvement of DYRK1A and nuclear factor of activated T cells signaling.  Gene expression profiling in whole islets treated with 5-IT revealed induction of proliferation- and cell cycle-related genes, suggesting that true proliferation is induced by 5-IT.  Furthermore, 5-IT promotes β-cell proliferation in human islets grafted under the kidney capsule of NOD-scid IL2Rgnull mice.  These results point to inhibition of DYRK1A as a therapeutic strategy to increase human β-cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLKPVi2wkdrVg90H21EOLACvtfcHk0ljnsCMez30Ayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP&md5=c383c8d1f2c1739252ad3cfe4361585c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258Dik%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A potential drug target for multiple down syndrome neuropathologies</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/18715273113126660186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2174%2F18715273113126660186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24152332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=26-33&author=W.+Beckerauthor=U.+Soppaauthor=F.+Tejedor&title=DYRK1A%3A+A+potential+drug+target+for+multiple+down+syndrome+neuropathologies&doi=10.2174%2F18715273113126660186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies</span></div><div class="casAuthors">Becker, Walter; Soppa, Ulf; Tejedor, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Down syndrome (DS), the most common genetic cause of intellectual disability, is caused by the trisomy of chromosome 21.  MNB/DYRK1A (Minibrain/dual specificity tyrosine phosphorylation-regulated kinase 1A) has possibly been the most extensively studied chromosome 21 gene during the last decade due to the remarkable correlation of its functions in the brain with important DS neuropathologies, such as neuronal deficits, dendrite atrophy, spine dysgenesis, precocious Alzheimer's-like neurodegeneration, and cognitive deficits.  MNB/DYRK1A has become an attractive drug target because increasing evidence suggests that its overexpression may induce DS-like neurobiol. alterations, and several small-mol. inhibitors of its protein kinase activity are available.  Here, we summarize the functional complexity of MNB/DYRK1A from a DS-research perspective, paying particular attention to the capacity of different MNB/DYRK1A inhibitors to reverse the neurobiol. alterations caused by the increased activity of MNB/DYRK1A in exptl. models.  Finally, we discuss the advantages and drawbacks of possible MNB/DYRK1A-based therapeutic strategies that result from the functional, mol., and pharmacol. complexity of MNB/DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaG-2GxDUKR7Vg90H21EOLACvtfcHk0liczOkyn0aTXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D&md5=4b9c141d30bbf23f35f73b63e31f3e65</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F18715273113126660186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715273113126660186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%26atitle%3DDYRK1A%253A%2520A%2520potential%2520drug%2520target%2520for%2520multiple%2520down%2520syndrome%2520neuropathologies%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D26%26epage%3D33%26doi%3D10.2174%2F18715273113126660186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21126318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, regulation, and inhibition of DYRK1A</span></div><div class="casAuthors">Becker, Walter; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-256</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiol.  Higher than normal levels of DYRK1A are assocd. with the pathol. of neurodegenerative diseases and have been implicated in some neurobiol. alterations of Down syndrome, such as mental retardation.  It is therefore important to understand the mol. mechanisms that control the activity of DYRK1A.  Here, the authors review current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases.  However, tyrosine phosphorylation does not appear to regulate the enzymic activity of DYRK1A.  Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins, and regulated nuclear translocation.  Finally, the authors compare the properties of small mol. inhibitors that target DYRK1A and evaluate their potential application and limitations.  The β-carboline alkaloid, harmine, is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_Eqb_-j05bVg90H21EOLACvtfcHk0liczOkyn0aTXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D&md5=958db7f4577f941bd8dfb56afc461335</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkarim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grougnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myrianthopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillequin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span> <span> </span><span class="NLM_article-title">Two new peltogynoids from Acacia nilotica Delile with kinase inhibitory activity</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1055/s-0029-1186226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1055%2Fs-0029-1186226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19844867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFSkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=458-460&author=A.+Ahmaduauthor=A.+Abdulkarimauthor=R.+Grougnetauthor=V.+Myrianthopoulosauthor=F.+Tillequinauthor=P.+Magiatisauthor=A.-L.+Skaltsounis&title=Two+new+peltogynoids+from+Acacia+nilotica+Delile+with+kinase+inhibitory+activity&doi=10.1055%2Fs-0029-1186226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Two new peltogynoids from Acacia nilotica Delile with kinase inhibitory activity</span></div><div class="casAuthors">Ahmadu, Augustine; Abdulkarim, Agunu; Grougnet, Raphael; Myrianthopoulos, Vassilios; Tillequin, Francois; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">458-460</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two new peltogynoids, acanilol A and B (I, II), were isolated from the stem bark of Acacia nilotica (L.) Delile, together with the known triterpene lupenone.  The structures of the new compds. were established on the basis of their spectral data, mainly UV, NMR, and mass spectrometry.  The new compds. were tested as kinase inhibitors against CDK1, GSK3, CK1, and DYRK1A, and acanilol B was identified as a DYRK1A inhibitor, with an IC50 of 19 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoifXyZ2W96bVg90H21EOLACvtfcHk0liczOkyn0aTXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFSkt7Y%253D&md5=28f53bfcb8e2e3a952906cb3d2c15ab1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1186226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1186226%26sid%3Dliteratum%253Aachs%26aulast%3DAhmadu%26aufirst%3DA.%26aulast%3DAbdulkarim%26aufirst%3DA.%26aulast%3DGrougnet%26aufirst%3DR.%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DTillequin%26aufirst%3DF.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26atitle%3DTwo%2520new%2520peltogynoids%2520from%2520Acacia%2520nilotica%2520Delile%2520with%2520kinase%2520inhibitory%2520activity%26jtitle%3DPlanta%2520Med.%26date%3D2010%26volume%3D76%26spage%3D458%26epage%3D460%26doi%3D10.1055%2Fs-0029-1186226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akue-Gedu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudhomme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4420</span>– <span class="NLM_lpage">4424</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmc.2009.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19477650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4420-4424&author=R.+Akue-Geduauthor=E.+Debitonauthor=Y.+Ferandinauthor=L.+Meijerauthor=M.+Prudhommeauthor=F.+Anizonauthor=P.+Moreau&title=Synthesis+and+biological+activities+of+aminopyrimidyl-indoles+structurally+related+to+meridianins&doi=10.1016%2Fj.bmc.2009.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins</span></div><div class="casAuthors">Akue-Gedu, Rufine; Debiton, Eric; Ferandin, Yoan; Meijer, Laurent; Prudhomme, Michelle; Anizon, Fabrice; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4420-4424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs. substituted at the C-5 position of the 2-aminopyrimidine ring by various aryl groups and substituted or not by a Me group on the indole nitrogen is described.  These compds. were tested for their kinase inhibitory potencies toward five kinases (CDK5/p25, CK1δ/ε, GSK-3α/β, Dyrk1A and Erk2) as well as their in vitro antiproliferative activities toward a human fibroblast primary culture and two human solid cancer cell lines (MCF-7 and PA 1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYufDKqEQZNrVg90H21EOLACvtfcHk0lji4h1Fv2kznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gru7c%253D&md5=f14ea49d5c54c32f5a6be1d9214d4bc7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DAkue-Gedu%26aufirst%3DR.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DPrudhomme%26aufirst%3DM.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520aminopyrimidyl-indoles%2520structurally%2520related%2520to%2520meridianins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D4420%26epage%3D4424%26doi%3D10.1016%2Fj.bmc.2009.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister-Lock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvanites, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, D. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3915</span>– <span class="NLM_lpage">3920</span>, <span class="refDoi"> DOI: 10.1073/pnas.1201149109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1073%2Fpnas.1201149109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22345561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3915-3920&author=J.+P.+Annesauthor=J.+H.+Ryuauthor=K.+Lamauthor=P.+J.+Carolanauthor=K.+Utzauthor=J.+Hollister-Lockauthor=A.+C.+Arvanitesauthor=L.+L.+Rubinauthor=G.+Weirauthor=D.+A.+Melton&title=Adenosine+kinase+inhibition+selectively+promotes+rodent+and+porcine+islet+%CE%B2-cell+replication&doi=10.1073%2Fpnas.1201149109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication</span></div><div class="casAuthors">Annes, Justin P.; Ryu, Jennifer Hyoje; Lam, Kelvin; Carolan, Peter J.; Utz, Katrina; Hollister-Lock, Jennifer; Arvanites, Anthony C.; Rubin, Lee L.; Weir, Gordon; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3915-3920</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Diabetes is a pathol. condition characterized by relative insulin deficiency, persistent hyperglycemia, and, consequently, diffuse micro- and macrovascular disease.  One therapeutic strategy is to amplify insulin-secretion capacity by increasing the no. of the insulin-producing β cells without triggering a generalized proliferative response.  Here, we present the development of a small-mol. screening platform for the identification of mols. that increase β-cell replication.  Using this platform, we identify a class of compds. [adenosine kinase inhibitors (ADK-Is)] that promote replication of primary β cells in three species (mouse, rat, and pig).  Furthermore, the replication effect of ADK-Is is cell type-selective: treatment of islet cell cultures with ADK-Is increases replication of β cells but not that of α cells, PP cells, or fibroblasts.  Short-term in vivo treatment with an ADK-I also increases β-cell replication but not exocrine cell or hepatocyte replication.  Therefore, we propose ADK inhibition as a strategy for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9d3QakDBpybVg90H21EOLACvtfcHk0lji4h1Fv2kznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFymtL8%253D&md5=2bec02ff18ef273ec38734a98c9395cb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1201149109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1201149109%26sid%3Dliteratum%253Aachs%26aulast%3DAnnes%26aufirst%3DJ.%2BP.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26aulast%3DLam%26aufirst%3DK.%26aulast%3DCarolan%26aufirst%3DP.%2BJ.%26aulast%3DUtz%26aufirst%3DK.%26aulast%3DHollister-Lock%26aufirst%3DJ.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DWeir%26aufirst%3DG.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DAdenosine%2520kinase%2520inhibition%2520selectively%2520promotes%2520rodent%2520and%2520porcine%2520islet%2520%25CE%25B2-cell%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3915%26epage%3D3920%26doi%3D10.1073%2Fpnas.1201149109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lji4h1Fv2kznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of alzheimer’s disease: effect on tau and amyloid pathologies in vitro</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.-S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=A+novel+DYRK1A+%28Dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+effect+on+tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0ljj7oYiEpZe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528Dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianoncelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1042/BJ20090069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1042%2FBJ20090069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19432557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell-permeable+inhibitor+of+protein+kinase+CK2&doi=10.1042%2FBJ20090069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span></div><div class="casAuthors">Cozza, Giorgio; Mazzorana, Marco; Papinutto, Elena; Bain, Jenny; Elliott, Matthew; di Maira, Giovanni; Gianoncelli, Alessandra; Pagano, Mario A.; Sarno, Stefania; Ruzzene, Maria; Battistutta, Roberto; Meggio, Flavio; Moro, Stefano; Zagotto, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-395</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is a moderately potent and poorly selective inhibitor of protein kinase CK2, one of the most pleiotropic serine/threonine protein kinases, implicated in neoplasia and in other global diseases.  By virtual screening of the MMS (Mol. Modeling Section) database, we have now identified quinalizarin (1,2,5,8-tetrahydroxyanthraquinone) as an inhibitor of CK2 that is more potent and selective than emodin.  CK2 inhibition by quinalizarin is competitive with respect to ATP, with a Ki value of approx. 50 nM.  Tested at 1 μM concn. on a panel of 75 protein kinases, quinalizarin drastically inhibits only CK2, with a promiscuity score (11.1), which is the lowest ever reported so far for a CK2 inhibitor.  Esp. remarkable is the ability of quinalizarin to discriminate between CK2 and a no. of kinases, notably DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase), PIM (provirus integration site for Moloney murine leukemia virus) 1, 2 and 3, HIPK2 (homeodomain-interacting protein kinase-2), MNK1 [MAPK (mitogen-activated protein kinase)-interacting kinase 1], ERK8 (extracellular-signal-regulated kinase 8) and PKD1 (protein kinase D 1), which conversely tend to be inhibited as drastically as CK2 by com. available CK2 inhibitors.  The detn. of the crystal structure of a complex between quinalizarin and CK2α subunit highlights the relevance of polar interactions in stabilizing the binding, an unusual characteristic for a CK2 inhibitor, and disclose other structural features which may account for the narrow selectivity of this compd.  Tested on Jurkat cells, quinalizarin proved able to inhibit endogenous CK2 and to induce apoptosis more efficiently than the commonly used CK2 inhibitors TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbz80w9Hmd9LVg90H21EOLACvtfcHk0ljj7oYiEpZe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D&md5=dc127c347d7e47419bee4594ff7572fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20090069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090069%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3Ddi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell-permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D387%26epage%3D395%26doi%3D10.1042%2FBJ20090069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clément, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): Synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/Cyclin A/meriolin complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/jm700940h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700940h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=737-751&author=A.+Echalierauthor=K.+Bettayebauthor=Y.+Ferandinauthor=O.+Lozachauthor=M.+Cl%C3%A9mentauthor=A.+Valetteauthor=F.+Ligerauthor=B.+Marquetauthor=J.+C.+Morrisauthor=J.+A.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=Meriolins+%283-%28pyrimidin-4-yl%29-7-azaindoles%29%3A+Synthesis%2C+kinase+inhibitory+activity%2C+cellular+effects%2C+and+structure+of+a+CDK2%2FCyclin+A%2Fmeriolin+complex&doi=10.1021%2Fjm700940h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex</span></div><div class="casAuthors">Echalier, Aude; Bettayeb, Karima; Ferandin, Yoan; Lozach, Olivier; Clelment, Monique; Valette, Annie; Liger, Francois; Marquet, Bernard; Morris, Jonathan C.; Endicott, Jane A.; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and biol. characterization of 3-(pyrimidin-4-yl)-7-azaindoles (meriolins), a chem. hybrid between the natural products meridianins and variolins, derived from marine organisms.  Meriolins display potent inhibitory activities toward cyclin-dependent kinases (CDKs) and, to a lesser extent, other kinases (GSK-3, DYRK1A).  The crystal structures of I (meriolin 5) and variolin B in complex with CDK2/cyclin A reveal that the two inhibitors are oriented in very different ways inside the ATP-binding pocket of the kinase.  A structure-activity relationship provides further insight into the mol. mechanism of action of this family of kinase inhibitors.  Meriolins are also potent antiproliferative and proapoptotic agents in cells cultured either as monolayers or in spheroids.  Proapoptotic efficacy of meriolins correlates best with their CDK2 and CDK9 inhibitory activity.  Meriolins thus constitute a promising class of pharmacol. agents to be further evaluated against the numerous human diseases that imply abnormal regulation of CDKs including cancers, neurodegenerative disorders, and polycystic kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJgno3A1_7LVg90H21EOLACvtfcHk0ljj7oYiEpZe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D&md5=1bfb3d02c6894c04237eee27bbccaa5b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm700940h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700940h%26sid%3Dliteratum%253Aachs%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DM.%26aulast%3DValette%26aufirst%3DA.%26aulast%3DLiger%26aufirst%3DF.%26aulast%3DMarquet%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeriolins%2520%25283-%2528pyrimidin-4-yl%2529-7-azaindoles%2529%253A%2520Synthesis%252C%2520kinase%2520inhibitory%2520activity%252C%2520cellular%2520effects%252C%2520and%2520structure%2520of%2520a%2520CDK2%252FCyclin%2520A%252Fmeriolin%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Fjm700940h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loaecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0lhOBA7dqPqh-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hédou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubouilh-Benard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">15411</span>– <span class="NLM_lpage">15439</span>, <span class="refDoi"> DOI: 10.3390/molecules191015411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.3390%2Fmolecules191015411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25264830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15411-15439&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=A.+Girardauthor=T.+Taverneauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=B.+Leblondauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+part+II&doi=10.3390%2Fmolecules191015411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span></div><div class="casAuthors">Foucourt, Alicia; Hedou, Damien; Dubouilh-Benard, Carole; Girard, Angelique; Taverne, Thierry; Casagrande, Anne-Sophie; Desire, Laurent; Leblond, Bertrand; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15411-15439, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a focused library (forty mols.) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines I (R = 4-MeOC6H4, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, etc.) was achieved mainly under microwave irradn.  A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile was used as a versatile mol. platform for the synthesis of various derivs.  Kinase inhibition, of the obtained final compds., was evaluated on a panel of two kinases (DYRK1A/1B) together with some known ref. DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41).  Compd. IC50 values were obtained and compared.  Five of the novel thiazolo[5,4-f]quinazoline derivs. prepd., I (R = 2,4-Cl2C6H3, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, 2,4-F2C6H3, 4-MeC6H4) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date.  DYRK1A/1B kinases are known to be involved in the regulation of various mol. pathways assocd. with oncol., neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing.  The compds. described in this communication constitute a highly potent set of novel mol. probes to evaluate the biol./pharmacol. of DYR1A/1B in such diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxocRjJkBbrVg90H21EOLACvtfcHk0lhOBA7dqPqh-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM&md5=cefa4032d967cd704a189f3a62a1738d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015411%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520part%2520II%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15411%26epage%3D15439%26doi%3D10.3390%2Fmolecules191015411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Théry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4489</span>, <span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0liV0JhA9Hjqrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denhez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9569</span>– <span class="NLM_lpage">9585</span>, <span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0liV0JhA9Hjqrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sébrié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivals, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4606</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1371%2Fjournal.pone.0004606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19242551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ms12lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=F.+Guedjauthor=C.+S%C3%A9bri%C3%A9author=I.+Rivalsauthor=A.+Ledruauthor=E.+Palyauthor=J.+C.+Bizotauthor=D.+Smithauthor=E.+Rubinauthor=B.+Gilletauthor=M.+Arbonesauthor=J.+M.+Delabar&title=Green+tea+polyphenols+rescue+of+brain+defects+induced+by+overexpression+of+DYRK1A&doi=10.1371%2Fjournal.pone.0004606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A</span></div><div class="casAuthors">Guedj Faycal; Sebrie Catherine; Rivals Isabelle; Ledru Aurelie; Paly Evelyne; Bizot Jean C; Smith Desmond; Rubin Edward; Gillet Brigitte; Arbones Mariona; Delabar Jean M</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e4606</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis.  They present also learning impairments modeling those encountered in Down syndrome.  Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions.  Gene dosage correction induces a rescue of the brain volume alterations.  DYRK1A is also involved in the control of synaptic plasticity and memory consolidation.  Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice.  Epigallocatechin gallate (EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor.  We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood.  The major features of the transgenic phenotype were rescued in these mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1k9_XvFuhS-dfST00W0BcfW6udTcc2ebRFTe6yt2ATLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ms12lsA%253D%253D&md5=72b96c0b213ce86fb70d456123e991e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004606%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DS%25C3%25A9bri%25C3%25A9%26aufirst%3DC.%26aulast%3DRivals%26aufirst%3DI.%26aulast%3DLedru%26aufirst%3DA.%26aulast%3DPaly%26aufirst%3DE.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DB.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DGreen%2520tea%2520polyphenols%2520rescue%2520of%2520brain%2520defects%2520induced%2520by%2520overexpression%2520of%2520DYRK1A%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kassis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzeszcz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guével, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillouzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewiński, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(phenyl) pyridine or pyrazine V-shaped molecules as kinase inhibitors and cytotoxic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2011.08.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21944287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5416-5434&author=P.+Kassisauthor=J.+Brzeszczauthor=V.+B%C3%A9n%C3%A9teauauthor=O.+Lozachauthor=L.+Meijerauthor=R.+Le+Gu%C3%A9velauthor=C.+Guillouzoauthor=K.+Lewi%C5%84skiauthor=S.+Bourgauthor=L.+Colliandreauthor=S.+Routierauthor=J.-Y.+M%C3%A9rour&title=Synthesis+and+biological+evaluation+of+new+3-%286-hydroxyindol-2-yl%29-5-%28phenyl%29+pyridine+or+pyrazine+V-shaped+molecules+as+kinase+inhibitors+and+cytotoxic+agents&doi=10.1016%2Fj.ejmech.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents</span></div><div class="casAuthors">Kassis, Pamela; Brzeszcz, Joanna; Beneteau, Valerie; Lozach, Olivier; Meijer, Laurent; Le Guevel, Remi; Guillouzo, Christiane; Lewinski, Krzysztof; Bourg, Stephane; Colliandre, Lionel; Routier, Sylvain; Merour, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5416-5434</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein is reported the synthesis and biol. evaluation of new 3-[(2-indolyl)]-5-phenyl-3,5-pyridine, 3-[(2-indolyl)]-5-phenyl-2,4-pyridine and 3-[(2-indolyl)]-5-phenyl-2,6-pyrazine derivs. designed as potential CDK inhibitors.  Indoles and phenyls were used to generate several substitutions of the pyridine and pyrazine rings.  The syntheses included Stille or Suzuki type reactions, which were carried out on the 3,5-dibromopyridine, 2,4-dichloropyridine and 2,6-dichloro-1-4-pyrazine moieties.  Cell effects of the V-shaped family were in the micromolar range.  Kinase assays were conducted and showed that compd. I inhibited CDK5 with an inhibitory concn. of 160 nM with a moderate selectivity over GSK3 compared to the ref. compd. II which exhibited a slightly lower activity on CDK5 (1.5 μM).  Compd. I was also found to be the most potent compd. in the series and was identified as a new lead for DYRK1A inhibitor discovery (IC50 = 60 nM).  Docking studies were carried out in order to investigate the inhibition of DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8p7-Tg5B6LVg90H21EOLACvtfcHk0lg21yXvXJsIDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ&md5=1b960c962e74420cf3ddad26ffeeec94</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DKassis%26aufirst%3DP.%26aulast%3DBrzeszcz%26aufirst%3DJ.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLe%2BGu%25C3%25A9vel%26aufirst%3DR.%26aulast%3DGuillouzo%26aufirst%3DC.%26aulast%3DLewi%25C5%2584ski%26aufirst%3DK.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25203-%25286-hydroxyindol-2-yl%2529-5-%2528phenyl%2529%2520pyridine%2520or%2520pyrazine%2520V-shaped%2520molecules%2520as%2520kinase%2520inhibitors%2520and%2520cytotoxic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5416%26epage%3D5434%26doi%3D10.1016%2Fj.ejmech.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0lg21yXvXJsIDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.-J.</span></span> <span> </span><span class="NLM_article-title">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3772</span>– <span class="NLM_lpage">3776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2006.04.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16698266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3772-3776&author=N.+D.+Kimauthor=J.+Yoonauthor=J.+H.+Kimauthor=J.+T.+Leeauthor=Y.+S.+Chonauthor=M.-K.+Hwangauthor=I.+Haauthor=W.-J.+Song&title=Putative+therapeutic+agents+for+the+learning+and+memory+deficits+of+people+with+Down+syndrome&doi=10.1016%2Fj.bmcl.2006.04.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span></div><div class="casAuthors">Kim, Nam Doo; Yoon, Jeonghyeok; Kim, Jung Ho; Lee, Jung Tae; Chon, Yong Sog; Hwang, Mi-Kyung; Ha, Ilho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3772-3776</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mental retardation is the most common and debilitating condition for individuals with Down syndrome (DS).  The hyper-activation of DYRK1A by overexpression causes significant learning and memory deficits in DS-model mice.  Thus far, no mechanism-based drug has been developed to address this.  After a combination of in silico and in vitro screenings, two DYRK1A inhibitors were isolated that are active in a cell-based assay.  Further optimization could lead to a novel drug discovery that could address DS learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCFzbIFHKqJbVg90H21EOLACvtfcHk0lgKvo-EDSNZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D&md5=5a6a306f3de1c958ac3d4b7f06d24c82</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DHwang%26aufirst%3DM.-K.%26aulast%3DHa%26aufirst%3DI.%26aulast%3DSong%26aufirst%3DW.-J.%26atitle%3DPutative%2520therapeutic%2520agents%2520for%2520the%2520learning%2520and%2520memory%2520deficits%2520of%2520people%2520with%2520Down%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3772%26epage%3D3776%26doi%3D10.1016%2Fj.bmcl.2006.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koo, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.-J.</span></span> <span> </span><span class="NLM_article-title">QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2328</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2009.02.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19282176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2324-2328&author=K.+A.+Kooauthor=N.+D.+Kimauthor=Y.+S.+Chonauthor=M.-S.+Jungauthor=B.-J.+Leeauthor=J.+H.+Kimauthor=W.-J.+Song&title=QSAR+analysis+of+pyrazolidine-3%2C5-diones+derivatives+as+Dyrk1A+inhibitors&doi=10.1016%2Fj.bmcl.2009.02.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors</span></div><div class="casAuthors">Koo, Kyung Ah; Kim, Nam Doo; Chon, Yong Sog; Jung, Min-Su; Lee, Burm-Jong; Kim, Jung Ho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2324-2328</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Individuals with Down syndrome (DS) suffer from mental retardation.  Overexpression and the resulting increased specific activity of Dyrk1A kinase located on chromosome 21 cause a learning and memory deficit in Dyrk1A transgenic mice.  To search for therapeutic agents with Dyrk1A inhibition activity, previously we obtained HCD160 as a new hit compd. for Dyrk1A inhibition.  In the present study, we synthesized 34 HCD160 derivs. to investigate the quant. structure-activity relationship (QSAR).  This anal. could provide important information for novel drug discovery for treatment of DS related learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyqYI1p0FQZLVg90H21EOLACvtfcHk0lgKvo-EDSNZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjtb0%253D&md5=07a2003db0fdb6b821a942e9f317b114</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.062%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DJung%26aufirst%3DM.-S.%26aulast%3DLee%26aufirst%3DB.-J.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSong%26aufirst%3DW.-J.%26atitle%3DQSAR%2520analysis%2520of%2520pyrazolidine-3%252C5-diones%2520derivatives%2520as%2520Dyrk1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2324%26epage%3D2328%26doi%3D10.1016%2Fj.bmcl.2009.02.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferr%C3%A9author=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstr%C3%B6mauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A%CE%B225-35+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0lgKvo-EDSNZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%25CE%25B225-35%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neagoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrenne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyrou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansiaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2012.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22305342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.-Y.+M%C3%A9rourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+Lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class&doi=10.1016%2Fj.ejmech.2012.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class</span></div><div class="casAuthors">Neagoie, Cleopatra; Vedrenne, Emeline; Buron, Frederic; Merour, Jean-Yves; Rosca, Sorin; Bourg, Stephane; Lozach, Olivier; Meijer, Laurent; Baldeyrou, Brigitte; Lansiaux, Amelie; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosteres.  Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonization step.  Twenty final compds. were tested in order to det. their activity against topoisomerase I and kinases, the two major biol. activities of Lamellarins.  One newly synthesized deriv. exhibited a strong topoisomerase activity comparable to ref. compds. such as campthotecin and Lamellarin with only a weak kinase inhibition.  Two other lead compds. were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range.  These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurol. or oncol. disorders in which DYRK1A is fully involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopoVhDdU5tMbVg90H21EOLACvtfcHk0lgKvo-EDSNZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D&md5=7d371529cde68f5fc4680c317a0d0a85</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520Lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396%26doi%3D10.1016%2Fj.ejmech.2012.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eY4i1V2H7EeYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3152</span>– <span class="NLM_lpage">3158</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2011.02.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21450467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3152-3158&author=A.+S.+Rosenthalauthor=C.+Tanegaauthor=M.+Shenauthor=B.+T.+Mottauthor=J.+M.+Bougieauthor=D.-T.+Nguyenauthor=T.+Misteliauthor=D.+S.+Auldauthor=D.+J.+Maloneyauthor=C.+J.+Thomas&title=Potent+and+selective+small+molecule+inhibitors+of+specific+isoforms+of+Cdc2-like+kinases+%28Clk%29+and+dual+specificity+tyrosine-phosphorylation-regulated+kinases+%28Dyrk%29&doi=10.1016%2Fj.bmcl.2011.02.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span></div><div class="casAuthors">Rosenthal, Andrew S.; Tanega, Cordelle; Shen, Min; Mott, Bryan T.; Bougie, James M.; Nguyen, Dac-Trung; Misteli, Tom; Auld, Douglas S.; Maloney, David J.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3152-3158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Continued examn. of substituted 6-arylquinazolin-4-amines as Clk4 kinase inhibitors resulted in selective inhibitors of Clk1, Clk4, Dyrk1A, and Dyrk1B kinases.  Several of the most potent inhibitors were validated as being highly selective within a comprehensive kinome scan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-t6jcT2g9qrVg90H21EOLACvtfcHk0lh2U7-fSJxYdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D&md5=37a7ffa16767005c19c559bbe9c3ae71</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.114%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DBougie%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DD.-T.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520specific%2520isoforms%2520of%2520Cdc2-like%2520kinases%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinases%2520%2528Dyrk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3152%26epage%3D3158%26doi%3D10.1016%2Fj.bmcl.2011.02.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braña, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4118</span>– <span class="NLM_lpage">4120</span>, <span class="refDoi"> DOI: 10.1039/B905068J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1039%2Fb905068j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19568652" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4118-4120&author=C.+S%C3%A1nchezauthor=A.+P.+Salasauthor=A.+F.+Bra%C3%B1aauthor=M.+Palominoauthor=A.+Pineda-Lucenaauthor=R.+J.+Carbajoauthor=C.+M%C3%A9ndezauthor=F.+Morisauthor=J.+A.+Salas&title=Generation+of+potent+and+selective+kinase+inhibitors+by+combinatorial+biosynthesis+of+glycosylated+indolocarbazoles&doi=10.1039%2FB905068J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fb905068j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905068j%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DA.%2BP.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DPalomino%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DMoris%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DGeneration%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520by%2520combinatorial%2520biosynthesis%2520of%2520glycosylated%2520indolocarbazoles%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D27%26spage%3D4118%26epage%3D4120%26doi%3D10.1039%2FB905068J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1007/s00018-011-0758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1007%2Fs00018-011-0758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21720886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=449-460&author=S.+Sarnoauthor=M.+Mazzoranaauthor=R.+Traynorauthor=M.+Ruzzeneauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=G.+Zagottoauthor=R.+Battistuttaauthor=L.+A.+Pinna&title=Structural+features+underlying+the+selectivity+of+the+kinase+inhibitors+NBC+and+dNBC%3A+role+of+a+nitro+group+that+discriminates+between+CK2+and+DYRK1A&doi=10.1007%2Fs00018-011-0758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span></div><div class="casAuthors">Sarno, Stefania; Mazzorana, Marco; Traynor, Ryan; Ruzzene, Maria; Cozza, Giorgio; Pagano, Mario A.; Meggio, Flavio; Zagotto, Giuseppe; Battistutta, Roberto; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-460</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">8-Hydroxy-4-methyl-9-nitrobenzo(g)chromen-2-one (NBC) has been found to be a fairly potent ATP site-directed inhibitor of protein kinase CK2 (Ki = 0.22 μM).  Here, we show that NBC also inhibits PIM kinases, esp. PIM1 and PIM3, the latter as potently as CK2.  Upon removal of the nitro group, to give 8-hydroxy-4-methyl-benzo(g)chromen-2-one (here referred to as "denitro NBC", dNBC), the inhibitory power toward CK2 is almost entirely lost (IC50 > 30 μM) whereas that toward PIM1 and PIM3 is maintained; in addn., dNBC is a potent inhibitor of a no. of other kinases that are weakly inhibited or unaffected by NBC, with special ref. to DYRK1A whose IC50 values with NBC and dNBC are 15 and 0.60 μM, resp.  Therefore, the observation that NBC, unlike dNBC, is a potent inducer of apoptosis is consistent with the notion that this effect is mediated by inhibition of endogenous CK2.  The structural features underlying NBC selectivity have been revealed by inspecting its 3D structure in complex with the catalytic subunit of Z. mays CK2.  The crucial role of the nitro group is exerted both through a direct electrostatic interaction with the side chain of Lys68 and, indirectly, by enhancing the acidic dissocn. const. of the adjacent hydroxyl group which interacts with a conserved water mol. in the deepest part of the cavity.  By contrast, the very same nitro group is deleterious for the binding to the active site of DYRK1A, as disclosed by mol. docking.  This provides the rationale for preferential inhibition of DYRK1A by dNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdF4WWERhM7Vg90H21EOLACvtfcHk0li-5VurjEFfkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D&md5=1105a1fc71bd6db43e10b23e073c1b37</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00018-011-0758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-011-0758-7%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DStructural%2520features%2520underlying%2520the%2520selectivity%2520of%2520the%2520kinase%2520inhibitors%2520NBC%2520and%2520dNBC%253A%2520role%2520of%2520a%2520nitro%2520group%2520that%2520discriminates%2520between%2520CK2%2520and%2520DYRK1A%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2012%26volume%3D69%26spage%3D449%26epage%3D460%26doi%3D10.1007%2Fs00018-011-0758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0li-5VurjEFfkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, C.</span></span> <span> </span><span class="NLM_article-title">Developments in harmine pharmacology - Implications for ayahuasca use and drug-dependence treatment</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2012.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.pnpbp.2012.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22691716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCjsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=263-272&author=D.+I.+Brierleyauthor=C.+Davidson&title=Developments+in+harmine+pharmacology+-+Implications+for+ayahuasca+use+and+drug-dependence+treatment&doi=10.1016%2Fj.pnpbp.2012.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in harmine pharmacology - Implications for ayahuasca use and drug-dependence treatment</span></div><div class="casAuthors">Brierley, Daniel I.; Davidson, Colin</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ayahuasca is a hallucinogenic botanical mixt. originating in the Amazon area where it is used ritually, but is now being taken globally.  The 2 main constituents of ayahuasca are N,N-dimethyltryptamine (DMT), a hallucinogen, and harmine, a monoamine oxidase inhibitor (MAOI) which attenuates the breakdown of DMT, which would otherwise be broken down very quickly after oral consumption.  Recent developments in ayahuasca use include the sale of these compds. on the internet and the substitution of related botanical (anahuasca) or synthetic (pharmahuasca) compds. to achieve the same desired hallucinogenic effects.  One intriguing result of ayahuasca use appears to be improved mental health and a redn. in recidivism to alternate (alc., cocaine) drug use.  In this review we discuss the pharmacol. of ayahuasca, with a focus on harmine, and suggest pharmacol. mechanisms for the putative redn. in recidivism to alc. and cocaine misuse.  These pharmacol. mechanisms include MAOI, effects at 5-HT2A and imidazoline receptors and inhibition of dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) and the dopamine transporter.  We also speculate on the therapeutic potential of harmine in other CNS conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBCBZzc81PPLVg90H21EOLACvtfcHk0li-5VurjEFfkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCjsr7P&md5=09e343f3b84458c57c6f9a00b3ba96c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2012.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2012.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBrierley%26aufirst%3DD.%2BI.%26aulast%3DDavidson%26aufirst%3DC.%26atitle%3DDevelopments%2520in%2520harmine%2520pharmacology%2520-%2520Implications%2520for%2520ayahuasca%2520use%2520and%2520drug-dependence%2520treatment%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2012%26volume%3D39%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.pnpbp.2012.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Airaksinen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecklin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomisto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gynther, J.</span></span> <span> </span><span class="NLM_article-title">Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0773.1987.tb01711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1600-0773.1987.tb01711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=3562389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADyaL2sXktFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=5-8&author=M.+M.+Airaksinenauthor=A.+Lecklinauthor=V.+Saanoauthor=L.+Tuomistoauthor=J.+Gynther&title=Tremorigenic+effect+and+inhibition+of+tryptamine+and+serotonin+receptor+binding+by+%CE%B2-carbolines&doi=10.1111%2Fj.1600-0773.1987.tb01711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines</span></div><div class="casAuthors">Airaksinen, M. M.; Lecklin, A.; Saano, V.; Tuomisto, L.; Gynther, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-8</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">The abilities were studied of some naturally occurring β-carbolines (BCs), dihydro-BCs, and tetrahydro-BCs to inhibit the specific binding of [3H]tryptamine (TA), [3H]ketanserine to rat brain membranes and to induce tremor in mice.  These compds., particularly DHBCs and BCs, showed affinity for TA binding sites than to 5-HT1 or 5-HT2 binding sites inhibiting the former at nanomolar and the two latter ones at micromolar or high micromolar concns.  The Ki values for norharmane, harmaline, and harmine, 17, 18, and 74 nM, resp., for TA sites indicate the highest affinity so far described for natural B-carbolines to any receptor sites and thus may indicate their major site of action.  Among the BC derivs. studies, the harmala alkaloids were the most potent inducers of tremor in mice, although the orders of the tremorigenic potency and the binding to TA site did not correlate.  Apparently, the tremorigenic effect of BC derivs. is partly on the binding to specific tryptamine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ydB1vzcvdrVg90H21EOLACvtfcHk0lhhq8g3OwU4Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktFOksb8%253D&md5=c25df7b404a2132d89f16944bf802fb8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1987.tb01711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1987.tb01711.x%26sid%3Dliteratum%253Aachs%26aulast%3DAiraksinen%26aufirst%3DM.%2BM.%26aulast%3DLecklin%26aufirst%3DA.%26aulast%3DSaano%26aufirst%3DV.%26aulast%3DTuomisto%26aufirst%3DL.%26aulast%3DGynther%26aufirst%3DJ.%26atitle%3DTremorigenic%2520effect%2520and%2520inhibition%2520of%2520tryptamine%2520and%2520serotonin%2520receptor%2520binding%2520by%2520%25CE%25B2-carbolines%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1987%26volume%3D60%26spage%3D5%26epage%3D8%26doi%3D10.1111%2Fj.1600-0773.1987.tb01711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuner, A. T. H.</span></span> <span> </span><span class="NLM_article-title">Oberdle wirkung der alkaloide von peganiro ilarroals insbesondere dea Harmallns</span>. <i>Arch. Exp. Pathol. Phannakol.</i> <span class="NLM_year" style="font-weight: bold;">1895</span>,  <span class="NLM_fpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1895&pages=35&author=A.+T.+H.+Neuner&title=Oberdle+wirkung+der+alkaloide+von+peganiro+ilarroals+insbesondere+dea+Harmallns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeuner%26aufirst%3DA.%2BT.%2BH.%26atitle%3DOberdle%2520wirkung%2520der%2520alkaloide%2520von%2520peganiro%2520ilarroals%2520insbesondere%2520dea%2520Harmallns%26jtitle%3DArch.%2520Exp.%2520Pathol.%2520Phannakol.%26date%3D1895%26spage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19264</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lhhq8g3OwU4Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">DNA binding properties of 9-substituted harmine derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.10.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bbrc.2005.10.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16288723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=1557-1563&author=R.+Caoauthor=W.+Pengauthor=H.+Chenauthor=Y.+Maauthor=X.+Liuauthor=X.+Houauthor=H.+Guanauthor=A.+Xu&title=DNA+binding+properties+of+9-substituted+harmine+derivatives&doi=10.1016%2Fj.bbrc.2005.10.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">DNA binding properties of 9-substituted harmine derivatives</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Chen, Hongsheng; Ma, Yan; Liu, Xiaodong; Hou, Xuerui; Guan, Huaji; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1557-1563</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The β-carboline alkaloids have been characterized as a group of potential antitumor agents.  The underlying mechanisms of harmine and its derivs. were investigated by DNA binding assay and Topoisomerase (Topo) inhibition assay.  Meanwhile, the DNA photocleavage potential of these compds. and their cytotoxicity were also examd. by DNA photocleavage assay and cytotoxicity assay in vitro.  Harmine and its derivs. exhibited remarkable DNA intercalation capacity and significant Topo I inhibition activity but no effect with Topo II.  Introducing an appropriate substituent into position-9 of β-carboline nucleus enhanced the affinity of the drug to DNA resulting in remarkable Topo I inhibition effects.  These results suggested that the ability of these compds. to act as intercalating agents and Topo I inhibitors was related to the antitumor activity.  Moreover, these data showing a correlation between cytotoxicity and Topo I inhibition or DNA binding capacity are very important as they strongly suggested that the Topo I-mediated DNA cleavage assay and DNA binding assay could be used as a guide to design and develop superior analogs for antitumor activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2X-pwVBln7Vg90H21EOLACvtfcHk0lhhq8g3OwU4Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egs73J&md5=ec4b1ac12a6ebbd3c0a17a65b11bc190</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.10.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.10.121%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DDNA%2520binding%2520properties%2520of%25209-substituted%2520harmine%2520derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26spage%3D1557%26epage%3D1563%26doi%3D10.1016%2Fj.bbrc.2005.10.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sobhani, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimi, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoudian, M.</span></span> <span> </span><span class="NLM_article-title">An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its β-carboline alkaloids</span>. <i>J. Pharm. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12042115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BD38zhs1antw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=19-23&author=A.+M.+Sobhaniauthor=S.-A.+Ebrahimiauthor=M.+Mahmoudian&title=An+in+vitro+evaluation+of+human+DNA+topoisomerase+I+inhibition+by+Peganum+harmala+L.+seeds+extract+and+its+%CE%B2-carboline+alkaloids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids</span></div><div class="casAuthors">Sobhani Armin Madadkar; Ebrahimi Sultan-Ahmad; Mahmoudian Massoud</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Peganum harmala L. (Zygophyllaceae) seeds extract is one of the main components of an ethnobotanical preparation used in the treatment of neoplasms in Iran.  Cytotoxic effects of P. harmala extract on cancerous cell-lines have been reported before. beta-carbolines like harmaline and harmine are the major alkaloids present in the seeds of the P. harmala.  Considering reports concerning DNA topoisomerase inhibition by other beta-carbolines like harmane, we have used DNA relaxation assays to investigate topoisomerase I inhibitory activity of P. harmala seeds extract and its beta-carboline alkaloids to further inspecting the mechanism of its cytotoxic activity.  METHODS:  Harmine and harmaline contents of the extract were determined using an HPTLC method.  DNA topoisomerase I enzyme needed for investigating inhibitory effect of the compounds using DNA relaxation assay, was partially purified from the human placenta.  DNA relaxation assay is based on the conversion of a supercoiled plasmid substrate to its relaxed form by the catalytic activity of the enzyme.  The supercoiled substrate and its relaxed product can be easily distinguished using agarose gel electrophoresis, since the relaxed topological isomers of DNA migrate more slowly than supercoiled species.  RESULTS:  Using HPTLC method, it was found that each gram of dried extract contained 55.5 and 79.0 mg of harmine and harmaline respectively.  In the DNA relaxation assay, order of potency was harmine > harmane > harmaline > extract.  The most active compound was harmine with IC50 value of 13.5 +/- 1.7 microg/ml.  CONCLUSIONS:  Our in vitro findings demonstrate that P. harmala seeds extract do inhibit human DNA topoisomerase I and based on the results of HPTLC analysis, it appears that the biological activity of the extract can be explained by its beta-carboline content.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTco1bQOg25AENHe_gFldTbfW6udTcc2eaqLVCuiiSaobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zhs1antw%253D%253D&md5=9a28f3bbbc901f48c665505be4e98b2a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobhani%26aufirst%3DA.%2BM.%26aulast%3DEbrahimi%26aufirst%3DS.-A.%26aulast%3DMahmoudian%26aufirst%3DM.%26atitle%3DAn%2520in%2520vitro%2520evaluation%2520of%2520human%2520DNA%2520topoisomerase%2520I%2520inhibition%2520by%2520Peganum%2520harmala%2520L.%2520seeds%2520extract%2520and%2520its%2520%25CE%25B2-carboline%2520alkaloids%26jtitle%3DJ.%2520Pharm.%2520Pharm.%2520Sci.%26date%3D2002%26volume%3D5%26spage%3D19%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine&doi=10.1016%2Fj.bbrc.2004.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0ljvSNNOHflTTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132%26doi%3D10.1016%2Fj.bbrc.2004.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-W.</span></span> <span> </span><span class="NLM_article-title">Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway</span>. <i>Hepatobiliary Pancreatic Dis. Int.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/S1499-3872(11)60102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2FS1499-3872%2811%2960102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22146623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1arsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=599-604&author=M.-R.+Caoauthor=Q.+Liauthor=Z.-L.+Liuauthor=H.-H.+Liuauthor=W.+Wangauthor=X.-L.+Liaoauthor=Y.-L.+Panauthor=J.-W.+Jiang&title=Harmine+induces+apoptosis+in+HepG2+cells+via+mitochondrial+signaling+pathway&doi=10.1016%2FS1499-3872%2811%2960102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway</span></div><div class="casAuthors">Cao, Ming-Rong; Li, Qiang; Liu, Zhi-Long; Liu, Hui-Hui; Wang, Wei; Liao, Xiao-Li; Pan, Yun-Long; Jiang, Jian-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Hepatobiliary & Pancreatic Diseases International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-604</span>CODEN:
                <span class="NLM_cas:coden">HPDIAJ</span>;
        ISSN:<span class="NLM_cas:issn">1499-3872</span>.
    
            (<span class="NLM_cas:orgname">First Affiliated Hospital, Zhejiang University School of Medicine</span>)
        </div><div class="casAbstract">BACKGROUND: Harmine has antitumor and antinociceptive effects, and inhibits human DNA topoisomerase.  However, no detailed data are available on the mechanisms of action of harmine in hepatocellular carcinoma.  This study aimed to investigate the effects of harmine on proliferation and apoptosis, and the underlying mechanisms in the human hepatocellular carcinoma cell line HepG2.  METHODS: The proliferation of HepG2 cells was detd. by the cell counting kit-8 (CCK-8) assay and the clone formation test.  The morphol. of HepG2 cells was examd. using fluorescence microscopy after Hoechst 33258 staining.  Annexin V/propidium iodide (PI) was used to analyze apoptosis and PI to analyze the cell cycle.  Western blotting was used to assess expression of the apoptosis-regulated genes Bcl-2, Bax, Bcl-xl, Mcl-1, caspase-3, and caspase-9.  Mitochondrial transmembrane potential (Ψm) was detd. using JC-1.  RESULTS: Harmine inhibited the proliferation of HepG2 cells in a dose-dependent manner.  Hoechst 33258 staining revealed nuclear fragmentation and chromosomal condensation, cell shrinkage, and attachment loss in HepG2 cells treated with harmine.  The percentage of the sub/G1 fraction was increased in a concn.-dependent manner, indicating apoptotic cell death.  PI staining showed that harmine changed the cell cycle distribution, by decreasing the proportion of cells in G0/G1 and increasing the proportion in S and G2/M.  Harmine induced apoptosis in a concn.-dependent manner, with rates of 20.0%, 32.7% and 64.9%, resp.  JC-1 revealed a decrease in Ψm.  Apoptosis of HepG2 cells was assocd. with caspase-3 and caspase-9 activation, down-regulation of Bcl-2, Mcl-1, and Bcl-xl, and no change in Bax.  CONCLUSIONS: Harmine had an anti-proliferative effect in HepG2 cells by inducing apoptosis.  Mitochondrial signal pathways were involved in the apoptosis.  The cancer-specific selectivity shown in this study suggested that harmine is a promising novel drug for human hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe5bUH_p6tALVg90H21EOLACvtfcHk0ljvSNNOHflTTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1arsA%253D%253D&md5=791b55a1d99c530a3ed3c67bc7d6a792</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS1499-3872%2811%2960102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1499-3872%252811%252960102-1%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DM.-R.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DH.-H.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DX.-L.%26aulast%3DPan%26aufirst%3DY.-L.%26aulast%3DJiang%26aufirst%3DJ.-W.%26atitle%3DHarmine%2520induces%2520apoptosis%2520in%2520HepG2%2520cells%2520via%2520mitochondrial%2520signaling%2520pathway%26jtitle%3DHepatobiliary%2520Pancreatic%2520Dis.%2520Int.%26date%3D2011%26volume%3D10%26spage%3D599%26epage%3D604%26doi%3D10.1016%2FS1499-3872%2811%2960102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taira, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiya, Y.</span></span> <span> </span><span class="NLM_article-title">Intercalation of six β-carboline derivatives into DNA</span>. <i>Eisei Kagaku</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1248/jhs1956.43.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1248%2Fjhs1956.43.83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1997&pages=83-91&author=Z.+Tairaauthor=S.+Kanzawaauthor=C.+Doharaauthor=S.+Ishidaauthor=M.+Matsumotoauthor=Y.+Sakiya&title=Intercalation+of+six+%CE%B2-carboline+derivatives+into+DNA&doi=10.1248%2Fjhs1956.43.83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1248%2Fjhs1956.43.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fjhs1956.43.83%26sid%3Dliteratum%253Aachs%26aulast%3DTaira%26aufirst%3DZ.%26aulast%3DKanzawa%26aufirst%3DS.%26aulast%3DDohara%26aufirst%3DC.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DSakiya%26aufirst%3DY.%26atitle%3DIntercalation%2520of%2520six%2520%25CE%25B2-carboline%2520derivatives%2520into%2520DNA%26jtitle%3DEisei%2520Kagaku%26date%3D1997%26volume%3D43%26spage%3D83%26epage%3D91%26doi%3D10.1248%2Fjhs1956.43.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdolazimi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegretti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalizi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annes, J. P.</span></span> <span> </span><span class="NLM_article-title">CC-401 promotes β-cell replication via pleiotropic consequences of DYRK1A/B inhibition</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">3143</span>– <span class="NLM_lpage">3157</span>, <span class="refDoi"> DOI: 10.1210/en.2018-00083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1210%2Fen.2018-00083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=29514186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCgu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=3143-3157&author=Y.+Abdolazimiauthor=Z.+Zhaoauthor=S.+Leeauthor=H.+Xuauthor=P.+Allegrettiauthor=T.+M.+Hortonauthor=B.+Yehauthor=H.+P.+Moellerauthor=R.+J.+Nicholsauthor=D.+McCutcheonauthor=A.+Shaliziauthor=M.+Smithauthor=N.+A.+Armstrongauthor=J.+P.+Annes&title=CC-401+promotes+%CE%B2-cell+replication+via+pleiotropic+consequences+of+DYRK1A%2FB+inhibition&doi=10.1210%2Fen.2018-00083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">CC-401 promotes β-cell replication via pleiotropic consequences of DYRK1A/B inhibition</span></div><div class="casAuthors">Abdolazimi, Yassan; Zhao, Zhengshan; Lee, Sooyeon; Xu, Haixia; Allegretti, Paul; Horton, Timothy M.; Yeh, Benjamin; Moeller, Hannah P.; Nichols, Robert J.; McCutcheon, David; Shalizi, Aryaman; Smith, Mark; Armstrong, Neali A.; Annes, Justin P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3143-3157</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pharmacol. expansion of endogenous β cells is a promising therapeutic strategy for diabetes.  To elucidate the mol. pathways that control β-cell growth we screened ∼2400 bioactive compds. for rat β-cell replication-modulating activity.  Numerous hit compds. impaired or promoted rat β-cell replication, including CC-401, an advanced clin. candidate previously characterized as a c-Jun N-terminal kinase inhibitor.  Surprisingly, CC-401 induced rodent (in vitro and in vivo) and human (in vitro) β-cell replication via dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) 1A and 1B inhibition.  In contrast to rat β cells, which were broadly growth responsive to compd. treatment, human β-cell replication was only consistently induced by DYRK1A/B inhibitors.  This effect was enhanced by simultaneous glycogen synthase kinase-3β (GSK-3β) or activin A receptor type II-like kinase/transforming growth factor-β (ALK5/TGF-β) inhibition.  Prior work emphasized DYRK1A/B inhibition-dependent activation of nuclear factor of activated T cells (NFAT) as the primary mechanism of human β-cell-replication induction.  However, inhibition of NFAT activity had limited effect on CC-401-induced β-cell replication.  Consequently, we investigated addnl. effects of CC-401-dependent DYRK1A/B inhibition.  Indeed, CC-401 inhibited DYRK1A-dependent phosphorylation/stabilization of the β-cell-replication inhibitor p27Kip1.  Addnl., CC-401 increased expression of numerous replication-promoting genes normally suppressed by the dimerization partner, RB-like, E2F and multivulval class B (DREAM) complex, which depends upon DYRK1A/B activity for integrity, including MYBL2 and FOXM1.  In summary, we present a compendium of compds. as a valuable resource for manipulating the signaling pathways that control β-cell replication and leverage a DYRK1A/B inhibitor (CC-401) to expand our understanding of the mol. pathways that control β-cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0bClqAWU1ZLVg90H21EOLACvtfcHk0lgyrfArxXfOsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCgu7rP&md5=35cb7f0245f44f2d8a66eae8a78b390e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1210%2Fen.2018-00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2018-00083%26sid%3Dliteratum%253Aachs%26aulast%3DAbdolazimi%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DAllegretti%26aufirst%3DP.%26aulast%3DHorton%26aufirst%3DT.%2BM.%26aulast%3DYeh%26aufirst%3DB.%26aulast%3DMoeller%26aufirst%3DH.%2BP.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DMcCutcheon%26aufirst%3DD.%26aulast%3DShalizi%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DN.%2BA.%26aulast%3DAnnes%26aufirst%3DJ.%2BP.%26atitle%3DCC-401%2520promotes%2520%25CE%25B2-cell%2520replication%2520via%2520pleiotropic%2520consequences%2520of%2520DYRK1A%252FB%2520inhibition%26jtitle%3DEndocrinology%26date%3D2018%26volume%3D159%26spage%3D3143%26epage%3D3157%26doi%3D10.1210%2Fen.2018-00083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man-Un Ung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2018.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30170319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ent7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=1005-1016&author=K.+Kumarauthor=P.+Man-Un+Ungauthor=P.+Wangauthor=H.+Wangauthor=H.+Liauthor=M.+K.+Andrewsauthor=A.+F.+Stewartauthor=A.+Schlessingerauthor=R.+J.+DeVita&title=Novel+selective+thiadiazine+DYRK1A+inhibitor+lead+scaffold+with+human+pancreatic+%CE%B2-cell+proliferation+activity&doi=10.1016%2Fj.ejmech.2018.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity</span></div><div class="casAuthors">Kumar, Kunal; Man-Un Ung, Peter; Wang, Peng; Wang, Hui; Li, Hailing; Andrews, Mary K.; Stewart, Andrew F.; Schlessinger, Avner; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) is an enzyme that has been implicated as an important drug target in various therapeutic areas, including neurol. disorders (Down syndrome, Alzheimer's disease), oncol., and diabetes (pancreatic β-cell expansion).  Current small mol. DYRK1A inhibitors are ATP-competitive inhibitors that bind to the kinase in an active conformation.  As a result, these inhibitors are promiscuous, resulting in pharmacol. side effects that limit their therapeutic applications.  None are in clin. trials at this time.  In order to identify a new DYRK1A inhibitor scaffold, we constructed a homol. model of DYRK1A in an inactive, DFG-out conformation.  Virtual screening of 2.2 million lead-like compds. from the ZINC database, followed by in vitro testing of selected 68 compds. revealed 8 hits representing 5 different chem. classes.  We chose to focus on one of the hits from the computational screen, thiadiazine 1 which was found to inhibit DYRK1A with IC50 of 9.41 μM (Kd = 7.3 μM).  Optimization of the hit compd. 1, using structure-activity relationship (SAR) anal. and in vitro testing led to the identification of potent thiadiazine analogs with significantly improved binding as compared to the initial hit (Kd = 71-185 nM).  Compd. 3-5 induced human β-cell proliferation at 5 μM while showing selectivity for DYRK1A over DYRK1B and DYRK2 at 10 μM.  This newly developed DYRK1A inhibitor scaffold with unique kinase selectivity profiles has potential to be further optimized as novel therapeutics for diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs8HXnn8ewabVg90H21EOLACvtfcHk0lgyrfArxXfOsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ent7vE&md5=026fe0a5ddf42ebeacdea9c5838b0565</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DMan-Un%2BUng%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DAndrews%26aufirst%3DM.%2BK.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DSchlessinger%26aufirst%3DA.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DNovel%2520selective%2520thiadiazine%2520DYRK1A%2520inhibitor%2520lead%2520scaffold%2520with%2520human%2520pancreatic%2520%25CE%25B2-cell%2520proliferation%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D1005%26epage%3D1016%26doi%3D10.1016%2Fj.ejmech.2018.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aamodt, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aramandla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. C.</span></span> <span> </span><span class="NLM_article-title">Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">E859</span>– <span class="NLM_lpage">E868</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00515.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1152%2Fajpendo.00515.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27624103" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=E859-E868&author=K.+I.+Aamodtauthor=R.+Aramandlaauthor=J.+J.+Brownauthor=N.+Fiaschi-Taeschauthor=P.+Wangauthor=A.+F.+Stewartauthor=M.+Brissovaauthor=A.+C.+Powers&title=Development+of+a+reliable+automated+screening+system+to+identify+small+molecules+and+biologics+that+promote+human+%CE%B2-cell+regeneration&doi=10.1152%2Fajpendo.00515.2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00515.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00515.2015%26sid%3Dliteratum%253Aachs%26aulast%3DAamodt%26aufirst%3DK.%2BI.%26aulast%3DAramandla%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DJ.%2BJ.%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DBrissova%26aufirst%3DM.%26aulast%3DPowers%26aufirst%3DA.%2BC.%26atitle%3DDevelopment%2520of%2520a%2520reliable%2520automated%2520screening%2520system%2520to%2520identify%2520small%2520molecules%2520and%2520biologics%2520that%2520promote%2520human%2520%25CE%25B2-cell%2520regeneration%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D311%26spage%3DE859%26epage%3DE868%26doi%3D10.1152%2Fajpendo.00515.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0ljNl6euq9vtuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaway, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habegger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriever, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cáceres, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabra, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembree, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irmler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabě de Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauvais-Jarvis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Tilve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfluger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarchi, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span> <span> </span><span class="NLM_article-title">Targeted estrogen delivery reverses the metabolic syndrome</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+Hrab%C4%9B+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Targeted+estrogen+delivery+reverses+the+metabolic+syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0ljNl6euq9vtuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DHrab%25C4%259B%2Bde%2BAngelis%26aufirst%3DM.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520estrogen%2520delivery%2520reverses%2520the%2520metabolic%2520syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauvais-Jarvis, F.</span></span> <span> </span><span class="NLM_article-title">Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">10211</span>, <span class="refDoi"> DOI: 10.1038/srep10211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fsrep10211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25970118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyhsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=10211&author=J.+P.+Tianoauthor=C.+R.+Tateauthor=B.+S.+Yangauthor=R.+DiMarchiauthor=F.+Mauvais-Jarvis&title=Effect+of+targeted+estrogen+delivery+using+glucagon-like+peptide-1+on+insulin+secretion%2C+insulin+sensitivity+and+glucose+homeostasis&doi=10.1038%2Fsrep10211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis</span></div><div class="casAuthors">Tiano, Joseph P.; Tate, Chandra R.; Yang, Bin S.; DiMarchi, Richard; Mauvais-Jarvis, Franck</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10211</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The female estrogen 17β-estradiol (E2) enhances pancreatic β-cell function via estrogen receptors (ERs).  However, the risk of hormone dependent cancer precludes the use of general estrogen therapy as a chronic treatment for diabetes.  To target E2 to β-cells without the undesirable effects of general estrogen therapy, we created fusion peptides combining active or inactive glucagon-like peptide-1 (GLP-1) and E2 in a single mol. (aGLP1-E2 and iGLP1-E2 resp.).  By combining the activities of GLP-1 and E2, we envisioned synergistic insulinotropic activities of these mols. on β-cells.  In cultured human islets and in C57BL/6 mice, both aGLP1 and aGLP1-E2 enhanced glucose-stimulated insulin secretion (GSIS) compared to vehicle and iGLP1-E2 without superior efficacy of aGLP1-E2 compared to GLP-1 alone.  However, aGLP1-E2 decreased fasting and fed blood glucose to a greater extent than aGLP1 and iGLP1-E2 alone.  Further, aGLP1-E2 exhibited improved insulin sensitivity compared to aGLP1 and iGLP1-E2 alone (HOMA-IR and insulin tolerance test).  In conclusion, targeted estrogen delivery to non-diabetic islets in the presence of GLP-1 does not enhance GSIS.  However, combining GLP-1 to estrogen delivers addnl. efficacy relative to GLP-1 alone on insulin sensitivity and glucose homeostasis in non-diabetic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra17oR2-_WP7Vg90H21EOLACvtfcHk0lhyciHm1Ymv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyhsrzK&md5=7141125efc709a1b572c8c74baaf8637</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsrep10211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep10211%26sid%3Dliteratum%253Aachs%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DTate%26aufirst%3DC.%2BR.%26aulast%3DYang%26aufirst%3DB.%2BS.%26aulast%3DDiMarchi%26aufirst%3DR.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26atitle%3DEffect%2520of%2520targeted%2520estrogen%2520delivery%2520using%2520glucagon-like%2520peptide-1%2520on%2520insulin%2520secretion%252C%2520insulin%2520sensitivity%2520and%2520glucose%2520homeostasis%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D10211%26doi%3D10.1038%2Fsrep10211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human β-cell proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7687</span>– <span class="NLM_lpage">7699</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSrsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7687-7699&author=K.+Kumarauthor=P.+Wangauthor=R.+Sanchezauthor=E.+A.+Swartzauthor=A.+F.+Stewartauthor=R.+J.+DeVita&title=Development+of+kinase-selective%2C+harmine-based+DYRK1A+inhibitors+that+induce+pancreatic+human+%CE%B2-cell+proliferation&doi=10.1021%2Facs.jmedchem.8b00658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation</span></div><div class="casAuthors">Kumar, Kunal; Wang, Peng; Sanchez, Roberto; Swartz, Ethan A.; Stewart, Andrew F.; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7687-7699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has been implicated as an important drug target in various therapeutic areas, including neurol. disorders and oncol.  DYRK1A has more recently been shown to be involved in pathways regulating human β-cell proliferation, thus making it a potential therapeutic target for both Type 1 and Type 2 diabetes.  Our group, using a high-throughput phenotypic screen identified harmine that is able to induce beta cell proliferation both in vitro and in vivo.  Since harmine has suboptimal kinase selectivity we sought to expand structure-activity relationships for harmine's DYRK1A activity, to enhance selectivity, while retaining human β-cell proliferation capability.  We carried out the optimization of the 1-position of harmine and synthesized 15 harmine analogs.  6 Compds. showed excellent DYRK1A inhibition with IC50 in the range of 49.5-264 nM.  Two compds., 2-2 and 2-8, exhibited excellent human β-cell proliferation at doses of 3-30 μM and compd. 2-2 showed improved kinase selectivity as compared to harmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFSDNEicChLVg90H21EOLACvtfcHk0lhyciHm1Ymv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSrsb7M&md5=e1b748db912ac5b0ef93b8729ad4b13e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00658%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DSwartz%26aufirst%3DE.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520kinase-selective%252C%2520harmine-based%2520DYRK1A%2520inhibitors%2520that%2520induce%2520pancreatic%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7687%26epage%3D7699%26doi%3D10.1021%2Facs.jmedchem.8b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0lhyciHm1Ymv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulyanova, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glicksman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. M. G.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2019</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2012.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22335895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlKmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2015-2019&author=G.+D.+Cunyauthor=N.+P.+Ulyanovaauthor=D.+Patnaikauthor=J.-F.+Liuauthor=X.+Linauthor=K.+Auerbachauthor=S.+S.+Rayauthor=J.+Xianauthor=M.+A.+Glicksmanauthor=R.+L.+Steinauthor=J.+M.+G.+Higgins&title=Structure-activity+relationship+study+of+beta-carboline+derivatives+as+haspin+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors</span></div><div class="casAuthors">Cuny, Gregory D.; Ulyanova, Natalia P.; Patnaik, Debasis; Liu, Ji-Feng; Lin, Xiangjie; Auerbach, Ken; Ray, Soumya S.; Xian, Jun; Glicksman, Marcie A.; Stein, Ross L.; Higgins, Jonathan M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2015-2019</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Haspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis that has emerged as a possible cancer therapeutic target.  High throughput screening of approx. 140,000 compds. identified the β-carbolines harmine and harmol as moderately potent haspin kinase inhibitors.  Based on information obtained from a structure-activity relationship study previously conducted for an acridine series of haspin inhibitors in conjunction with in silico docking using a recently disclosed crystal structure of the kinase, harmine analogs were designed that resulted in significantly increased haspin kinase inhibitory potency.  The harmine derivs. also demonstrated less activity towards DYRK2 compared to the acridine series.  In vitro mouse liver microsome stability and kinase profiling of a representative member of the harmine series (42, LDN-211898) are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDv6AjhnkUVrVg90H21EOLACvtfcHk0lhT__ljtTAcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlKmt7Y%253D&md5=b4d8195c003327228b5ab153fedc1c73</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DUlyanova%26aufirst%3DN.%2BP.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.-F.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DAuerbach%26aufirst%3DK.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DHiggins%26aufirst%3DJ.%2BM.%2BG.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520beta-carboline%2520derivatives%2520as%2520haspin%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2015%26epage%3D2019%26doi%3D10.1016%2Fj.bmcl.2012.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. S.</span></span> <span> </span><span class="NLM_article-title">Pd–C-induced catalytic transfer hydrogenation with triethylsilane</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6599</span>– <span class="NLM_lpage">6601</span>, <span class="refDoi"> DOI: 10.1021/jo0706123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0706123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFegsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6599-6601&author=P.+K.+Mandalauthor=J.+S.+McMurray&title=Pd%E2%80%93C-induced+catalytic+transfer+hydrogenation+with+triethylsilane&doi=10.1021%2Fjo0706123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-C-Induced Catalytic Transfer Hydrogenation with Triethylsilane</span></div><div class="casAuthors">Mandal, Pijus K.; McMurray, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6599-6601</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In situ generation of mol. hydrogen by addn. of triethylsilane to palladium-charcoal catalyst results in rapid and efficient redn. of multiple bonds, azides, imines, and nitro groups, as well as benzyl group and allyl group deprotection under mild, neutral conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfxyBSLp44bVg90H21EOLACvtfcHk0lhT__ljtTAcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFegsLg%253D&md5=d1f8e323daef824e892eafc43f941222</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo0706123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0706123%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DPd%25E2%2580%2593C-induced%2520catalytic%2520transfer%2520hydrogenation%2520with%2520triethylsilane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D6599%26epage%3D6601%26doi%3D10.1021%2Fjo0706123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. W. P.</span>; <span class="NLM_string-name">Swartz, E.A.</span>; <span class="NLM_string-name">Sanchez, R.</span>; <span class="NLM_string-name">Stewart, A.F.</span>; <span class="NLM_string-name">DeVita, R.J.</span></span>,unpublished</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kumar%2C+K.+W.+P.%3B+Swartz%2C+E.A.%3B+Sanchez%2C+R.%3B+Stewart%2C+A.F.%3B+DeVita%2C+R.J.%2Cunpublished"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%2BW.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Badura, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamowicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprouse, J.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.122846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1124%2Fjpet.107.122846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=17502429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=730-738&author=L.+Baduraauthor=T.+Swansonauthor=W.+Adamowiczauthor=J.+Adamsauthor=J.+Cianfrognaauthor=K.+Fisherauthor=J.+Hollandauthor=R.+Kleimanauthor=F.+Nelsonauthor=L.+Reynoldsauthor=K.+S.+Germainauthor=E.+Schaefferauthor=B.+Tateauthor=J.+Sprouse&title=An+inhibitor+of+casein+kinase+I%CE%B5+induces+phase+delays+in+circadian+rhythms+under+free-running+and+entrained+conditions&doi=10.1124%2Fjpet.107.122846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span></div><div class="casAuthors">Badura, Lori; Swanson, Terri; Adamowicz, Wendy; Adams, Jessica; Cianfrogna, Julie; Fisher, Katherine; Holland, Janice; Kleiman, Robin; Nelson, Frederick; Reynolds, Linda; St. Germain, Kristin; Schaeffer, Eric; Tate, Barbara; Sprouse, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Casein kinase Iε (CKIε) is an essential component of the biol. clock, phosphorylating PER proteins, and in doing so regulating their turnover and nuclear entry in oscillator cells of the suprachiasmatic nucleus (SCN).  Although hereditary decreases in PER phosphorylation have been well characterized, little is known about the consequences of acute enzyme inhibition by pharmacol. means.  A novel reagent, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), proved to be both a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 addnl. kinases) inhibitor of CKIε in isolated enzyme prepns.; in transfected whole cell assays, it caused a concn.-related redistribution of nuclear vs. cytosolic PER.  When tested in free-running animals, 50 mg/kg s.c. PF-670462 produced robust phase delays when dosed at circadian time (CT)9 (-1.97 ± 0.17 h).  Entrained rats dosed in normal light-dark (LD) and then released to const. darkness also experienced phase delays that were dose- and time of dosing-dependent.  PF-670462 yielded only phase delays across the circadian cycle with the most sensitive time at CT12 when PER levels are near their peak in the SCN.  Most importantly, these drug-induced phase delays persisted in animals entrained and maintained in LD throughout the entire expt.; re-entrainment to the prevailing LD required days in contrast to the rapid elimination of the drug (t1/2 = 0.46 ± 0.04 h).  Together, these results suggest that inhibition of CKIε yields a perturbation of oscillator function that forestalls light as a zeitgeber, and they demonstrate that pharmacol. tools such as PF-670462 may yield valuable insight into clock function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfqMEeisE8I7Vg90H21EOLACvtfcHk0lhT__ljtTAcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D&md5=ec355b6d0cee0f1ad9d37cad55f0936d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122846%26sid%3Dliteratum%253Aachs%26aulast%3DBadura%26aufirst%3DL.%26aulast%3DSwanson%26aufirst%3DT.%26aulast%3DAdamowicz%26aufirst%3DW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DK.%2BS.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DSprouse%26aufirst%3DJ.%26atitle%3DAn%2520inhibitor%2520of%2520casein%2520kinase%2520I%25CE%25B5%2520induces%2520phase%2520delays%2520in%2520circadian%2520rhythms%2520under%2520free-running%2520and%2520entrained%2520conditions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D730%26epage%3D738%26doi%3D10.1124%2Fjpet.107.122846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevsky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waltman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langan, P.</span></span> <span> </span><span class="NLM_article-title">Low- and room-temperature X-ray structures of protein kinase A ternary complexes shed new light on its activity</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1107/S0907444912014886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444912014886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22751671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=854-860&author=A.+Y.+Kovalevskyauthor=H.+Johnsonauthor=B.+L.+Hansonauthor=M.+J.+Waltmanauthor=S.+Z.+Fisherauthor=S.+Taylorauthor=P.+Langan&title=Low-+and+room-temperature+X-ray+structures+of+protein+kinase+A+ternary+complexes+shed+new+light+on+its+activity&doi=10.1107%2FS0907444912014886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Low- and room-temperature X-ray structures of protein kinase A ternary complexes shed new light on its activity</span></div><div class="casAuthors">Kovalevsky, Andrey Y.; Johnson, Hanna; Hanson, B. Leif; Waltman, Mary Jo; Fisher, S. Zoe; Taylor, Susan; Langan, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">854-860</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Post-translational protein phosphorylation by protein kinase A (PKA) is a ubiquitous signalling mechanism which regulates many cellular processes.  A low-temp. X-ray structure of the ternary complex of the PKA catalytic subunit (PKAc) with ATP and a 20-residue peptidic inhibitor (IP20) at the physiol. Mg2+ concn. of ∼0.5 mM (LT PKA-MgATP-IP20) revealed a single metal ion in the active site.  The lack of a second metal in LT PKA-MgATP-IP20 renders the β- and γ-phosphoryl groups of ATP very flexible, with high thermal B factors.  Thus, the second metal is crucial for tight positioning of the terminal phosphoryl group for transfer to a substrate, as demonstrated by comparison of the former structure with that of the LT PKA-Mg2ATP-IP20 complex obtained at high Mg2+ concn.  In addn. to its kinase activity, PKAc is also able to slowly catalyze the hydrolysis of ATP using a water mol. as a substrate.  It was found that ATP can be readily and completely hydrolyzed to ADP and a free phosphate ion in the crystals of the ternary complex PKA-Mg2ATP-IP20 by X-ray irradn. at room temp.  The cleavage of ATP may be aided by X-ray-generated free hydroxyl radicals, a very reactive chem. species, which move rapidly through the crystal at room temp.  The phosphate anion is clearly visible in the electron-d. maps; it remains in the active site but slides about 2 Å from its position in ATP towards Ala21 of IP20, which mimics the phosphorylation site.  The phosphate thus pushes the peptidic inhibitor away from the product ADP, while resulting in dramatic conformational changes of the terminal residues 24 and 25 of IP20.  X-ray structures of PKAc in complex with the nonhydrolysable ATP analog AMP-PNP at both room and low temp. demonstrated no temp. effects on the conformation and position of IP20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHHJMAvF9CVbVg90H21EOLACvtfcHk0ljFE71jNixt4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKntLo%253D&md5=ac54b7be35741645baf4e367f4276a0e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444912014886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912014886%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevsky%26aufirst%3DA.%2BY.%26aulast%3DJohnson%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DB.%2BL.%26aulast%3DWaltman%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DS.%2BZ.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DLangan%26aufirst%3DP.%26atitle%3DLow-%2520and%2520room-temperature%2520X-ray%2520structures%2520of%2520protein%2520kinase%2520A%2520ternary%2520complexes%2520shed%2520new%2520light%2520on%2520its%2520activity%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D854%26epage%3D860%26doi%3D10.1107%2FS0907444912014886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. R. W.</span></span> <span> </span><span class="NLM_article-title">The analysis of drug-induced tremor in mice</span>. <i>Br. J. Pharmacol. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1959.tb00255.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1476-5381.1959.tb00255.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=13792135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADyaF3c7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1959&pages=350-354&author=A.+Ahmedauthor=N.+R.+W.+Taylor&title=The+analysis+of+drug-induced+tremor+in+mice&doi=10.1111%2Fj.1476-5381.1959.tb00255.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The analysis of drug-induced tremor in mice</span></div><div class="casAuthors">AHMED A; TAYLOR N R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology and chemotherapy</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">350-4</span>
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">An improved method of recording tremor in mice has been developed using a gramophone pick-up and a cathode ray oscillograph.  Permanent records are made on 35 mm. film from which it is possible to determine qualitative differences in the tremor caused by various drugs.  In addition, the severity of the tremor may be estimated quantitatively by a tremor index.  The rate and variations in the rhythm and amplitude and in the tremor index have been determined for Tremorine (1,4-dipyrrolidin-1'-ylbut-2-yne), harmine, harmaline, 3-amino-1,1,3-triphenylpropan-1-ol and lysergic acid diethylamide.  The incidence of side effects has also been noted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ54s5KS7l7ozslzEEsg76ufW6udTcc2eaJcPmCHEx2gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c7ht1Crtg%253D%253D&md5=a5ca7ef7d3e06730585ff5cd29a58722</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1959.tb00255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1959.tb00255.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DN.%2BR.%2BW.%26atitle%3DThe%2520analysis%2520of%2520drug-induced%2520tremor%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1959%26volume%3D14%26spage%3D350%26epage%3D354%26doi%3D10.1111%2Fj.1476-5381.1959.tb00255.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayukawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothstein, J. D.</span></span> <span> </span><span class="NLM_article-title">Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1168</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.neuropharm.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21034752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1168-1175&author=Y.+Liauthor=R.+Sattlerauthor=E.-J.+Yangauthor=A.+Nunesauthor=Y.+Ayukawaauthor=S.+Akhtarauthor=G.+Jiauthor=P.-W.+Zhangauthor=J.+D.+Rothstein&title=Harmine%2C+a+natural+beta-carboline+alkaloid%2C+upregulates+astroglial+glutamate+transporter+expression&doi=10.1016%2Fj.neuropharm.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression</span></div><div class="casAuthors">Li, Yun; Sattler, Rita; Yang, Eun-Ju; Nunes, Alice; Ayukawa, Yoko; Akhtar, Sadia; Ji, Grace; Zhang, Ping-Wu; Rothstein, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1168-1175</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutamate is the predominant excitatory amino acid neurotransmitter in the mammalian central nervous system (CNS).  Glutamate transporter EAAT2/GLT-1 is the physiol. dominant astroglial protein that inactivates synaptic glutamate.  Previous studies have shown that EAAT2 dysfunction leads to excessive extracellular glutamate and may contribute to various neurol. disorders including amyotrophic lateral sclerosis (ALS).  The recent discovery of the neuroprotective properties of ceftriaxone, a beta lactam antibiotic, suggested that increasing EAAT2/GLT-1 gene expression might be beneficial in ALS and other neurol./psychiatric disorders by augmenting astrocytic glutamate uptake.  Here we report our efforts to develop a new screening assay for identifying compds. that activate EAAT2 gene expression.  We generated fetal derived-human immortalized astroglial cells that are stably expressing a firefly luciferase reporter under the control of the human EAAT2 promoter.  When screening a library of 1040 FDA approved compds. and natural products, we identified harmine, a naturally occurring beta-carboline alkaloid, as one of the top hits for activating the EAAT2 promoter.  We further tested harmine in our in vitro cell culture systems and confirmed its ability to increase EAAT2/GLT1 gene expression and functional glutamate uptake activity.  We next tested its efficacy in both wild type animals and in an ALS animal model of disease and demonstrated that harmine effectively increased GLT-1 protein and glutamate transporter activity in vivo.  Our studies provide potential novel neurotherapeutics by modulating the activity of glutamate transporters via gene activation.  This article is part of a Special Issue entitled Trends in Neuropharmacol.: In Memory of Erminio Costa'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzo1F7uOuH9bVg90H21EOLACvtfcHk0ljFE71jNixt4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKitLw%253D&md5=1263b8e50c747350e60b999e176f7884</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSattler%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DE.-J.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DAyukawa%26aufirst%3DY.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.-W.%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DHarmine%252C%2520a%2520natural%2520beta-carboline%2520alkaloid%252C%2520upregulates%2520astroglial%2520glutamate%2520transporter%2520expression%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D1168%26epage%3D1175%26doi%3D10.1016%2Fj.neuropharm.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demirci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casinelli, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado-Gil, J. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rausell-Palamos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasavada, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.2337/db13-0333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb13-0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24089510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=216-223&author=J.+C.+Alvarez-Perezauthor=S.+Ernstauthor=C.+Demirciauthor=G.+P.+Casinelliauthor=J.+M.+D.+Mellado-Gilauthor=F.+Rausell-Palamosauthor=R.+C.+Vasavadaauthor=A.+Garcia-Ocana&title=Hepatocyte+growth+factor%2Fc-Met+signaling+is+required+for+%CE%B2-cell+regeneration&doi=10.2337%2Fdb13-0333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration</span></div><div class="casAuthors">Alvarez-Perez, Juan Carlos; Ernst, Sara; Demirci, Cem; Casinelli, Gabriella P.; Mellado-Gil, Jose Manuel D.; Rausell-Palamos, Francisco; Vasavada, Rupangi C.; Garcia-Ocana, Adolfo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216-223</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) is a mitogen required for β-cell replication during pregnancy.  To det. whether HGF/c-Met signaling is required for β-cell regeneration, we characterized mice with pancreatic deletion of the HGF receptor, c-Met (PancMet KO mice), in two models of reduced β-cell mass and regeneration: multiple low-dose streptozotocin (MLDS) and partial pancreatectomy (Ppx).  We also analyzed whether HGF administration could accelerate β-cell regeneration in wild-type (WT) mice after Ppx.  Mouse islets obtained 7 days post-Ppx displayed significantly increased c-Met, suggesting a potential role for HGF/c-Met in β-cell proliferation in situations of reduced β-cell mass.  Indeed, adult PancMet KO mice displayed markedly reduced β-cell replication compared with WT mice 7 days post-Ppx.  Similarly, β-cell proliferation was decreased in PancMet KO mice in the MLDS mouse model.  The decrease in β-cell proliferation post-Ppx correlated with a striking decrease in D-cyclin levels.  Importantly, PancMet KO mice showed significantly diminished β-cell mass, decreased glucose tolerance, and impaired insulin secretion compared with WT mice 28 days post-Ppx.  Conversely, HGF administration in WT Ppx mice further accelerated β-cell regeneration.  These results indicate that HGF/c-Met signaling is crit. for β-cell proliferation in situations of diminished β-cell mass and suggest that activation of this pathway can enhance β-cell regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt81XkL5IvN7Vg90H21EOLACvtfcHk0liaNukwbQNTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtw%253D%253D&md5=5bba6716d3ef34fde1cdc1a0d569d0b7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0333%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DErnst%26aufirst%3DS.%26aulast%3DDemirci%26aufirst%3DC.%26aulast%3DCasinelli%26aufirst%3DG.%2BP.%26aulast%3DMellado-Gil%26aufirst%3DJ.%2BM.%2BD.%26aulast%3DRausell-Palamos%26aufirst%3DF.%26aulast%3DVasavada%26aufirst%3DR.%2BC.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-Met%2520signaling%2520is%2520required%2520for%2520%25CE%25B2-cell%2520regeneration%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D216%26epage%3D223%26doi%3D10.2337%2Fdb13-0333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
León, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahima, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffers, D. A.</span></span> <span> </span><span class="NLM_article-title">Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2337/diabetes.52.2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdiabetes.52.2.365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12540609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=365-371&author=D.+D.+De%0ALe%C3%B3nauthor=S.+Dengauthor=R.+Madaniauthor=R.+S.+Ahimaauthor=D.+J.+Druckerauthor=D.+A.+Stoffers&title=Role+of+endogenous+glucagon-like+peptide-1+in+islet+regeneration+after+partial+pancreatectomy&doi=10.2337%2Fdiabetes.52.2.365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy</span></div><div class="casAuthors">De Leon, Diva D.; Deng, Shaoping; Madani, Reza; Ahima, Rexford S.; Drucker, Daniel J.; Stoffers, Doris A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-371</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">A redn. in β-cell mass is an important causative factor in type 1 and type 2 diabetes.  Glucagon-like peptide-1 (GLP-1) and the long-acting agonist exendin 4 (Ex-4) expand β-cell mass by stimulating neogenesis and proliferation.  In the partial pancreatectomy (Ppx) model, exogenous Ex-4 promotes islet regeneration, leading to sustained improvement in glucose tolerance.  In this study, the authors investigate the potential role of endogenous GLP-1 in islet growth.  The authors examd. β-cell mass regeneration after 70% Ppx in mice receiving the GLP-1 antagonist Ex9-39 and in GLP-1R-/- mice.  In Ex9-39-treated sham-operated mice, persistent fasting hyperglycemia was obsd., but β-cell mass was not diminished.  In pancreatectomized mice, persistent glucose intolerance was noted, but this was not further exacerbated by Ex9-39.  Accordingly, β-cell mass recovery of Ppx mice was not impaired by Ex9-39.  In contrast, GLP-1R-/- CD1 mice showed worse glucose intolerance after Ppx compared with wild-type CD1 Ppx mice, and this correlated with a significant defect in β-cell mass regeneration.  The recovery of β-cell mass differed markedly in the BALB/c and CD1 control mice, indicating a significant role of genetic background in the regulation of β-cell mass.  These studies point to a role for endogenous GLP-1 in β-cell regeneration after Ppx in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorHP2L4qw57rVg90H21EOLACvtfcHk0liaNukwbQNTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFans74%253D&md5=c268594ec12721ec54e6811f7d571828</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.2.365%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLe%25C3%25B3n%26aufirst%3DD.%2BD.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DMadani%26aufirst%3DR.%26aulast%3DAhima%26aufirst%3DR.%2BS.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DStoffers%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520endogenous%2520glucagon-like%2520peptide-1%2520in%2520islet%2520regeneration%2520after%2520partial%2520pancreatectomy%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D365%26epage%3D371%26doi%3D10.2337%2Fdiabetes.52.2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Leon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimple, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamming, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrins, M. J.</span></span> <span> </span><span class="NLM_article-title">Age-dependent protection of insulin secretion in diet induced obese mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">17814</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36289-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fs41598-018-36289-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30546031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslKju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=17814&author=E.+R.+De%0ALeonauthor=J.+A.+Brinkmanauthor=R.+J.+Fenskeauthor=T.+Greggauthor=B.+A.+Schmidtauthor=D.+S.+Shermanauthor=N.+E.+Cummingsauthor=D.+C.+Peterauthor=M.+E.+Kimpleauthor=D.+W.+Lammingauthor=M.+J.+Merrins&title=Age-dependent+protection+of+insulin+secretion+in+diet+induced+obese+mice&doi=10.1038%2Fs41598-018-36289-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Age-Dependent Protection of Insulin Secretion in Diet Induced Obese Mice</span></div><div class="casAuthors">De Leon, Elizabeth R.; Brinkman, Jacqueline A.; Fenske, Rachel J.; Gregg, Trillian; Schmidt, Brian A.; Sherman, Dawn S.; Cummings, Nicole E.; Peter, Darby C.; Kimple, Michelle E.; Lamming, Dudley W.; Merrins, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17814</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Type 2 diabetes is an age-and-obesity assocd. disease driven by impairments in glucose homeostasis that ultimately result in defective insulin secretion from pancreatic β-cells.  To deconvolve the effects of age and obesity in an exptl. model of prediabetes, we fed young and aged mice either chow or a short-term high-fat/high-sucrose Western diet (WD) and examd. how wt., glucose tolerance, and β-cell function were affected.  Although WD induced a similar degree of wt. gain in young and aged mice, a high degree of heterogeneity was found exclusively in aged mice.  Wt. gain in WD-fed aged mice was well-correlated with glucose intolerance, fasting insulin, and in vivo glucose-stimulated insulin secretion, relationships that were not obsd. in young animals.  Although β-cell mass expansion in the WD-fed aged mice was only three-quarters of that obsd. in young mice, the islets from aged mice were resistant to the sharp WD-induced decline in ex vivo insulin secretion obsd. in young mice.  Our findings demonstrate that age is assocd. with the protection of islet function in diet-induced obese mice, and furthermore, that WD challenge exposes variability in the resilience of the insulin secretory pathway in aged mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7-1qc9KPErVg90H21EOLACvtfcHk0liaNukwbQNTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslKju7s%253D&md5=1a52e008ef17d4c50361dfe5c07f3b48</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36289-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36289-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeon%26aufirst%3DE.%2BR.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DFenske%26aufirst%3DR.%2BJ.%26aulast%3DGregg%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%2BA.%26aulast%3DSherman%26aufirst%3DD.%2BS.%26aulast%3DCummings%26aufirst%3DN.%2BE.%26aulast%3DPeter%26aufirst%3DD.%2BC.%26aulast%3DKimple%26aufirst%3DM.%2BE.%26aulast%3DLamming%26aufirst%3DD.%2BW.%26aulast%3DMerrins%26aufirst%3DM.%2BJ.%26atitle%3DAge-dependent%2520protection%2520of%2520insulin%2520secretion%2520in%2520diet%2520induced%2520obese%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D17814%26doi%3D10.1038%2Fs41598-018-36289-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talchai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accili, D.</span></span> <span> </span><span class="NLM_article-title">Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">1223</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cell.2012.07.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22980982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKrsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=1223-1234&author=C.+Talchaiauthor=S.+Xuanauthor=H.+V.+Linauthor=L.+Susselauthor=D.+Accili&title=Pancreatic+%CE%B2+cell+dedifferentiation+as+a+mechanism+of+diabetic+%CE%B2+cell+failure&doi=10.1016%2Fj.cell.2012.07.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic β Cell dedifferentiation as a mechanism of diabetic β cell failure</span></div><div class="casAuthors">Talchai, Chutima; Xuan, Shouhong; Lin, Hua V.; Sussel, Lori; Accili, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1223-1234</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetes is assocd. with β cell failure.  But it remains unclear whether the latter results from reduced β cell no. or function.  FoxO1 integrates β cell proliferation with adaptive β cell function.  We interrogated the contribution of these two processes to β cell dysfunction, using mice lacking FoxO1 in β cells.  FoxO1 ablation caused hyperglycemia with reduced β cell mass following physiol. stress, such as multiparity and aging.  Surprisingly, lineage-tracing expts. demonstrated that loss of β cell mass was due to β cell dedifferentiation, not death.  Dedifferentiated β cells reverted to progenitor-like cells expressing neurogenin 3, Oct4, Nanog, and L-Myc.  A subset of FoxO1-deficient β cells adopted the α cell fate, resulting in hyperglucagonemia.  Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes.  We propose that dedifferentiation trumps endocrine cell death in the natural history of β cell failure and suggest that treatment of β cell dysfunction should restore differentiation, rather than promoting β cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQ0PPawickLVg90H21EOLACvtfcHk0ljUyVTQd1hgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKrsbzI&md5=a6633771235960936013b269a8932815</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DTalchai%26aufirst%3DC.%26aulast%3DXuan%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DH.%2BV.%26aulast%3DSussel%26aufirst%3DL.%26aulast%3DAccili%26aufirst%3DD.%26atitle%3DPancreatic%2520%25CE%25B2%2520cell%2520dedifferentiation%2520as%2520a%2520mechanism%2520of%2520diabetic%2520%25CE%25B2%2520cell%2520failure%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D1223%26epage%3D1234%26doi%3D10.1016%2Fj.cell.2012.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cinti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim-Muller, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suleiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratner, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accili, D.</span></span> <span> </span><span class="NLM_article-title">Evidence of β-cell dedifferentiation in human type 2 diabetes</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1210/jc.2015-2860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1210%2Fjc.2015-2860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26713822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=1044-1054&author=F.+Cintiauthor=R.+Bouchiauthor=J.+Y.+Kim-Mullerauthor=Y.+Ohmuraauthor=P.+R.+Sandovalauthor=M.+Masiniauthor=L.+Marselliauthor=M.+Suleimanauthor=L.+E.+Ratnerauthor=P.+Marchettiauthor=D.+Accili&title=Evidence+of+%CE%B2-cell+dedifferentiation+in+human+type+2+diabetes&doi=10.1210%2Fjc.2015-2860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of β-cell dedifferentiation in human type 2 diabetes</span></div><div class="casAuthors">Cinti, Francesca; Bouchi, Ryotaro; Kim-Muller, Ja Young; Ohmura, Yoshiaki; Sandoval, P. R.; Masini, Matilde; Marselli, Lorella; Suleiman, Mara; Ratner, Lloyd E.; Marchetti, Piero; Accili, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-1054</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1945-7197</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Diabetes is assocd. with a deficit of insulin-producing β-cells.  Animal studies show that β-cells become dedifferentiated in diabetes, reverting to a progenitor-like stage, and partly converting to other endocrine cell types.  Objective: To det. whether similar processes occur in human type 2 diabetes, we surveyed pancreatic islets from 15 diabetic and 15 nondiabetic organ donors.  Design: We scored dedifferentiation using markers of endocrine lineage, β-cell-specific transcription factors, and a newly identified endocrine progenitor cell marker, aldehyde dehydrogenase 1A3.  Results: By these criteria, dedifferentiated cells accounted for 31.9% of β-cells in type 2 diabetics vs 8.7% in controls, and for 16.8% vs 6.5% of all endocrine cells (P < .001).  The no. of aldehyde dehydrogenase 1A3-pos./hormone-neg. cells was 3-fold higher in diabetics compared with controls.  Moreover, β-cell-specific transcription factors were ectopically found in glucagon- and somatostatin-producing cells of diabetic subjects.  Conclusions: The data support the view that pancreatic β-cells become dedifferentiated and convert to α- and δ-"like" cells in human type 2 diabetes.  The findings should prompt a reassessment of goals in the prevention and treatment of β-cell dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoiaTHE04TK7Vg90H21EOLACvtfcHk0ljUyVTQd1hgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrtL%252FK&md5=dee3ac8677607c299bc4c3d9a225554c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1210%2Fjc.2015-2860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2015-2860%26sid%3Dliteratum%253Aachs%26aulast%3DCinti%26aufirst%3DF.%26aulast%3DBouchi%26aufirst%3DR.%26aulast%3DKim-Muller%26aufirst%3DJ.%2BY.%26aulast%3DOhmura%26aufirst%3DY.%26aulast%3DSandoval%26aufirst%3DP.%2BR.%26aulast%3DMasini%26aufirst%3DM.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DSuleiman%26aufirst%3DM.%26aulast%3DRatner%26aufirst%3DL.%2BE.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DAccili%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520%25CE%25B2-cell%2520dedifferentiation%2520in%2520human%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D101%26spage%3D1044%26epage%3D1054%26doi%3D10.1210%2Fjc.2015-2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdigoto, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, K. C.</span></span> <span> </span><span class="NLM_article-title">β cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cmet.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=28190773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisF2is7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=727-738&author=J.+Ruiauthor=S.+Dengauthor=A.+Araziauthor=A.+L.+Perdigotoauthor=Z.+Liuauthor=K.+C.+Herold&title=%CE%B2+cells+that+resist+immunological+attack+develop+during+progression+of+autoimmune+diabetes+in+NOD+mice&doi=10.1016%2Fj.cmet.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice</span></div><div class="casAuthors">Rui, Jinxiu; Deng, Songyan; Arazi, Arnon; Perdigoto, Ana Luisa; Liu, Zongzhi; Herold, Kevan C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Type 1 diabetes (T1D) is a chronic autoimmune disease that involves immune-mediated destruction of β cells.  How β cells respond to immune attack is unknown.  We identified a population of β cells during the progression of T1D in non-obese diabetic (NOD) mice that survives immune attack.  This population develops from normal β cells confronted with islet infiltrates.  Pathways involving cell movement, growth and proliferation, immune responses, and cell death and survival are activated in these cells.  There is reduced expression of β cell identity genes and diabetes antigens and increased immune inhibitory markers and stemness genes.  This new subpopulation is resistant to killing when diabetes is pptd. with cyclophosphamide.  Human β cells show similar changes when cultured with immune cells.  These changes may account for the chronicity of the disease and the long-term survival of β cells in some patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr951jKBj2H-LVg90H21EOLACvtfcHk0ljUyVTQd1hgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisF2is7w%253D&md5=743d47adc2f8c0c531067a495c99a55b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRui%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DArazi%26aufirst%3DA.%26aulast%3DPerdigoto%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHerold%26aufirst%3DK.%2BC.%26atitle%3D%25CE%25B2%2520cells%2520that%2520resist%2520immunological%2520attack%2520develop%2520during%2520progression%2520of%2520autoimmune%2520diabetes%2520in%2520NOD%2520mice%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D727%26epage%3D738%26doi%3D10.1016%2Fj.cmet.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakose, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackeifi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">652.e5</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cmet.2018.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30581122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2ht7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=638-652.e5&author=P.+Wangauthor=E.+Karakoseauthor=H.+Liuauthor=E.+Swartzauthor=C.+Ackeifiauthor=V.+Zlatanicauthor=J.+Wilsonauthor=B.+J.+Gonz%C3%A1lezauthor=A.+Benderauthor=K.+K.+Takaneauthor=L.+Yeauthor=G.+Harbauthor=F.+Pagliucaauthor=D.+Homannauthor=D.+Egliauthor=C.+Argmannauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=Combined+inhibition+of+DYRK1A%2C+SMAD%2C+and+trithorax+pathways+synergizes+to+induce+robust+replication+in+adult+human+beta+cells&doi=10.1016%2Fj.cmet.2018.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells</span></div><div class="casAuthors">Wang, Peng; Karakose, Esra; Liu, Hongtao; Swartz, Ethan; Ackeifi, Courtney; Zlatanic, Viktor; Wilson, Jessica; Gonzalez, Bryan J.; Bender, Aaron; Takane, Karen K.; Ye, Lillian; Harb, George; Pagliuca, Felicia; Homann, Dirk; Egli, Dieter; Argmann, Carmen; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-652.e5</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of dual-specificity tyrosine-regulated kinase 1A (DYRK1A) induce human beta cells to proliferate, generating a labeling index of 1.5%-3%.  Here, we demonstrate that combined pharmacol. inhibition of DYRK1A and transforming growth factor beta superfamily (TGFβSF)/SMAD signaling generates remarkable further synergistic increases in human beta cell proliferation (av. labeling index, 5%-8%, and as high as 15%-18%), and increases in both mouse and human beta cell nos.  This synergy reflects activation of cyclins and cdks by DYRK1A inhibition, accompanied by simultaneous redns. in key cell-cycle inhibitors (CDKN1C and CDKN1A).  The latter results from interference with the basal Trithorax- and SMAD-mediated transactivation of CDKN1C and CDKN1A.  Notably, combined DYRK1A and TGFβ inhibition allows preservation of beta cell differentiated function.  These beneficial effects extend from normal human beta cells and stem cell-derived human beta cells to those from people with type 2 diabetes, and occur both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTj3UaJV2-V7Vg90H21EOLACvtfcHk0ljgCwOXVHU3oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2ht7jN&md5=99322b62913a95e1209524c958db8380</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKarakose%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSwartz%26aufirst%3DE.%26aulast%3DAckeifi%26aufirst%3DC.%26aulast%3DZlatanic%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DB.%2BJ.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DPagliuca%26aufirst%3DF.%26aulast%3DHomann%26aufirst%3DD.%26aulast%3DEgli%26aufirst%3DD.%26aulast%3DArgmann%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DCombined%2520inhibition%2520of%2520DYRK1A%252C%2520SMAD%252C%2520and%2520trithorax%2520pathways%2520synergizes%2520to%2520induce%2520robust%2520replication%2520in%2520adult%2520human%2520beta%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2019%26volume%3D29%26spage%3D638%26epage%3D652.e5%26doi%3D10.1016%2Fj.cmet.2018.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozar-Castellano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasavada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Lessons from the first comprehensive molecular characterization of cell cycle control in rodent insulinoma cell lines</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3056</span>– <span class="NLM_lpage">3068</span>, <span class="refDoi"> DOI: 10.2337/db08-0393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb08-0393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=18650366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsleis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=3056-3068&author=I.+Cozar-Castellanoauthor=G.+Harbauthor=K.+Selkauthor=K.+Takaneauthor=R.+Vasavadaauthor=B.+Sicariauthor=B.+Lawauthor=P.+Zhangauthor=D.+K.+Scottauthor=N.+Fiaschi-Taeschauthor=A.+F.+Stewart&title=Lessons+from+the+first+comprehensive+molecular+characterization+of+cell+cycle+control+in+rodent+insulinoma+cell+lines&doi=10.2337%2Fdb08-0393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the first comprehensive molecular characterization of cell cycle control in rodent insulinoma cell lines</span></div><div class="casAuthors">Cozar-Castellano, Irene; Harb, George; Selk, Karen; Takane, Karen; Vasavada, Rupangi; Sicari, Brian; Law, Brian; Zhang, Pili; Scott, Donald K.; Fiaschi-Taesch, Nathalie; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3056-3068</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-Rodent insulinoma cell lines may serve as a model for designing continuously replicating human β-cell lines and provide clues as to the central cell cycle regulatory mols. in the β-cell.  Research Design and Methods-We performed a comprehensive G1/S proteome anal. on the four most widely studied rodent insulinoma cell lines and defined their flow cytometric profiles and growth characteristics.  Results-(1) Despite their common T-antigen-derived origins, MIN6 and BTC3 cells display markedly different G1/S expression profiles; (2) despite their common radiation origins, RINm5F and INS1 cells display striking differences in cell cycle protein profiles; (3) phosphorylation of pRb is absent in INS1 and RINm5F cells; (4) cyclin D2 is absent in RINm5F and BTC3 cells and therefore apparently dispensable for their proliferation; (5) every cell cycle inhibitor is upregulated, presumably in a futile attempt to halt proliferation; (6) among the G1/S proteome members, seven are pro-proliferation mols.: cyclin-dependent kinase-1, -2, -4, and -6 and cyclins A, E, and D3; and (7) overexpression of the combination of these seven converts arrested proliferation rates in primary rat β-cells to those in insulinoma cells.  Unfortunately, this therapeutic overexpression appears to mildly attenuate β-cell differentiation and function.  Conclusions-These studies underscore the importance of characterizing the cell cycle at the protein level in rodent insulinoma cell lines.  They also emphasize the hazards of interpreting data from rodent insulinoma cell lines as modeling normal cell cycle progression.  Most importantly, they provide seven candidate targets for inducing proliferation in human β-cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlf9Hag2a0LVg90H21EOLACvtfcHk0liOFvYssq1JCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsleis78%253D&md5=583e3b8dab223d6b31982d506b0dea2e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0393%26sid%3Dliteratum%253Aachs%26aulast%3DCozar-Castellano%26aufirst%3DI.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DSelk%26aufirst%3DK.%26aulast%3DTakane%26aufirst%3DK.%26aulast%3DVasavada%26aufirst%3DR.%26aulast%3DSicari%26aufirst%3DB.%26aulast%3DLaw%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DLessons%2520from%2520the%2520first%2520comprehensive%2520molecular%2520characterization%2520of%2520cell%2520cycle%2520control%2520in%2520rodent%2520insulinoma%2520cell%2520lines%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D3056%26epage%3D3068%26doi%3D10.2337%2Fdb08-0393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.,  III.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lélias, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.-M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0liOFvYssq1JCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.-M.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eswaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0liOFvYssq1JCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr. Sect., D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lhHj-Nnh27U7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%2520Sect.%252C%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lhHj-Nnh27U7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhHj-Nnh27U7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lju7-enJqjvsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lju7-enJqjvsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span>. <i>Acta Crystallogr D Biol Crystallogr</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lhJKqw_AX3Qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr%2520D%2520Biol%2520Crystallogr%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P. S. A.</span>; <span class="NLM_string-name">Smart, O.S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T.O.</span></span> <i>BUSTER version 2.10.3</i>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+S.+A.+Roversi&author=O.S.+Smart&author=C.+Vonrhein&author=T.O.+Womack&title=BUSTER+version+2.10.3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%2520version%25202.10.3%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1107/S0907444911056058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444911056058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22505257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Gns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=368-380&author=O.+S.+Smartauthor=T.+O.+Womackauthor=C.+Flensburgauthor=P.+Kellerauthor=W.+Paciorekauthor=A.+Sharffauthor=C.+Vonrheinauthor=G.+Bricogne&title=Exploiting+structure+similarity+in+refinement%3A+automated+NCS+and+target-structure+restraints+in+BUSTER&doi=10.1107%2FS0907444911056058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER</span></div><div class="casAuthors">Smart, Oliver S.; Womack, Thomas O.; Flensburg, Claus; Keller, Peter; Paciorek, Wlodek; Sharff, Andrew; Vonrhein, Clemens; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-380</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Maximum-likelihood X-ray macromol. structure refinement in BUSTER has been extended with restraints facilitating the exploitation of structural similarity.  The similarity can be between two or more chains within the structure being refined, thus favoring NCS, or to a distinct 'target' structure that remains fixed during refinement.  The local structural similarity restraints (LSSR) approach considers all distances less than 5.5 Å between pairs of atoms in the chain to be restrained.  For each, the difference from the distance between the corresponding atoms in the related chain is found.  LSSR applies a restraint penalty on each difference.  A functional form that reaches a plateau for large differences is used to avoid the restraints distorting parts of the structure that are not similar.  Because LSSR are local, there is no need to sep. out domains.  Some restraint pruning is still necessary, but this has been automated.  LSSR have been available to academic users of BUSTER since 2009 with the easy-to-use and options.  The use of LSSR is illustrated in the re-refinement of PDB entries , where enables the correct ligand-binding structure to be found, and , where contributes to the location of an addnl. copy of the cyclic peptide ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu-qo0DGjn3bVg90H21EOLACvtfcHk0lhJKqw_AX3Qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Gns78%253D&md5=bea89f86f489e8dbd00a9866a3d7dab9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444911056058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911056058%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26aulast%3DWomack%26aufirst%3DT.%2BO.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DExploiting%2520structure%2520similarity%2520in%2520refinement%253A%2520automated%2520NCS%2520and%2520target-structure%2520restraints%2520in%2520BUSTER%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D368%26epage%3D380%26doi%3D10.1107%2FS0907444911056058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">Optimal description of a protein structure in terms of multiple groups undergoing TLS motion</span>. <i>Acta Crystallogr., D. Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1107/S0907444906005270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444906005270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16552146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=439-450&author=J.+Painterauthor=E.+A.+Merritt&title=Optimal+description+of+a+protein+structure+in+terms+of+multiple+groups+undergoing+TLS+motion&doi=10.1107%2FS0907444906005270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal description of a protein structure in terms of multiple groups undergoing TLS motion</span></div><div class="casAuthors">Painter, Jay; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-450</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A single protein crystal structure contains information about dynamic properties of the protein as well as providing a static view of one three-dimensional conformation.  This addnl. information is to be found in the distribution of obsd. electron d. about the mean position of each atom.  It is general practice to account for this by refining a sep. at. displacement parameter (ADP) for each at. center.  However, these same displacements are often described well by simpler models based on TLS (translation/libration/screw) rigid-body motion of large groups of atoms, for example interdomain hinge motion.  A procedure, TLSMD, has been developed that analyzes the distribution of ADPs in a previously refined protein crystal structure in order to generate optimal multi-group TLS descriptions of the constituent protein chains.  TLSMD is applicable to crystal structures at any resoln.  The models generated by TLSMD anal. can significantly improve the std. crystallog. residuals R and Rfree and can reveal intrinsic dynamic properties of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIR_NcneJBNbVg90H21EOLACvtfcHk0lhJKqw_AX3Qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gkt74%253D&md5=6289483d19fb6dd64fe9b032e9c45005</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0907444906005270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906005270%26sid%3Dliteratum%253Aachs%26aulast%3DPainter%26aufirst%3DJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DOptimal%2520description%2520of%2520a%2520protein%2520structure%2520in%2520terms%2520of%2520multiple%2520groups%2520undergoing%2520TLS%2520motion%26jtitle%3DActa%2520Crystallogr.%252C%2520D.%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D439%26epage%3D450%26doi%3D10.1107%2FS0907444906005270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">TLSMD web server for the generation of multi-group TLS models</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1107/S0021889805038987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0021889805038987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=109-111&author=J.+Painterauthor=E.+A.+Merritt&title=TLSMD+web+server+for+the+generation+of+multi-group+TLS+models&doi=10.1107%2FS0021889805038987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">TLSMD web server for the generation of multi-group TLS models</span></div><div class="casAuthors">Painter, Jay; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-111</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The TLSMD web server exts. information about dynamic properties of a protein based on information derived from a single-crystal structure.  It does so by analyzing the spatial distribution of individual at. thermal parameters present in an input structural model.  The server partitions the protein structure into multiple, contiguous chain segments, each segment corresponding to one group in a multi-group description of the protein's overall dynamic motion.  For each polypeptide chain of the input protein, the anal. generates the optimal partition into two segments, three segments,... up to 20 segments.  Each such partition is optimal in the sense that it is the best approxn. of the overall spatial distribution of input thermal parameters in terms of N chain segments, each acting as a rigid group undergoing TLS (translation/libration/screw) motion.  This multi-group TLS model may be used as a starting point for further crystallog. refinement, or as the basis for analyzing inter-domain and other large-scale motions implied by the crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhkwf2sopjVrVg90H21EOLACvtfcHk0lhJKqw_AX3Qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVyjsA%253D%253D&md5=5d16d5d6310baa5434064bdf0ec81e24</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889805038987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889805038987%26sid%3Dliteratum%253Aachs%26aulast%3DPainter%26aufirst%3DJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DTLSMD%2520web%2520server%2520for%2520the%2520generation%2520of%2520multi-group%2520TLS%2520models%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2006%26volume%3D39%26spage%3D109%26epage%3D111%26doi%3D10.1107%2FS0021889805038987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liSWiCO61W2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0liSWiCO61W2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roccisana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trucco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span> <span> </span><span class="NLM_article-title">Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1664</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.2337/diabetes.54.6.1664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdiabetes.54.6.1664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15919787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1664-1675&author=P.+Raoauthor=J.+Roccisanaauthor=K.+K.+Takaneauthor=R.+Bottinoauthor=A.+Zhaoauthor=M.+Truccoauthor=A.+Garcia-Ocana&title=Gene+transfer+of+constitutively+active+Akt+markedly+improves+human+islet+transplant+outcomes+in+diabetic+severe+combined+immunodeficient+mice&doi=10.2337%2Fdiabetes.54.6.1664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice</span></div><div class="casAuthors">Rao, Poornima; Roccisana, Jennifer; Takane, Karen K.; Bottino, Rita; Zhao, Allan; Trucco, Massimo; Garcia-Ocana, Adolfo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1664-1675</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Akt is an important intracellular mediator of β-cell growth and survival in rodents.  However, whether constitutive activation of Akt in human β-cells enhances the survival and function of transplanted islets is unknown.  In the current study, we examd. the efficacy of constitutive activation of Akt in improving human islet transplant outcomes using a marginal mass model in diabetic severe combined immunodeficient (SCID) mice.  Human islets transduced with adenoviruses encoding constitutively active Akt1 (Adv-CA-Akt) displayed increased total and phosphorylated Akt and Akt kinase activity compared with control islets.  Expression of CA-Akt in human islets induced a significant increase in β-cell replication and a significant decrease in β-cell death induced by serum and glucose deprivation or chronic hyperglycemia.  Two control groups of islets (1,500 uninfected or adenovirus LacZ [Adv-LacZ]-transduced human islet equiv. [IEQs]) transplanted under the kidney capsule of streptozotocin-induced diabetic SCID mice were insufficient to correct hyperglycemia.  Importantly and in marked contrast to these controls, 1,500 Adv-CA-Akt-transduced IEQs were capable of restoring euglycemia in diabetic SCID mice.  Moreover, blood glucose normalization persisted for at least 6 mo.  Human plasma insulin at day 54 after transplant was 10-fold higher in Adv-CA-Akt islet recipients (2.4±0.4 ng/mL) compared with those receiving Adv-LacZ islets (0.25±0.08 ng/mL) (P < 0.05).  In summary, expression of CA-Akt in human islets improves islet transplant outcomes in a subcapsular renal graft model in SCID mice.  Akt is an attractive target for future strategies aimed at reducing the no. of islets required for successful islet transplantation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgrV4aNbQA7Vg90H21EOLACvtfcHk0liSWiCO61W2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaitr0%253D&md5=40a87c83cfd090918b34fc20dd5ef1c2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.6.1664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.6.1664%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DP.%26aulast%3DRoccisana%26aufirst%3DJ.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DBottino%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DA.%26aulast%3DTrucco%26aufirst%3DM.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26atitle%3DGene%2520transfer%2520of%2520constitutively%2520active%2520Akt%2520markedly%2520improves%2520human%2520islet%2520transplant%2520outcomes%2520in%2520diabetic%2520severe%2520combined%2520immunodeficient%2520mice%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D1664%26epage%3D1675%26doi%3D10.2337%2Fdiabetes.54.6.1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicari, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricordi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenyon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor enhances engraftment and function of non-human primate islets</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2745</span>– <span class="NLM_lpage">2754</span>, <span class="refDoi"> DOI: 10.2337/db07-1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb07-1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=18820214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1KntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2745-2754&author=N.+M.+Fiaschi-Taeschauthor=D.+M.+Bermanauthor=B.+M.+Sicariauthor=K.+K.+Takaneauthor=A.+Garcia-Ocanaauthor=C.+Ricordiauthor=N.+S.+Kenyonauthor=A.+F.+Stewart&title=Hepatocyte+growth+factor+enhances+engraftment+and+function+of+non-human+primate+islets&doi=10.2337%2Fdb07-1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets</span></div><div class="casAuthors">Fiaschi-Taesch, Nathalie M.; Berman, Dora M.; Sicari, Brian M.; Takane, Karen K.; Garcia-Ocana, Adolfo; Ricordi, Camillo; Kenyon, Norma S.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2745-2754</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Adenoviral delivery of hepatocyte growth factor (HGF) to rodent islets improves islet graft survival and function, markedly reducing the no. of islets required to achieve glucose control.  Here, we asked whether these prior observations in rodent models extend to nonhuman primate (NHP) islets.  NHP islets were transduced with murine (Ad.mHGF) or human (Ad.hHGF) adenoviral HGF (Ad.HGF) at low multiplicity of infection and studied in vitro.  To study the function of Ad.HGF-transduced NHP islets in vivo, a renal subcapsular marginal mass islet transplant model was developed in streptozotocin-induced diabetic NOD-SCID mice.  Baseline glucose values were 454.7 mg/dL.  Transplant of 500 NHP islet equiv. (IE) had only a marginal effect on blood glucose (369.1 mg/dL).  In striking contrast, 500 NHP IE transduced with Ad.mHGF promptly and continuously cor. blood glucose (142.0 mg/dL) for the 6-wk duration of the expt.  Unilateral nephrectomy resulted in an immediate return of glucose to baseline diabetic levels.  Interestingly, adenoviral DNA, as well as mouse HGF (mHGF) mRNA derived from the adenovirus, were present for 42 days posttransplantation.  Surprisingly, transplant of 500 IE with Ad.hHGF, as compared with Ad.mHGF, resulted in only marginal correction of blood glucose, suggesting that human HGF is less efficient than mHGF in this system.  These studies demonstrate that mHGF markedly improves islet transplant outcomes in the highest preclin. species examd. to date.  HGF has promise as an agent that can improve islet mass and function in transplant models and likely in other models of types 1 and 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg9S7GJNO7JrVg90H21EOLACvtfcHk0lif2rZv4HHBeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1KntrY%253D&md5=db53465e117b4b3acdf8714d1aff91ab</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2337%2Fdb07-1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb07-1085%26sid%3Dliteratum%253Aachs%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%2BM.%26aulast%3DBerman%26aufirst%3DD.%2BM.%26aulast%3DSicari%26aufirst%3DB.%2BM.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DRicordi%26aufirst%3DC.%26aulast%3DKenyon%26aufirst%3DN.%2BS.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DHepatocyte%2520growth%2520factor%2520enhances%2520engraftment%2520and%2520function%2520of%2520non-human%2520primate%2520islets%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D2745%26epage%3D2754%26doi%3D10.2337%2Fdb07-1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lif2rZv4HHBeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lif2rZv4HHBeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljJuwOjuQnj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">Web servers and services for electrostatics calculations with APBS and PDB2PQR</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1002/jcc.21720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1002%2Fjcc.21720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21425296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1488-1491&author=S.+Unniauthor=Y.+Huangauthor=R.+M.+Hansonauthor=M.+Tobiasauthor=S.+Krishnanauthor=W.+W.+Liauthor=J.+E.+Nielsenauthor=N.+A.+Baker&title=Web+servers+and+services+for+electrostatics+calculations+with+APBS+and+PDB2PQR&doi=10.1002%2Fjcc.21720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Web servers and services for electrostatics calculations with APBS and PDB2PQR</span></div><div class="casAuthors">Unni, Samir; Huang, Yong; Hanson, Robert M.; Tobias, Malcolm; Krishnan, Sriram; Li, Wilfred W.; Nielsen, Jens E.; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1488-1491</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">APBS and PDB2PQR are widely utilized free software packages for biomol. electrostatics calcns.  Using the Opal toolkit, we have developed a Web services framework for these software packages that enables the use of APBS and PDB2PQR by users who do not have local access to the necessary amt. of computational capabilities.  This not only increases accessibility of the software to a wider range of scientists, educators, and students but also increases the availability of electrostatics calcns. on portable computing platforms.  Users can access this new functionality in two ways.  First, an Opal-enabled version of APBS is provided in current distributions, available freely on the web.  Second, we have extended the PDB2PQR web server to provide an interface for the setup, execution, and visualization of electrostatic potentials as calcd. by APBS.  This web interface also uses the Opal framework which ensures the scalability needed to support the large APBS user community.  Both of these resources are available from the APBS/PDB2PQR website: . © 2011 Wiley Periodicals, Inc. J Comput Chem, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIIBjEkcmTaLVg90H21EOLACvtfcHk0ljJuwOjuQnj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsF2isb8%253D&md5=631ec77858bda82621dc10470a373e4f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21720%26sid%3Dliteratum%253Aachs%26aulast%3DUnni%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHanson%26aufirst%3DR.%2BM.%26aulast%3DTobias%26aufirst%3DM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%2BW.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DWeb%2520servers%2520and%2520services%2520for%2520electrostatics%2520calculations%2520with%2520APBS%2520and%2520PDB2PQR%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2011%26volume%3D32%26spage%3D1488%26epage%3D1491%26doi%3D10.1002%2Fjcc.21720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurrus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Star, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felberg, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohara, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konecny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head-Gordon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">Improvements to the APBS biomolecular solvation software suite</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1002/pro.3280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1002%2Fpro.3280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=28836357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSkt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=112-128&author=E.+Jurrusauthor=D.+Engelauthor=K.+Starauthor=K.+Monsonauthor=J.+Brandiauthor=L.+E.+Felbergauthor=D.+H.+Brookesauthor=L.+Wilsonauthor=J.+Chenauthor=K.+Lilesauthor=M.+Chunauthor=P.+Liauthor=D.+W.+Goharaauthor=T.+Dolinskyauthor=R.+Konecnyauthor=D.+R.+Koesauthor=J.+E.+Nielsenauthor=T.+Head-Gordonauthor=W.+Gengauthor=R.+Krasnyauthor=G.+W.+Weiauthor=M.+J.+Holstauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=Improvements+to+the+APBS+biomolecular+solvation+software+suite&doi=10.1002%2Fpro.3280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Improvements to the APBS biomolecular solvation software suite</span></div><div class="casAuthors">Jurrus, Elizabeth; Engel, Dave; Star, Keith; Monson, Kyle; Brandi, Juan; Felberg, Lisa E.; Brookes, David H.; Wilson, Leighton; Chen, Jiahui; Liles, Karina; Chun, Minju; Li, Peter; Gohara, David W.; Dolinsky, Todd; Konecny, Robert; Koes, David R.; Nielsen, Jens Erik; Head-Gordon, Teresa; Geng, Weihua; Krasny, Robert; Wei, Guo-Wei; Holst, Michael J.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-128</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Adaptive Poisson-Boltzmann Solver (APBS) software was developed to solve the equations of continuum electrostatics for large biomol. assemblages that have provided impact in the study of a broad range of chem., biol., and biomedical applications.  APBS addresses the three key technol. challenges for understanding solvation and electrostatics in biomedical applications: accurate and efficient models for biomol. solvation and electrostatics, robust and scalable software for applying those theories to biomol. systems, and mechanisms for sharing and analyzing biomol. electrostatics data in the scientific community.  To address new research applications and advancing computational capabilities, we have continually updated APBS and its suite of accompanying software since its release in 2001.  In this article, we discuss the models and capabilities that have recently been implemented within the APBS software package including a Poisson-Boltzmann anal. and a semi-anal. solver, an optimized boundary element solver, a geometry-based geometric flow solvation model, a graph theory-based algorithm for detg. pKa values, and an improved web-based visualization tool for viewing electrostatics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBO7hbYoyPZrVg90H21EOLACvtfcHk0ljJuwOjuQnj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSkt7vI&md5=99651d125e38f4a85d453fecf0f71652</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fpro.3280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3280%26sid%3Dliteratum%253Aachs%26aulast%3DJurrus%26aufirst%3DE.%26aulast%3DEngel%26aufirst%3DD.%26aulast%3DStar%26aufirst%3DK.%26aulast%3DMonson%26aufirst%3DK.%26aulast%3DBrandi%26aufirst%3DJ.%26aulast%3DFelberg%26aufirst%3DL.%2BE.%26aulast%3DBrookes%26aufirst%3DD.%2BH.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiles%26aufirst%3DK.%26aulast%3DChun%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DGohara%26aufirst%3DD.%2BW.%26aulast%3DDolinsky%26aufirst%3DT.%26aulast%3DKonecny%26aufirst%3DR.%26aulast%3DKoes%26aufirst%3DD.%2BR.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DHead-Gordon%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DKrasny%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DG.%2BW.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DImprovements%2520to%2520the%2520APBS%2520biomolecular%2520solvation%2520software%2520suite%26jtitle%3DProtein%2520Sci.%26date%3D2018%26volume%3D27%26spage%3D112%26epage%3D128%26doi%3D10.1002%2Fpro.3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Scott H. Henderson, Fiona Sorrell, James Bennett, Oleg Fedorov, Marcus T. Hanley, Paulo H. Godoi, Roberta Ruela de Sousa, Sean Robinson, Alexander Ashall-Kelly, Iva Hopkins Navratilova, Daryl S. Walter, Jonathan M. Elkins, <span class="NLM_string-name hlFld-ContribAuthor">Simon E. Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c01115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c01115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BSelective%252Band%252BLigand-Efficient%252BDYRK%252BInhibitors%26aulast%3DHenderson%26aufirst%3DScott%2BH.%26date%3D2021%26date%3D2021%26date%3D21062021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Csaba Weber, Melinda Sipos, Attila Paczal, Balazs Balint, Vilibald Kun, Nicolas Foloppe, Pawel Dokurno, Andrew J. Massey, David Lee Walmsley, Roderick E. Hubbard, James Murray, Karen Benwell, Thomas Edmonds, Didier Demarles, Alain Bruno, Mike Burbridge, Francisco Cruzalegui, <span class="NLM_string-name hlFld-ContribAuthor">Andras Kotschy</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6745-6764. <a href="https://doi.org/10.1021/acs.jmedchem.1c00023" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDiscovery%252Bof%252BPotent%252Band%252BSelective%252BDYRK1A%252BInhibitors%26aulast%3DWeber%26aufirst%3DCsaba%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D12052021%26volume%3D64%26issue%3D10%26spage%3D6745%26epage%3D6764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kunal Kumar, Chalada Suebsuwong, Peng Wang, Adolfo Garcia-Ocana, Andrew F. Stewart, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. DeVita</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 2901-2922. <a href="https://doi.org/10.1021/acs.jmedchem.0c02050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDYRK1A%252BInhibitors%252Bas%252BPotential%252BTherapeutics%252Bfor%252B%2525CE%2525B2-Cell%252BRegeneration%252Bfor%252BDiabetes%26aulast%3DKumar%26aufirst%3DKunal%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D08032021%26volume%3D64%26issue%3D6%26spage%3D2901%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aurélien Beato, Anthonin Gori, Benjamin Boucherle, Marine Peuchmaur, <span class="NLM_string-name hlFld-ContribAuthor">Romain Haudecoeur</span>. </span><span class="cited-content_cbyCitation_article-title">β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1392-1422. <a href="https://doi.org/10.1021/acs.jmedchem.0c01887" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01887%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Carboline%252Bas%252Ba%252BPrivileged%252BScaffold%252Bfor%252BMultitarget%252BStrategies%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DBeato%26aufirst%3DAur%25C3%25A9lien%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D31102020%26date%3D02022021%26volume%3D64%26issue%3D3%26spage%3D1392%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xueyuan Chen, Yi Zheng, Songlin Song, Ying Liu, Yi Wang, Yong Huang, Xiaoyi Zhang, Meng Zhang, Ming Zhao, Yuji Wang, <span class="NLM_string-name hlFld-ContribAuthor">Li Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (18)
                                     , 11618-11625. <a href="https://doi.org/10.1021/acs.joc.0c01067" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01067%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBiotinylated%252BBivalent%252BCarboline%252BDerivatives%252Bas%252BPotent%252BAntitumor%252BAgents%26aulast%3DChen%26aufirst%3DXueyuan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02052020%26date%3D31082020%26date%3D18082020%26volume%3D85%26issue%3D18%26spage%3D11618%26epage%3D11625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinran  Zhao</span>, <span class="hlFld-ContribAuthor ">Longbiao  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">He  Bao</span>, <span class="hlFld-ContribAuthor ">Pengfei  Li</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of indole compounds with potential antidiabetic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113665. <a href="https://doi.org/10.1016/j.ejmech.2021.113665" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113665%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bindole%252Bcompounds%252Bwith%252Bpotential%252Bantidiabetic%252Bactivity%26aulast%3DZhu%26aufirst%3DYuqian%26date%3D2021%26volume%3D223%26spage%3D113665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwu  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Liting  Tian</span>, <span class="hlFld-ContribAuthor ">Yaping  Gao</span>, <span class="hlFld-ContribAuthor ">Wenjie  Liu</span>, <span class="hlFld-ContribAuthor ">Huanhua  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Jiang</span>, <span class="hlFld-ContribAuthor ">Zihua  Xu</span>, <span class="hlFld-ContribAuthor ">Huaiwei  Ding</span>, <span class="hlFld-ContribAuthor ">Qingchun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113554. <a href="https://doi.org/10.1016/j.ejmech.2021.113554" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113554%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bharmine%252Bderivatives%252Bas%252Bpotent%252BGSK-3%2525CE%2525B2%25252FDYRK1A%252Bdual%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DWenwu%26date%3D2021%26volume%3D222%26spage%3D113554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Esra  Karakose</span>, <span class="hlFld-ContribAuthor ">Lauryn  Choleva</span>, <span class="hlFld-ContribAuthor ">Kunal  Kumar</span>, <span class="hlFld-ContribAuthor ">Robert J.  DeVita</span>, <span class="hlFld-ContribAuthor ">Adolfo  Garcia-Ocaña</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Stewart</span>. </span><span class="cited-content_cbyCitation_article-title">Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.671946" title="DOI URL">https://doi.org/10.3389/fendo.2021.671946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.671946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.671946%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DHuman%252BBeta%252BCell%252BRegenerative%252BDrug%252BTherapy%252Bfor%252BDiabetes%25253A%252BPast%252BAchievements%252Band%252BFuture%252BChallenges%26aulast%3DWang%26aufirst%3DPeng%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Qingzhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Canrong  Wu</span>, <span class="hlFld-ContribAuthor ">Kaiyin  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuorui  Song</span>, <span class="hlFld-ContribAuthor ">Qiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Li</span>, <span class="hlFld-ContribAuthor ">Yirong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiachun  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A natural DYRK1A inhibitor as a potential stimulator for β‐cell proliferation in diabetes. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     <a href="https://doi.org/10.1002/ctm2.494" title="DOI URL">https://doi.org/10.1002/ctm2.494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ctm2.494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fctm2.494%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DA%252Bnatural%252BDYRK1A%252Binhibitor%252Bas%252Ba%252Bpotential%252Bstimulator%252Bfor%252B%2525CE%2525B2%2525E2%252580%252590cell%252Bproliferation%252Bin%252Bdiabetes%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Okka  Scholz</span>, <span class="hlFld-ContribAuthor ">Silke  Otter</span>, <span class="hlFld-ContribAuthor ">Alena  Welters</span>, <span class="hlFld-ContribAuthor ">Laura  Wörmeyer</span>, <span class="hlFld-ContribAuthor ">Jurij  Dolenšek</span>, <span class="hlFld-ContribAuthor ">Maša Skelin  Klemen</span>, <span class="hlFld-ContribAuthor ">Viljem  Pohorec</span>, <span class="hlFld-ContribAuthor ">Daniel  Eberhard</span>, <span class="hlFld-ContribAuthor ">Jessica  Mrugala</span>, <span class="hlFld-ContribAuthor ">Anna  Hamacher</span>, <span class="hlFld-ContribAuthor ">Angela  Koch</span>, <span class="hlFld-ContribAuthor ">Miguel  Sanz</span>, <span class="hlFld-ContribAuthor ">Torsten  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Jens  Hogeback</span>, <span class="hlFld-ContribAuthor ">Diran  Herebian</span>, <span class="hlFld-ContribAuthor ">Nikolaj  Klöcker</span>, <span class="hlFld-ContribAuthor ">Alexander  Piechot</span>, <span class="hlFld-ContribAuthor ">Ertan  Mayatepek</span>, <span class="hlFld-ContribAuthor ">Thomas  Meissner</span>, <span class="hlFld-ContribAuthor ">Andraž  Stožer</span>, <span class="hlFld-ContribAuthor ">Eckhard  Lammert</span>. </span><span class="cited-content_cbyCitation_article-title">Peripherally active dextromethorphan derivatives lower blood glucose levels by targeting pancreatic islets. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.1016/j.chembiol.2021.05.011" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DPeripherally%252Bactive%252Bdextromethorphan%252Bderivatives%252Blower%252Bblood%252Bglucose%252Blevels%252Bby%252Btargeting%252Bpancreatic%252Bislets%26aulast%3DScholz%26aufirst%3DOkka%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Gang  Gao</span>, <span class="hlFld-ContribAuthor ">Yanbing  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Cao</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>40 </em>, 127952. <a href="https://doi.org/10.1016/j.bmcl.2021.127952" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127952%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%2525CE%2525B2-carboline-%252528phenylsulfonyl%252529furoxan%252Bhybrids%252Bas%252Bpotential%252Banti-breast%252Bcancer%252Bagents%26aulast%3DHu%26aufirst%3DXu%26date%3D2021%26volume%3D40%26spage%3D127952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai‐Jun  Leng</span>, <span class="hlFld-ContribAuthor ">Yu‐Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang‐Hong  He</span>, <span class="hlFld-ContribAuthor ">Hou‐Lin  Xia</span>, <span class="hlFld-ContribAuthor ">Peng‐Shuai  Xu</span>, <span class="hlFld-ContribAuthor ">Peng  Xiang</span>, <span class="hlFld-ContribAuthor ">Qing‐Qing  He</span>, <span class="hlFld-ContribAuthor ">Gu  Zhan</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Efficient Synthesis of RalA Inhibitors Containing the Dihydro‐α‐carboline Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 851-859. <a href="https://doi.org/10.1002/cmdc.202000722" title="DOI URL">https://doi.org/10.1002/cmdc.202000722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000722%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BEfficient%252BSynthesis%252Bof%252BRalA%252BInhibitors%252BContaining%252Bthe%252BDihydro%2525E2%252580%252590%2525CE%2525B1%2525E2%252580%252590carboline%252BScaffold%26aulast%3DLeng%26aufirst%3DHai%25E2%2580%2590Jun%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D851%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy M.  Horton</span>, <span class="hlFld-ContribAuthor ">Benjamin R.  Kraemer</span>, <span class="hlFld-ContribAuthor ">Justin P.  Annes</span>. </span><span class="cited-content_cbyCitation_article-title">Protocol for determining zinc-dependent β cell-selective small-molecule delivery in mouse pancreas. </span><span class="cited-content_cbyCitation_journal-name">STAR Protocols</span><span> <strong>2021,</strong> <em>2 </em>
                                    (1)
                                     , 100263. <a href="https://doi.org/10.1016/j.xpro.2020.100263" title="DOI URL">https://doi.org/10.1016/j.xpro.2020.100263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xpro.2020.100263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xpro.2020.100263%26sid%3Dliteratum%253Aachs%26jtitle%3DSTAR%2520Protocols%26atitle%3DProtocol%252Bfor%252Bdetermining%252Bzinc-dependent%252B%2525CE%2525B2%252Bcell-selective%252Bsmall-molecule%252Bdelivery%252Bin%252Bmouse%252Bpancreas%26aulast%3DHorton%26aufirst%3DTimothy%2BM.%26date%3D2021%26volume%3D2%26issue%3D1%26spage%3D100263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolina  Rosselot</span>, <span class="hlFld-ContribAuthor ">Sharon  Baumel-Alterzon</span>, <span class="hlFld-ContribAuthor ">Yansui  Li</span>, <span class="hlFld-ContribAuthor ">Gabriel  Brill</span>, <span class="hlFld-ContribAuthor ">Luca  Lambertini</span>, <span class="hlFld-ContribAuthor ">Liora S.  Katz</span>, <span class="hlFld-ContribAuthor ">Geming  Lu</span>, <span class="hlFld-ContribAuthor ">Adolfo  Garcia-Ocaña</span>, <span class="hlFld-ContribAuthor ">Donald K.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">The many lives of Myc in the pancreatic β-cell. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100122. <a href="https://doi.org/10.1074/jbc.REV120.011149" title="DOI URL">https://doi.org/10.1074/jbc.REV120.011149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV120.011149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV120.011149%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DThe%252Bmany%252Blives%252Bof%252BMyc%252Bin%252Bthe%252Bpancreatic%252B%2525CE%2525B2-cell%26aulast%3DRosselot%26aufirst%3DCarolina%26date%3D2021%26volume%3D296%26spage%3D100122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Dengchang  Li</span>, <span class="hlFld-ContribAuthor ">Shenglan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological effects of harmine and its derivatives: a review. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2020,</strong> <em>43 </em>
                                    (12)
                                     , 1259-1275. <a href="https://doi.org/10.1007/s12272-020-01283-6" title="DOI URL">https://doi.org/10.1007/s12272-020-01283-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-020-01283-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-020-01283-6%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DPharmacological%252Beffects%252Bof%252Bharmine%252Band%252Bits%252Bderivatives%25253A%252Ba%252Breview%26aulast%3DZhang%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D12%26spage%3D1259%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahu A.  Liu</span>, <span class="hlFld-ContribAuthor ">Qihui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiang  Ding</span>, <span class="hlFld-ContribAuthor ">Xueshi  Hao</span>, <span class="hlFld-ContribAuthor ">Tingting  Mo</span>, <span class="hlFld-ContribAuthor ">Shanshan  Yan</span>, <span class="hlFld-ContribAuthor ">Yefen  Zou</span>, <span class="hlFld-ContribAuthor ">Zhihong  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenqi  Gao</span>, <span class="hlFld-ContribAuthor ">Tom Y.‐H.  Wu</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Badry  Bursalaya</span>, <span class="hlFld-ContribAuthor ">Michael  Di Donato</span>, <span class="hlFld-ContribAuthor ">You‐Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Lisa  Deaton</span>, <span class="hlFld-ContribAuthor ">Weijun  Shen</span>, <span class="hlFld-ContribAuthor ">Brandon  Taylor</span>, <span class="hlFld-ContribAuthor ">Anwesh  Kamireddy</span>, <span class="hlFld-ContribAuthor ">George  Harb</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Schumacher</span>, <span class="hlFld-ContribAuthor ">Bryan  Laffitte</span>, <span class="hlFld-ContribAuthor ">Richard  Glynne</span>, <span class="hlFld-ContribAuthor ">Shifeng  Pan</span>, <span class="hlFld-ContribAuthor ">Peter  McNamara</span>, <span class="hlFld-ContribAuthor ">Valentina  Molteni</span>, <span class="hlFld-ContribAuthor ">Jon  Loren</span>. </span><span class="cited-content_cbyCitation_article-title">A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (16)
                                     , 1562-1570. <a href="https://doi.org/10.1002/cmdc.202000183" title="DOI URL">https://doi.org/10.1002/cmdc.202000183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000183%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BDual%252BInhibitor%252Bof%252BDYRK1A%252Band%252BGSK3%2525CE%2525B2%252Bfor%252B%2525CE%2525B2%2525E2%252580%252590Cell%252BProliferation%25253A%252BAminopyrazine%252BDerivative%252BGNF4877%26aulast%3DLiu%26aufirst%3DYahu%2BA.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D16%26spage%3D1562%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Kumar</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Ethan  A. Swartz</span>, <span class="hlFld-ContribAuthor ">Susmita  Khamrui</span>, <span class="hlFld-ContribAuthor ">Cody  Secor</span>, <span class="hlFld-ContribAuthor ">Michael  B. Lazarus</span>, <span class="hlFld-ContribAuthor ">Roberto  Sanchez</span>, <span class="hlFld-ContribAuthor ">Andrew  F. Stewart</span>, <span class="hlFld-ContribAuthor ">Robert J.  DeVita</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (8)
                                     , 1983. <a href="https://doi.org/10.3390/molecules25081983" title="DOI URL">https://doi.org/10.3390/molecules25081983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25081983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25081983%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BBiological%252BEvaluation%252Bof%252B7-Substituted%252BHarmine%252BAnalogs%252Bfor%252BHuman%252B%2525CE%2525B2-Cell%252BProliferation%26aulast%3DKumar%26aufirst%3DKunal%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D8%26spage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">勇  王</span>. </span><span class="cited-content_cbyCitation_article-title">The Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 1A and the Advances of Its Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>08 </em>
                                    (02)
                                     , 38-50. <a href="https://doi.org/10.12677/HJMCe.2020.82006" title="DOI URL">https://doi.org/10.12677/HJMCe.2020.82006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2020.82006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2020.82006%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDual-Specificity%252BTyrosine%252BPhosphorylation%252BRegulated%252BKinase%252B1A%252Band%252Bthe%252BAdvances%252Bof%252BIts%252BInhibitors%26aulast%3D%25E7%258E%258B%26aufirst%3D%25E5%258B%2587%26date%3D2020%26volume%3D08%26issue%3D02%26spage%3D38%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization of the 1-position of harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 9-<i>N-</i>Substituted Harmine Analog<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH (2 equiv), Br(CH<sub>2</sub>)<i><sub>n</sub></i>CO<sub>2</sub>R (2 equiv), DMF, 50 °C, 12 h, 21–82%; (b) 7 N NH<sub>3</sub> in MeOH (20 equiv), 90 °C, 12 h, 40–100%; (c) 4 N HCl in dioxane, rt, 12 h, 60–100%; (d) Et<sub>3</sub>SiH (8 equiv), Pd-C, MeOH, rt, 1 h, 6–64% (2 steps); (e) NaH (2 equiv), Br(CH<sub>2</sub>)<i><sub>n</sub></i>NHPhth (2 equiv) (for <b>2-1m</b> and <b>2-1n</b>) and Br(CH<sub>2</sub>)<sub>3</sub>NHBoc (2 equiv) (for <b>2-1o</b>), DMF, 50 °C, 12 h, 60–84%; (f) hydrazine monohydrate (20 equiv), MeOH, reflux, 3 h, 34–36%; (g) acetic anhydride (1 equiv), Et<sub>3</sub>N (2.2 equiv), DCM, rt, 12 h, 38–63%; (h) (i) ethylformate (0.5 equiv), EtOH, microwave, 150 °C, 30 min; (ii) LiAlH<sub>4</sub> (3 equiv), THF, reflux, 4 h, 27–41%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Substituents explored for optimization of the 9-<i>N-</i>position of harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of harmine and new analogs on human β-cell proliferation. (A) Initial screening of harmine analogs on human β-cell proliferation at 10 μM. DMSO was used as a negative control, and harmine was used as a positive control (<i>N</i> = 3 independent experiments with different human islet donors for each compound). (B) Representative example from (A) of Ki67–insulin double-positive cells induced by <b>2-2c.</b> (C) Dose–response curves for human β-cell proliferation for <b>1-2b</b>, <b>2-2c</b>, <b>2-2d</b>, <b>2-2f</b>, <b>2-1k</b>, and <b>2-1l</b> in human β cells (<i>N</i> = 3 independent experiments with different human islet donors for each dose); harmine (10 μM) is the positive control. Dosage: 1, 3, 10, and 30 μM. Abbreviation H = harmine, D = DMSO. (D) Quantitation of nuclear frequency of NFATC1-GFP in the R7T1 mouse insulinoma cell line treated with the compounds that showed proliferation in human islets. DMSO was used as a negative control, and harmine was used as a positive control (10 μM, 24 h; <i>N</i> = 3 independent experiments for each compound). (E) Representative example of <b>2-2c</b> (10 μM, 24 h), increasing the nuclear frequency of NFATC1-GFP in R7T1 rodent β-cells. (F) Effects in human islets of DMSO or <b>2-2c</b> treatment as in (A) on mRNA expression of four canonical markers of β-cell differentiation, <i>INS, PDX1</i>, <i>NKX6.1</i>, and <i>MAFA</i>, in three different human islet preparations (<i>N</i> = 3 independent experiments). Error bars indicate SEM and * indicates <i>P</i> < 0.05. A minimum of 1000 β-cells was counted for each graph. In all relevant panels, error bars indicate SEM and * indicates <i>P</i> < 0.05. A minimum of 1000 β-cells was counted for each graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of compound <b>2-2c</b> bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>). (A) Overlay of harmine (cyan) with the crystal structure of <b>2-2c</b> (yellow) bound to DYRK1A. The previously published harmine structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>) was superimposed on the new <b>2-2c</b> structure. (B) Contacts of <b>2-2c</b> are shown, including the new contacts of the amide of <b>2-2c</b> to the Glu291 backbone and the Asn244 side chain of chain D, along with the hinge binding and Lys188 previously seen in harmine. (C) Overlay of the <b>2-2c</b> structure and ATP. Using the structure of ATP bound to PKA (4DH3),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> the ATP position was superimposed onto DYRK1A, showing the overlapping areas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome scan data of compound <b>2-2c</b>, harmine, and compound <b>I</b>. (A) Compounds were screened at 10 μM against 468 kinases using Discoverx kinome scan (<i>N</i> = 2 independent experiments). Results for primary screen binding interactions are reported as “% DMSO Ctrl” where lower values indicate stronger affinity (see the Supporting Information for details). (B) TreeSpot interaction map for harmine and compound <b>2-2c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro and in vivo CNS off-target activity of compound <b>2-2c</b>. (A) Percent inhibition of a selected panel of CNS off-targets (known for harmine) at 10 μM of compound <b>2-2c</b> and harmine. <i>N</i> = 2 independent experiments. (B) Brain plasma ratio of compound <b>2-2c</b> in CD-1 mice after oral dosing at 30 mg/kg. (C) Effects of compound <b>2-2c</b> and harmine in the induction of tremor in mice. Representatives of snapshots from the video of 12 week-old C57BL6/N male mice that received i.p. injections of either (a) saline, (b) harmine 10 mg/kg, and (c) compound <b>2-2c</b> 30 mg/kg. Mice were analyzed for 15 min after injection (video attached as supplementary material).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/medium/jm9b01379_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compound <b>2-2c</b> in three in vivo models of β-cell replication and regeneration. (A) Representative images (<i>n</i> = 10–20 images per animal) of Ki67 immunolabeling of β-cells in 12 week-old C57BL6N male mice receiving daily i.p. injections of either saline or different doses of compound <b>2-2c</b> and harmine for 7 days. (B) Quantification of Ki67 labeling of β-cells in saline and compound <b>2-2c</b>-treated mice, with 6 to 12 mice in each group. *<i>P</i> < 0.05 vs saline. (C) Quantification of Ki67 labeling of β-cells in saline- and harmine-treated mice, with four mice in each group. *<i>P</i> < 0.05 vs saline. (D) Quantification of Ki67 labeling of β-cells in 12 week-old C57BL6N male mice receiving sham operation or partial pancreatectomy (PPx) and treated daily i.p. injections of either saline or compound <b>2-2c</b> for 7 days, with five to six mice in each group. *<i>P</i> < 0.05. (E) Quantification of β-cell mass in saline- and compound <b>2-2c</b>-treated mice receiving sham operation or PPx and either saline or compound <b>2-2c</b> for 7 days, with five to six mice in each group. *<i>P</i> < 0.05. (F) Representative images of Ki67 immunolabeling of human β-cells in islet grafts transplanted under the kidney capsule of immunodeficient mice receiving daily injections of either saline, <b>2-2c</b>, or harmine for 7 days. (G) Quantification of Ki67 labeling of human β-cells in saline-, <b>2-2c</b>-, and harmine-treated mice, with four different human islet preparations in four mice per treatment. *<i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b01379/20200323/images/large/jm9b01379_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01379&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 86 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.-X.+Gongauthor=Y.-W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lgk0u8PHErIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of alzheimer’s?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+A+new+avenue+for+a+disease+modifying+treatment+of+alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lgk0u8PHErIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520A%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ionescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbcke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span> <span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0lhJEhAQ_1OJ3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Martínez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Gómez, P.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span>. <i>Mol. Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e970048</span> <span class="refDoi"> DOI: 10.4161/23723548.2014.970048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.4161%2F23723548.2014.970048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27308401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=P.+Fern%C3%A1ndez-Mart%C3%ADnezauthor=C.+Zahoneroauthor=P.+S%C3%A1nchez-G%C3%B3mez&title=DYRK1A%3A+the+double-edged+kinase+as+a+protagonist+in+cell+growth+and+tumorigenesis&doi=10.4161%2F23723548.2014.970048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span></div><div class="casAuthors">Fernandez-Martinez, P.; Zahonero, C.; Sanchez-Gomez, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e970048/1-e970048/11</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">DYRK1A (dual-specificity tyrosine-regulated kinase 1A) is a kinase with multiple implications for embryonic development, esp. in the nervous system where it regulates the balance between proliferation and differentiation of neural progenitors.  The DYRK1A gene is located in the Down syndrome crit. region and may play a significant role in the developmental brain defects, early neurodegeneration, and cancer susceptibility of individuals with this syndrome.  DYRK1A is also expressed in adults, where it might participate in the regulation of cell cycle, survival, and tumorigenesis, thus representing a potential therapeutic target for certain types of cancer.  However, the final readout of DYRK1A overexpression or inhibition depends strongly on the cellular context, as it has both tumor suppressor and oncogenic activities.  Here, we will discuss the functions and substrates of DYRK1A assocd. with the control of cell growth and tumorigenesis with a focus on the potential use of DYRK1A inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OUDGl-nB87Vg90H21EOLACvtfcHk0lhJEhAQ_1OJ3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D&md5=27153f30af11f2572ba271ee09dd9939</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.970048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.970048%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Mart%25C3%25ADnez%26aufirst%3DP.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DS%25C3%25A1nchez-G%25C3%25B3mez%26aufirst%3DP.%26atitle%3DDYRK1A%253A%2520the%2520double-edged%2520kinase%2520as%2520a%2520protagonist%2520in%2520cell%2520growth%2520and%2520tumorigenesis%26jtitle%3DMol.%2520Cell.%2520Oncol.%26date%3D2015%26volume%3D2%26doi%3D10.4161%2F23723548.2014.970048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.-C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0lgZDOC97yN-6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.-C.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swafford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursalaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pinzon, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8372</span>, <span class="refDoi"> DOI: 10.1038/ncomms9372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms9372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26496802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8372&author=W.+Shenauthor=B.+Taylorauthor=Q.+Jinauthor=V.+Nguyen-Tranauthor=S.+Meeusenauthor=Y.-Q.+Zhangauthor=A.+Kamireddyauthor=A.+Swaffordauthor=A.+F.+Powersauthor=J.+Walkerauthor=J.+Lambauthor=B.+Bursalayaauthor=M.+DiDonatoauthor=G.+Harbauthor=M.+Qiuauthor=C.+M.+Filippiauthor=L.+Deatonauthor=C.+N.+Turkauthor=W.+L.+Suarez-Pinzonauthor=Y.+Liuauthor=X.+Haoauthor=T.+Moauthor=S.+Yanauthor=J.+Liauthor=A.+E.+Hermanauthor=B.+J.+Heringauthor=T.+Wuauthor=H.+M.+Seidelauthor=P.+McNamaraauthor=R.+Glynneauthor=B.+Laffitte&title=Inhibition+of+DYRK1A+and+GSK3B+induces+human+%CE%B2-cell+proliferation&doi=10.1038%2Fncomms9372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span></div><div class="casAuthors">Shen, Weijun; Taylor, Brandon; Jin, Qihui; Nguyen-Tran, Van; Meeusen, Shelly; Zhang, You-Qing; Kamireddy, Anwesh; Swafford, Austin; Powers, Andrew F.; Walker, John; Lamb, John; Bursalaya, Badry; DiDonato, Michael; Harb, George; Qiu, Minhua; Filippi, Christophe M.; Deaton, Lisa; Turk, Carolina N.; Suarez-Pinzon, Wilma L.; Liu, Yahu; Hao, Xueshi; Mo, Tingting; Yan, Shanshan; Li, Jing; Herman, Ann E.; Hering, Bernhard J.; Wu, Tom; Seidel, H. Martin; McNamara, Peter; Glynne, Richard; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8372</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insufficient pancreatic β-cell mass or function results in diabetes mellitus.  While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacol. agents have been described that increase β-cell replication in humans.  Here we report aminopyrazine compds. that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B.  Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice.  Oral dosing of these compds. in diabetic mice induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycemic control.  Biochem., genetic and cell biol. data point to Dyrk1a as the key mol. target.  This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVHzP-VkH5nrVg90H21EOLACvtfcHk0lgZDOC97yN-6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK&md5=5ef960af3bfd2795b9fdce52876e5d59</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncomms9372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9372%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DNguyen-Tran%26aufirst%3DV.%26aulast%3DMeeusen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DKamireddy%26aufirst%3DA.%26aulast%3DSwafford%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DBursalaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DFilippi%26aufirst%3DC.%2BM.%26aulast%3DDeaton%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DSuarez-Pinzon%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DA.%2BE.%26aulast%3DHering%26aufirst%3DB.%2BJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520DYRK1A%2520and%2520GSK3B%2520induces%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8372%26doi%3D10.1038%2Fncomms9372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachdi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kariyawasam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aïello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharfmann, R.</span></span> <span> </span><span class="NLM_article-title">Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2229</span>, <span class="refDoi"> DOI: 10.4161/cc.29250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.4161%2Fcc.29250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24870561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WisLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2221-2229&author=L.+Rachdiauthor=D.+Kariyawasamauthor=V.+A%C3%AFelloauthor=Y.+Heraultauthor=N.+Janelauthor=J.-M.+Delabarauthor=M.+Polakauthor=R.+Scharfmann&title=Dyrk1A+induces+pancreatic+%CE%B2+cell+mass+expansion+and+improves+glucose+tolerance&doi=10.4161%2Fcc.29250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance</span></div><div class="casAuthors">Rachdi, Latif; Kariyawasam, Dulanjalee; Aiello, Virginie; Herault, Yann; Janel, Nathalie; Delabar, Jean-Maurice; Polak, Michel; Scharfmann, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2221-2229</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Type 2 diabetes is caused by a limited capacity of insulin-producing pancreatic β cells to increase their mass and function in response to insulin resistance.  The signaling pathways that pos. regulate functional β cell mass have not been fully elucidated.  DYRK1A (also called minibrain/MNB) is a member of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family.  A significant amt. of data implicates DYRK1A in brain growth and Down syndrome, and recent data indicate that Dyrk1A haploinsufficient mice have a low functional β cell mass.  Here we ask whether Dyrk1A upregulation could be a way to increase functional β cell mass.  We used mice overexpressing Dyrk1A under the control of its own regulatory sequences (mBACTgDyrk1A).  These mice exhibit decreased glucose levels and hyperinsulinemia in the fasting state.  Improved glucose tolerance is obsd. in these mice as early as 4 wk of age.  Upregulation of Dyrk1A in β cells induces expansion of β cell mass through increased proliferation and cell size.  Importantly, mBACTgDyrk1A mice are protected against high-fat-diet-induced β cell failure through increase in β cell mass and insulin sensitivity.  These studies show the crucial role of the DYRK1A pathway in the regulation of β cell mass and carbohydrate metab. in vivo.  Activating the DYRK1A pathway could thus represent an innovative way to increase functional β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre5nXGBuindrVg90H21EOLACvtfcHk0licMAVtWDDr4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WisLzP&md5=92dc7241ee0f258a91351b6bffd941d8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4161%2Fcc.29250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.29250%26sid%3Dliteratum%253Aachs%26aulast%3DRachdi%26aufirst%3DL.%26aulast%3DKariyawasam%26aufirst%3DD.%26aulast%3DA%25C3%25AFello%26aufirst%3DV.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.-M.%26aulast%3DPolak%26aufirst%3DM.%26aulast%3DScharfmann%26aufirst%3DR.%26atitle%3DDyrk1A%2520induces%2520pancreatic%2520%25CE%25B2%2520cell%2520mass%2520expansion%2520and%2520improves%2520glucose%2520tolerance%26jtitle%3DCell%2520Cycle%26date%3D2014%26volume%3D13%26spage%3D2221%26epage%3D2229%26doi%3D10.4161%2Fcc.29250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dančik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human β-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26953159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8Dikauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A stimulates human beta-cell proliferation</span></div><div class="casAuthors">Dirice, Ercument; Walpita, Deepika; Vetere, Amedeo; Meier, Bennett C.; Kahraman, Sevim; Hu, Jiang; Dancik, Vlado; Burns, Sean M.; Gilbert, Tamara J.; Olson, David E.; Clemons, Paul A.; Kulkarni, Rohit N.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1660-1671</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1).  While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle applies to humans, as human β-cells are remarkably resistant to stimulation of division (3,4).  Here, we show that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increase proliferation in rodent and porcine islets (5), strongly and selectively increases human β-cell proliferation in vitro and in vivo.  Remarkably, 5-IT also increased glucose-dependent insulin secretion after prolonged treatment.  Kinome profiling revealed 5-IT to be a potent and selective inhibitor of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) and cell division cycle-like kinase families.  Induction of β-cell proliferation by either 5-IT or harmine, another natural product DYRK1A inhibitor, was suppressed by coincubation with the calcineurin inhibitor FK506, suggesting involvement of DYRK1A and nuclear factor of activated T cells signaling.  Gene expression profiling in whole islets treated with 5-IT revealed induction of proliferation- and cell cycle-related genes, suggesting that true proliferation is induced by 5-IT.  Furthermore, 5-IT promotes β-cell proliferation in human islets grafted under the kidney capsule of NOD-scid IL2Rgnull mice.  These results point to inhibition of DYRK1A as a therapeutic strategy to increase human β-cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLKPVi2wkdrVg90H21EOLACvtfcHk0licMAVtWDDr4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP&md5=c383c8d1f2c1739252ad3cfe4361585c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258Dik%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A potential drug target for multiple down syndrome neuropathologies</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/18715273113126660186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2174%2F18715273113126660186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24152332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=26-33&author=W.+Beckerauthor=U.+Soppaauthor=F.+Tejedor&title=DYRK1A%3A+A+potential+drug+target+for+multiple+down+syndrome+neuropathologies&doi=10.2174%2F18715273113126660186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies</span></div><div class="casAuthors">Becker, Walter; Soppa, Ulf; Tejedor, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Down syndrome (DS), the most common genetic cause of intellectual disability, is caused by the trisomy of chromosome 21.  MNB/DYRK1A (Minibrain/dual specificity tyrosine phosphorylation-regulated kinase 1A) has possibly been the most extensively studied chromosome 21 gene during the last decade due to the remarkable correlation of its functions in the brain with important DS neuropathologies, such as neuronal deficits, dendrite atrophy, spine dysgenesis, precocious Alzheimer's-like neurodegeneration, and cognitive deficits.  MNB/DYRK1A has become an attractive drug target because increasing evidence suggests that its overexpression may induce DS-like neurobiol. alterations, and several small-mol. inhibitors of its protein kinase activity are available.  Here, we summarize the functional complexity of MNB/DYRK1A from a DS-research perspective, paying particular attention to the capacity of different MNB/DYRK1A inhibitors to reverse the neurobiol. alterations caused by the increased activity of MNB/DYRK1A in exptl. models.  Finally, we discuss the advantages and drawbacks of possible MNB/DYRK1A-based therapeutic strategies that result from the functional, mol., and pharmacol. complexity of MNB/DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaG-2GxDUKR7Vg90H21EOLACvtfcHk0licMAVtWDDr4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D&md5=4b9c141d30bbf23f35f73b63e31f3e65</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F18715273113126660186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715273113126660186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%26atitle%3DDYRK1A%253A%2520A%2520potential%2520drug%2520target%2520for%2520multiple%2520down%2520syndrome%2520neuropathologies%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D26%26epage%3D33%26doi%3D10.2174%2F18715273113126660186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21126318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, regulation, and inhibition of DYRK1A</span></div><div class="casAuthors">Becker, Walter; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-256</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiol.  Higher than normal levels of DYRK1A are assocd. with the pathol. of neurodegenerative diseases and have been implicated in some neurobiol. alterations of Down syndrome, such as mental retardation.  It is therefore important to understand the mol. mechanisms that control the activity of DYRK1A.  Here, the authors review current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases.  However, tyrosine phosphorylation does not appear to regulate the enzymic activity of DYRK1A.  Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins, and regulated nuclear translocation.  Finally, the authors compare the properties of small mol. inhibitors that target DYRK1A and evaluate their potential application and limitations.  The β-carboline alkaloid, harmine, is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_Eqb_-j05bVg90H21EOLACvtfcHk0lgsgvfCeEFoDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7s%253D&md5=958db7f4577f941bd8dfb56afc461335</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkarim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grougnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myrianthopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillequin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span> <span> </span><span class="NLM_article-title">Two new peltogynoids from Acacia nilotica Delile with kinase inhibitory activity</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1055/s-0029-1186226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1055%2Fs-0029-1186226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19844867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFSkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=458-460&author=A.+Ahmaduauthor=A.+Abdulkarimauthor=R.+Grougnetauthor=V.+Myrianthopoulosauthor=F.+Tillequinauthor=P.+Magiatisauthor=A.-L.+Skaltsounis&title=Two+new+peltogynoids+from+Acacia+nilotica+Delile+with+kinase+inhibitory+activity&doi=10.1055%2Fs-0029-1186226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Two new peltogynoids from Acacia nilotica Delile with kinase inhibitory activity</span></div><div class="casAuthors">Ahmadu, Augustine; Abdulkarim, Agunu; Grougnet, Raphael; Myrianthopoulos, Vassilios; Tillequin, Francois; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">458-460</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two new peltogynoids, acanilol A and B (I, II), were isolated from the stem bark of Acacia nilotica (L.) Delile, together with the known triterpene lupenone.  The structures of the new compds. were established on the basis of their spectral data, mainly UV, NMR, and mass spectrometry.  The new compds. were tested as kinase inhibitors against CDK1, GSK3, CK1, and DYRK1A, and acanilol B was identified as a DYRK1A inhibitor, with an IC50 of 19 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoifXyZ2W96bVg90H21EOLACvtfcHk0lgsgvfCeEFoDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFSkt7Y%253D&md5=28f53bfcb8e2e3a952906cb3d2c15ab1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1055%2Fs-0029-1186226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0029-1186226%26sid%3Dliteratum%253Aachs%26aulast%3DAhmadu%26aufirst%3DA.%26aulast%3DAbdulkarim%26aufirst%3DA.%26aulast%3DGrougnet%26aufirst%3DR.%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DTillequin%26aufirst%3DF.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26atitle%3DTwo%2520new%2520peltogynoids%2520from%2520Acacia%2520nilotica%2520Delile%2520with%2520kinase%2520inhibitory%2520activity%26jtitle%3DPlanta%2520Med.%26date%3D2010%26volume%3D76%26spage%3D458%26epage%3D460%26doi%3D10.1055%2Fs-0029-1186226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akue-Gedu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudhomme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4420</span>– <span class="NLM_lpage">4424</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmc.2009.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19477650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4420-4424&author=R.+Akue-Geduauthor=E.+Debitonauthor=Y.+Ferandinauthor=L.+Meijerauthor=M.+Prudhommeauthor=F.+Anizonauthor=P.+Moreau&title=Synthesis+and+biological+activities+of+aminopyrimidyl-indoles+structurally+related+to+meridianins&doi=10.1016%2Fj.bmc.2009.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins</span></div><div class="casAuthors">Akue-Gedu, Rufine; Debiton, Eric; Ferandin, Yoan; Meijer, Laurent; Prudhomme, Michelle; Anizon, Fabrice; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4420-4424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs. substituted at the C-5 position of the 2-aminopyrimidine ring by various aryl groups and substituted or not by a Me group on the indole nitrogen is described.  These compds. were tested for their kinase inhibitory potencies toward five kinases (CDK5/p25, CK1δ/ε, GSK-3α/β, Dyrk1A and Erk2) as well as their in vitro antiproliferative activities toward a human fibroblast primary culture and two human solid cancer cell lines (MCF-7 and PA 1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYufDKqEQZNrVg90H21EOLACvtfcHk0lgsgvfCeEFoDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gru7c%253D&md5=f14ea49d5c54c32f5a6be1d9214d4bc7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DAkue-Gedu%26aufirst%3DR.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DPrudhomme%26aufirst%3DM.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520aminopyrimidyl-indoles%2520structurally%2520related%2520to%2520meridianins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D4420%26epage%3D4424%26doi%3D10.1016%2Fj.bmc.2009.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister-Lock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvanites, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, D. A.</span></span> <span> </span><span class="NLM_article-title">Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3915</span>– <span class="NLM_lpage">3920</span>, <span class="refDoi"> DOI: 10.1073/pnas.1201149109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1073%2Fpnas.1201149109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22345561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFymtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3915-3920&author=J.+P.+Annesauthor=J.+H.+Ryuauthor=K.+Lamauthor=P.+J.+Carolanauthor=K.+Utzauthor=J.+Hollister-Lockauthor=A.+C.+Arvanitesauthor=L.+L.+Rubinauthor=G.+Weirauthor=D.+A.+Melton&title=Adenosine+kinase+inhibition+selectively+promotes+rodent+and+porcine+islet+%CE%B2-cell+replication&doi=10.1073%2Fpnas.1201149109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication</span></div><div class="casAuthors">Annes, Justin P.; Ryu, Jennifer Hyoje; Lam, Kelvin; Carolan, Peter J.; Utz, Katrina; Hollister-Lock, Jennifer; Arvanites, Anthony C.; Rubin, Lee L.; Weir, Gordon; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3915-3920</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Diabetes is a pathol. condition characterized by relative insulin deficiency, persistent hyperglycemia, and, consequently, diffuse micro- and macrovascular disease.  One therapeutic strategy is to amplify insulin-secretion capacity by increasing the no. of the insulin-producing β cells without triggering a generalized proliferative response.  Here, we present the development of a small-mol. screening platform for the identification of mols. that increase β-cell replication.  Using this platform, we identify a class of compds. [adenosine kinase inhibitors (ADK-Is)] that promote replication of primary β cells in three species (mouse, rat, and pig).  Furthermore, the replication effect of ADK-Is is cell type-selective: treatment of islet cell cultures with ADK-Is increases replication of β cells but not that of α cells, PP cells, or fibroblasts.  Short-term in vivo treatment with an ADK-I also increases β-cell replication but not exocrine cell or hepatocyte replication.  Therefore, we propose ADK inhibition as a strategy for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9d3QakDBpybVg90H21EOLACvtfcHk0ljKeZ81fJY5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFymtL8%253D&md5=2bec02ff18ef273ec38734a98c9395cb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1201149109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1201149109%26sid%3Dliteratum%253Aachs%26aulast%3DAnnes%26aufirst%3DJ.%2BP.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26aulast%3DLam%26aufirst%3DK.%26aulast%3DCarolan%26aufirst%3DP.%2BJ.%26aulast%3DUtz%26aufirst%3DK.%26aulast%3DHollister-Lock%26aufirst%3DJ.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DWeir%26aufirst%3DG.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DAdenosine%2520kinase%2520inhibition%2520selectively%2520promotes%2520rodent%2520and%2520porcine%2520islet%2520%25CE%25B2-cell%2520replication%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3915%26epage%3D3920%26doi%3D10.1073%2Fpnas.1201149109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0ljKeZ81fJY5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of alzheimer’s disease: effect on tau and amyloid pathologies in vitro</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.-S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=A+novel+DYRK1A+%28Dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+alzheimer%E2%80%99s+disease%3A+effect+on+tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0ljQAumsKlrcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528Dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianoncelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1042/BJ20090069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1042%2FBJ20090069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19432557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell-permeable+inhibitor+of+protein+kinase+CK2&doi=10.1042%2FBJ20090069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span></div><div class="casAuthors">Cozza, Giorgio; Mazzorana, Marco; Papinutto, Elena; Bain, Jenny; Elliott, Matthew; di Maira, Giovanni; Gianoncelli, Alessandra; Pagano, Mario A.; Sarno, Stefania; Ruzzene, Maria; Battistutta, Roberto; Meggio, Flavio; Moro, Stefano; Zagotto, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-395</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is a moderately potent and poorly selective inhibitor of protein kinase CK2, one of the most pleiotropic serine/threonine protein kinases, implicated in neoplasia and in other global diseases.  By virtual screening of the MMS (Mol. Modeling Section) database, we have now identified quinalizarin (1,2,5,8-tetrahydroxyanthraquinone) as an inhibitor of CK2 that is more potent and selective than emodin.  CK2 inhibition by quinalizarin is competitive with respect to ATP, with a Ki value of approx. 50 nM.  Tested at 1 μM concn. on a panel of 75 protein kinases, quinalizarin drastically inhibits only CK2, with a promiscuity score (11.1), which is the lowest ever reported so far for a CK2 inhibitor.  Esp. remarkable is the ability of quinalizarin to discriminate between CK2 and a no. of kinases, notably DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase), PIM (provirus integration site for Moloney murine leukemia virus) 1, 2 and 3, HIPK2 (homeodomain-interacting protein kinase-2), MNK1 [MAPK (mitogen-activated protein kinase)-interacting kinase 1], ERK8 (extracellular-signal-regulated kinase 8) and PKD1 (protein kinase D 1), which conversely tend to be inhibited as drastically as CK2 by com. available CK2 inhibitors.  The detn. of the crystal structure of a complex between quinalizarin and CK2α subunit highlights the relevance of polar interactions in stabilizing the binding, an unusual characteristic for a CK2 inhibitor, and disclose other structural features which may account for the narrow selectivity of this compd.  Tested on Jurkat cells, quinalizarin proved able to inhibit endogenous CK2 and to induce apoptosis more efficiently than the commonly used CK2 inhibitors TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbz80w9Hmd9LVg90H21EOLACvtfcHk0ljQAumsKlrcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D&md5=dc127c347d7e47419bee4594ff7572fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1042%2FBJ20090069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090069%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3Ddi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell-permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D387%26epage%3D395%26doi%3D10.1042%2FBJ20090069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clément, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): Synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/Cyclin A/meriolin complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/jm700940h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700940h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=737-751&author=A.+Echalierauthor=K.+Bettayebauthor=Y.+Ferandinauthor=O.+Lozachauthor=M.+Cl%C3%A9mentauthor=A.+Valetteauthor=F.+Ligerauthor=B.+Marquetauthor=J.+C.+Morrisauthor=J.+A.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=Meriolins+%283-%28pyrimidin-4-yl%29-7-azaindoles%29%3A+Synthesis%2C+kinase+inhibitory+activity%2C+cellular+effects%2C+and+structure+of+a+CDK2%2FCyclin+A%2Fmeriolin+complex&doi=10.1021%2Fjm700940h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex</span></div><div class="casAuthors">Echalier, Aude; Bettayeb, Karima; Ferandin, Yoan; Lozach, Olivier; Clelment, Monique; Valette, Annie; Liger, Francois; Marquet, Bernard; Morris, Jonathan C.; Endicott, Jane A.; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and biol. characterization of 3-(pyrimidin-4-yl)-7-azaindoles (meriolins), a chem. hybrid between the natural products meridianins and variolins, derived from marine organisms.  Meriolins display potent inhibitory activities toward cyclin-dependent kinases (CDKs) and, to a lesser extent, other kinases (GSK-3, DYRK1A).  The crystal structures of I (meriolin 5) and variolin B in complex with CDK2/cyclin A reveal that the two inhibitors are oriented in very different ways inside the ATP-binding pocket of the kinase.  A structure-activity relationship provides further insight into the mol. mechanism of action of this family of kinase inhibitors.  Meriolins are also potent antiproliferative and proapoptotic agents in cells cultured either as monolayers or in spheroids.  Proapoptotic efficacy of meriolins correlates best with their CDK2 and CDK9 inhibitory activity.  Meriolins thus constitute a promising class of pharmacol. agents to be further evaluated against the numerous human diseases that imply abnormal regulation of CDKs including cancers, neurodegenerative disorders, and polycystic kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJgno3A1_7LVg90H21EOLACvtfcHk0ljQAumsKlrcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D&md5=1bfb3d02c6894c04237eee27bbccaa5b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm700940h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700940h%26sid%3Dliteratum%253Aachs%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DM.%26aulast%3DValette%26aufirst%3DA.%26aulast%3DLiger%26aufirst%3DF.%26aulast%3DMarquet%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeriolins%2520%25283-%2528pyrimidin-4-yl%2529-7-azaindoles%2529%253A%2520Synthesis%252C%2520kinase%2520inhibitory%2520activity%252C%2520cellular%2520effects%252C%2520and%2520structure%2520of%2520a%2520CDK2%252FCyclin%2520A%252Fmeriolin%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Fjm700940h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loaecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0lhMjgxDaDapOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hédou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubouilh-Benard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">15411</span>– <span class="NLM_lpage">15439</span>, <span class="refDoi"> DOI: 10.3390/molecules191015411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.3390%2Fmolecules191015411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25264830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15411-15439&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=A.+Girardauthor=T.+Taverneauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=B.+Leblondauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+part+II&doi=10.3390%2Fmolecules191015411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span></div><div class="casAuthors">Foucourt, Alicia; Hedou, Damien; Dubouilh-Benard, Carole; Girard, Angelique; Taverne, Thierry; Casagrande, Anne-Sophie; Desire, Laurent; Leblond, Bertrand; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15411-15439, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a focused library (forty mols.) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines I (R = 4-MeOC6H4, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, etc.) was achieved mainly under microwave irradn.  A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile was used as a versatile mol. platform for the synthesis of various derivs.  Kinase inhibition, of the obtained final compds., was evaluated on a panel of two kinases (DYRK1A/1B) together with some known ref. DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41).  Compd. IC50 values were obtained and compared.  Five of the novel thiazolo[5,4-f]quinazoline derivs. prepd., I (R = 2,4-Cl2C6H3, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, 2,4-F2C6H3, 4-MeC6H4) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date.  DYRK1A/1B kinases are known to be involved in the regulation of various mol. pathways assocd. with oncol., neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing.  The compds. described in this communication constitute a highly potent set of novel mol. probes to evaluate the biol./pharmacol. of DYR1A/1B in such diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxocRjJkBbrVg90H21EOLACvtfcHk0lhMjgxDaDapOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM&md5=cefa4032d967cd704a189f3a62a1738d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015411%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520part%2520II%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15411%26epage%3D15439%26doi%3D10.3390%2Fmolecules191015411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Théry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4489</span>, <span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Th%C3%A9ryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0liFznkdU1z5_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DTh%25C3%25A9ry%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denhez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9569</span>– <span class="NLM_lpage">9585</span>, <span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0liFznkdU1z5_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sébrié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivals, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e4606</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0004606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1371%2Fjournal.pone.0004606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19242551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ms12lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=F.+Guedjauthor=C.+S%C3%A9bri%C3%A9author=I.+Rivalsauthor=A.+Ledruauthor=E.+Palyauthor=J.+C.+Bizotauthor=D.+Smithauthor=E.+Rubinauthor=B.+Gilletauthor=M.+Arbonesauthor=J.+M.+Delabar&title=Green+tea+polyphenols+rescue+of+brain+defects+induced+by+overexpression+of+DYRK1A&doi=10.1371%2Fjournal.pone.0004606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A</span></div><div class="casAuthors">Guedj Faycal; Sebrie Catherine; Rivals Isabelle; Ledru Aurelie; Paly Evelyne; Bizot Jean C; Smith Desmond; Rubin Edward; Gillet Brigitte; Arbones Mariona; Delabar Jean M</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e4606</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis.  They present also learning impairments modeling those encountered in Down syndrome.  Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions.  Gene dosage correction induces a rescue of the brain volume alterations.  DYRK1A is also involved in the control of synaptic plasticity and memory consolidation.  Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice.  Epigallocatechin gallate (EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor.  We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood.  The major features of the transgenic phenotype were rescued in these mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1k9_XvFuhS-dfST00W0BcfW6udTcc2eaNvilbxI1Y5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ms12lsA%253D%253D&md5=72b96c0b213ce86fb70d456123e991e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004606%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DS%25C3%25A9bri%25C3%25A9%26aufirst%3DC.%26aulast%3DRivals%26aufirst%3DI.%26aulast%3DLedru%26aufirst%3DA.%26aulast%3DPaly%26aufirst%3DE.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DB.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DGreen%2520tea%2520polyphenols%2520rescue%2520of%2520brain%2520defects%2520induced%2520by%2520overexpression%2520of%2520DYRK1A%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0004606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kassis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzeszcz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guével, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillouzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewiński, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(phenyl) pyridine or pyrazine V-shaped molecules as kinase inhibitors and cytotoxic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2011.08.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21944287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5416-5434&author=P.+Kassisauthor=J.+Brzeszczauthor=V.+B%C3%A9n%C3%A9teauauthor=O.+Lozachauthor=L.+Meijerauthor=R.+Le+Gu%C3%A9velauthor=C.+Guillouzoauthor=K.+Lewi%C5%84skiauthor=S.+Bourgauthor=L.+Colliandreauthor=S.+Routierauthor=J.-Y.+M%C3%A9rour&title=Synthesis+and+biological+evaluation+of+new+3-%286-hydroxyindol-2-yl%29-5-%28phenyl%29+pyridine+or+pyrazine+V-shaped+molecules+as+kinase+inhibitors+and+cytotoxic+agents&doi=10.1016%2Fj.ejmech.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents</span></div><div class="casAuthors">Kassis, Pamela; Brzeszcz, Joanna; Beneteau, Valerie; Lozach, Olivier; Meijer, Laurent; Le Guevel, Remi; Guillouzo, Christiane; Lewinski, Krzysztof; Bourg, Stephane; Colliandre, Lionel; Routier, Sylvain; Merour, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5416-5434</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein is reported the synthesis and biol. evaluation of new 3-[(2-indolyl)]-5-phenyl-3,5-pyridine, 3-[(2-indolyl)]-5-phenyl-2,4-pyridine and 3-[(2-indolyl)]-5-phenyl-2,6-pyrazine derivs. designed as potential CDK inhibitors.  Indoles and phenyls were used to generate several substitutions of the pyridine and pyrazine rings.  The syntheses included Stille or Suzuki type reactions, which were carried out on the 3,5-dibromopyridine, 2,4-dichloropyridine and 2,6-dichloro-1-4-pyrazine moieties.  Cell effects of the V-shaped family were in the micromolar range.  Kinase assays were conducted and showed that compd. I inhibited CDK5 with an inhibitory concn. of 160 nM with a moderate selectivity over GSK3 compared to the ref. compd. II which exhibited a slightly lower activity on CDK5 (1.5 μM).  Compd. I was also found to be the most potent compd. in the series and was identified as a new lead for DYRK1A inhibitor discovery (IC50 = 60 nM).  Docking studies were carried out in order to investigate the inhibition of DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8p7-Tg5B6LVg90H21EOLACvtfcHk0ljXCHjUu0en9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ&md5=1b960c962e74420cf3ddad26ffeeec94</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DKassis%26aufirst%3DP.%26aulast%3DBrzeszcz%26aufirst%3DJ.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLe%2BGu%25C3%25A9vel%26aufirst%3DR.%26aulast%3DGuillouzo%26aufirst%3DC.%26aulast%3DLewi%25C5%2584ski%26aufirst%3DK.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25203-%25286-hydroxyindol-2-yl%2529-5-%2528phenyl%2529%2520pyridine%2520or%2520pyrazine%2520V-shaped%2520molecules%2520as%2520kinase%2520inhibitors%2520and%2520cytotoxic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5416%26epage%3D5434%26doi%3D10.1016%2Fj.ejmech.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0ljXCHjUu0en9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.-J.</span></span> <span> </span><span class="NLM_article-title">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3772</span>– <span class="NLM_lpage">3776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2006.04.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16698266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3772-3776&author=N.+D.+Kimauthor=J.+Yoonauthor=J.+H.+Kimauthor=J.+T.+Leeauthor=Y.+S.+Chonauthor=M.-K.+Hwangauthor=I.+Haauthor=W.-J.+Song&title=Putative+therapeutic+agents+for+the+learning+and+memory+deficits+of+people+with+Down+syndrome&doi=10.1016%2Fj.bmcl.2006.04.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span></div><div class="casAuthors">Kim, Nam Doo; Yoon, Jeonghyeok; Kim, Jung Ho; Lee, Jung Tae; Chon, Yong Sog; Hwang, Mi-Kyung; Ha, Ilho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3772-3776</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mental retardation is the most common and debilitating condition for individuals with Down syndrome (DS).  The hyper-activation of DYRK1A by overexpression causes significant learning and memory deficits in DS-model mice.  Thus far, no mechanism-based drug has been developed to address this.  After a combination of in silico and in vitro screenings, two DYRK1A inhibitors were isolated that are active in a cell-based assay.  Further optimization could lead to a novel drug discovery that could address DS learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCFzbIFHKqJbVg90H21EOLACvtfcHk0ljXCHjUu0en9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D&md5=5a6a306f3de1c958ac3d4b7f06d24c82</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DHwang%26aufirst%3DM.-K.%26aulast%3DHa%26aufirst%3DI.%26aulast%3DSong%26aufirst%3DW.-J.%26atitle%3DPutative%2520therapeutic%2520agents%2520for%2520the%2520learning%2520and%2520memory%2520deficits%2520of%2520people%2520with%2520Down%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3772%26epage%3D3776%26doi%3D10.1016%2Fj.bmcl.2006.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koo, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.-J.</span></span> <span> </span><span class="NLM_article-title">QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2324</span>– <span class="NLM_lpage">2328</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2009.02.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19282176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2324-2328&author=K.+A.+Kooauthor=N.+D.+Kimauthor=Y.+S.+Chonauthor=M.-S.+Jungauthor=B.-J.+Leeauthor=J.+H.+Kimauthor=W.-J.+Song&title=QSAR+analysis+of+pyrazolidine-3%2C5-diones+derivatives+as+Dyrk1A+inhibitors&doi=10.1016%2Fj.bmcl.2009.02.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors</span></div><div class="casAuthors">Koo, Kyung Ah; Kim, Nam Doo; Chon, Yong Sog; Jung, Min-Su; Lee, Burm-Jong; Kim, Jung Ho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2324-2328</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Individuals with Down syndrome (DS) suffer from mental retardation.  Overexpression and the resulting increased specific activity of Dyrk1A kinase located on chromosome 21 cause a learning and memory deficit in Dyrk1A transgenic mice.  To search for therapeutic agents with Dyrk1A inhibition activity, previously we obtained HCD160 as a new hit compd. for Dyrk1A inhibition.  In the present study, we synthesized 34 HCD160 derivs. to investigate the quant. structure-activity relationship (QSAR).  This anal. could provide important information for novel drug discovery for treatment of DS related learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyqYI1p0FQZLVg90H21EOLACvtfcHk0lgxL1tSb4IV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjtb0%253D&md5=07a2003db0fdb6b821a942e9f317b114</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.062%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DJung%26aufirst%3DM.-S.%26aulast%3DLee%26aufirst%3DB.-J.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSong%26aufirst%3DW.-J.%26atitle%3DQSAR%2520analysis%2520of%2520pyrazolidine-3%252C5-diones%2520derivatives%2520as%2520Dyrk1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2324%26epage%3D2328%26doi%3D10.1016%2Fj.bmcl.2009.02.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferr%C3%A9author=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstr%C3%B6mauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A%CE%B225-35+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0lgxL1tSb4IV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%25CE%25B225-35%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neagoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrenne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyrou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansiaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2012.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22305342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.-Y.+M%C3%A9rourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+Lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class&doi=10.1016%2Fj.ejmech.2012.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class</span></div><div class="casAuthors">Neagoie, Cleopatra; Vedrenne, Emeline; Buron, Frederic; Merour, Jean-Yves; Rosca, Sorin; Bourg, Stephane; Lozach, Olivier; Meijer, Laurent; Baldeyrou, Brigitte; Lansiaux, Amelie; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosteres.  Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonization step.  Twenty final compds. were tested in order to det. their activity against topoisomerase I and kinases, the two major biol. activities of Lamellarins.  One newly synthesized deriv. exhibited a strong topoisomerase activity comparable to ref. compds. such as campthotecin and Lamellarin with only a weak kinase inhibition.  Two other lead compds. were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range.  These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurol. or oncol. disorders in which DYRK1A is fully involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopoVhDdU5tMbVg90H21EOLACvtfcHk0lgxL1tSb4IV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D&md5=7d371529cde68f5fc4680c317a0d0a85</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520Lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396%26doi%3D10.1016%2Fj.ejmech.2012.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eYosaIJOW4h8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3152</span>– <span class="NLM_lpage">3158</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2011.02.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21450467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3152-3158&author=A.+S.+Rosenthalauthor=C.+Tanegaauthor=M.+Shenauthor=B.+T.+Mottauthor=J.+M.+Bougieauthor=D.-T.+Nguyenauthor=T.+Misteliauthor=D.+S.+Auldauthor=D.+J.+Maloneyauthor=C.+J.+Thomas&title=Potent+and+selective+small+molecule+inhibitors+of+specific+isoforms+of+Cdc2-like+kinases+%28Clk%29+and+dual+specificity+tyrosine-phosphorylation-regulated+kinases+%28Dyrk%29&doi=10.1016%2Fj.bmcl.2011.02.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span></div><div class="casAuthors">Rosenthal, Andrew S.; Tanega, Cordelle; Shen, Min; Mott, Bryan T.; Bougie, James M.; Nguyen, Dac-Trung; Misteli, Tom; Auld, Douglas S.; Maloney, David J.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3152-3158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Continued examn. of substituted 6-arylquinazolin-4-amines as Clk4 kinase inhibitors resulted in selective inhibitors of Clk1, Clk4, Dyrk1A, and Dyrk1B kinases.  Several of the most potent inhibitors were validated as being highly selective within a comprehensive kinome scan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-t6jcT2g9qrVg90H21EOLACvtfcHk0liZZRP_SufiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D&md5=37a7ffa16767005c19c559bbe9c3ae71</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.114%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DBougie%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DD.-T.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520specific%2520isoforms%2520of%2520Cdc2-like%2520kinases%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinases%2520%2528Dyrk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3152%26epage%3D3158%26doi%3D10.1016%2Fj.bmcl.2011.02.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braña, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4118</span>– <span class="NLM_lpage">4120</span>, <span class="refDoi"> DOI: 10.1039/B905068J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1039%2Fb905068j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19568652" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4118-4120&author=C.+S%C3%A1nchezauthor=A.+P.+Salasauthor=A.+F.+Bra%C3%B1aauthor=M.+Palominoauthor=A.+Pineda-Lucenaauthor=R.+J.+Carbajoauthor=C.+M%C3%A9ndezauthor=F.+Morisauthor=J.+A.+Salas&title=Generation+of+potent+and+selective+kinase+inhibitors+by+combinatorial+biosynthesis+of+glycosylated+indolocarbazoles&doi=10.1039%2FB905068J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fb905068j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905068j%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DA.%2BP.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DPalomino%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DMoris%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DGeneration%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520by%2520combinatorial%2520biosynthesis%2520of%2520glycosylated%2520indolocarbazoles%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D27%26spage%3D4118%26epage%3D4120%26doi%3D10.1039%2FB905068J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1007/s00018-011-0758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1007%2Fs00018-011-0758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21720886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=449-460&author=S.+Sarnoauthor=M.+Mazzoranaauthor=R.+Traynorauthor=M.+Ruzzeneauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=G.+Zagottoauthor=R.+Battistuttaauthor=L.+A.+Pinna&title=Structural+features+underlying+the+selectivity+of+the+kinase+inhibitors+NBC+and+dNBC%3A+role+of+a+nitro+group+that+discriminates+between+CK2+and+DYRK1A&doi=10.1007%2Fs00018-011-0758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span></div><div class="casAuthors">Sarno, Stefania; Mazzorana, Marco; Traynor, Ryan; Ruzzene, Maria; Cozza, Giorgio; Pagano, Mario A.; Meggio, Flavio; Zagotto, Giuseppe; Battistutta, Roberto; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-460</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">8-Hydroxy-4-methyl-9-nitrobenzo(g)chromen-2-one (NBC) has been found to be a fairly potent ATP site-directed inhibitor of protein kinase CK2 (Ki = 0.22 μM).  Here, we show that NBC also inhibits PIM kinases, esp. PIM1 and PIM3, the latter as potently as CK2.  Upon removal of the nitro group, to give 8-hydroxy-4-methyl-benzo(g)chromen-2-one (here referred to as "denitro NBC", dNBC), the inhibitory power toward CK2 is almost entirely lost (IC50 > 30 μM) whereas that toward PIM1 and PIM3 is maintained; in addn., dNBC is a potent inhibitor of a no. of other kinases that are weakly inhibited or unaffected by NBC, with special ref. to DYRK1A whose IC50 values with NBC and dNBC are 15 and 0.60 μM, resp.  Therefore, the observation that NBC, unlike dNBC, is a potent inducer of apoptosis is consistent with the notion that this effect is mediated by inhibition of endogenous CK2.  The structural features underlying NBC selectivity have been revealed by inspecting its 3D structure in complex with the catalytic subunit of Z. mays CK2.  The crucial role of the nitro group is exerted both through a direct electrostatic interaction with the side chain of Lys68 and, indirectly, by enhancing the acidic dissocn. const. of the adjacent hydroxyl group which interacts with a conserved water mol. in the deepest part of the cavity.  By contrast, the very same nitro group is deleterious for the binding to the active site of DYRK1A, as disclosed by mol. docking.  This provides the rationale for preferential inhibition of DYRK1A by dNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdF4WWERhM7Vg90H21EOLACvtfcHk0lgH9rgnLbl39Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D&md5=1105a1fc71bd6db43e10b23e073c1b37</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00018-011-0758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-011-0758-7%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DStructural%2520features%2520underlying%2520the%2520selectivity%2520of%2520the%2520kinase%2520inhibitors%2520NBC%2520and%2520dNBC%253A%2520role%2520of%2520a%2520nitro%2520group%2520that%2520discriminates%2520between%2520CK2%2520and%2520DYRK1A%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2012%26volume%3D69%26spage%3D449%26epage%3D460%26doi%3D10.1007%2Fs00018-011-0758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lgH9rgnLbl39Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brierley, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, C.</span></span> <span> </span><span class="NLM_article-title">Developments in harmine pharmacology - Implications for ayahuasca use and drug-dependence treatment</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2012.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.pnpbp.2012.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22691716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCjsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=263-272&author=D.+I.+Brierleyauthor=C.+Davidson&title=Developments+in+harmine+pharmacology+-+Implications+for+ayahuasca+use+and+drug-dependence+treatment&doi=10.1016%2Fj.pnpbp.2012.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in harmine pharmacology - Implications for ayahuasca use and drug-dependence treatment</span></div><div class="casAuthors">Brierley, Daniel I.; Davidson, Colin</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ayahuasca is a hallucinogenic botanical mixt. originating in the Amazon area where it is used ritually, but is now being taken globally.  The 2 main constituents of ayahuasca are N,N-dimethyltryptamine (DMT), a hallucinogen, and harmine, a monoamine oxidase inhibitor (MAOI) which attenuates the breakdown of DMT, which would otherwise be broken down very quickly after oral consumption.  Recent developments in ayahuasca use include the sale of these compds. on the internet and the substitution of related botanical (anahuasca) or synthetic (pharmahuasca) compds. to achieve the same desired hallucinogenic effects.  One intriguing result of ayahuasca use appears to be improved mental health and a redn. in recidivism to alternate (alc., cocaine) drug use.  In this review we discuss the pharmacol. of ayahuasca, with a focus on harmine, and suggest pharmacol. mechanisms for the putative redn. in recidivism to alc. and cocaine misuse.  These pharmacol. mechanisms include MAOI, effects at 5-HT2A and imidazoline receptors and inhibition of dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) and the dopamine transporter.  We also speculate on the therapeutic potential of harmine in other CNS conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBCBZzc81PPLVg90H21EOLACvtfcHk0lgH9rgnLbl39Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCjsr7P&md5=09e343f3b84458c57c6f9a00b3ba96c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2012.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2012.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBrierley%26aufirst%3DD.%2BI.%26aulast%3DDavidson%26aufirst%3DC.%26atitle%3DDevelopments%2520in%2520harmine%2520pharmacology%2520-%2520Implications%2520for%2520ayahuasca%2520use%2520and%2520drug-dependence%2520treatment%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2012%26volume%3D39%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.pnpbp.2012.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Airaksinen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecklin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuomisto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gynther, J.</span></span> <span> </span><span class="NLM_article-title">Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0773.1987.tb01711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1600-0773.1987.tb01711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=3562389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADyaL2sXktFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=5-8&author=M.+M.+Airaksinenauthor=A.+Lecklinauthor=V.+Saanoauthor=L.+Tuomistoauthor=J.+Gynther&title=Tremorigenic+effect+and+inhibition+of+tryptamine+and+serotonin+receptor+binding+by+%CE%B2-carbolines&doi=10.1111%2Fj.1600-0773.1987.tb01711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines</span></div><div class="casAuthors">Airaksinen, M. M.; Lecklin, A.; Saano, V.; Tuomisto, L.; Gynther, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-8</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">The abilities were studied of some naturally occurring β-carbolines (BCs), dihydro-BCs, and tetrahydro-BCs to inhibit the specific binding of [3H]tryptamine (TA), [3H]ketanserine to rat brain membranes and to induce tremor in mice.  These compds., particularly DHBCs and BCs, showed affinity for TA binding sites than to 5-HT1 or 5-HT2 binding sites inhibiting the former at nanomolar and the two latter ones at micromolar or high micromolar concns.  The Ki values for norharmane, harmaline, and harmine, 17, 18, and 74 nM, resp., for TA sites indicate the highest affinity so far described for natural B-carbolines to any receptor sites and thus may indicate their major site of action.  Among the BC derivs. studies, the harmala alkaloids were the most potent inducers of tremor in mice, although the orders of the tremorigenic potency and the binding to TA site did not correlate.  Apparently, the tremorigenic effect of BC derivs. is partly on the binding to specific tryptamine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ydB1vzcvdrVg90H21EOLACvtfcHk0lij1PF0LISMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktFOksb8%253D&md5=c25df7b404a2132d89f16944bf802fb8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1987.tb01711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1987.tb01711.x%26sid%3Dliteratum%253Aachs%26aulast%3DAiraksinen%26aufirst%3DM.%2BM.%26aulast%3DLecklin%26aufirst%3DA.%26aulast%3DSaano%26aufirst%3DV.%26aulast%3DTuomisto%26aufirst%3DL.%26aulast%3DGynther%26aufirst%3DJ.%26atitle%3DTremorigenic%2520effect%2520and%2520inhibition%2520of%2520tryptamine%2520and%2520serotonin%2520receptor%2520binding%2520by%2520%25CE%25B2-carbolines%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1987%26volume%3D60%26spage%3D5%26epage%3D8%26doi%3D10.1111%2Fj.1600-0773.1987.tb01711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuner, A. T. H.</span></span> <span> </span><span class="NLM_article-title">Oberdle wirkung der alkaloide von peganiro ilarroals insbesondere dea Harmallns</span>. <i>Arch. Exp. Pathol. Phannakol.</i> <span class="NLM_year" style="font-weight: bold;">1895</span>,  <span class="NLM_fpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1895&pages=35&author=A.+T.+H.+Neuner&title=Oberdle+wirkung+der+alkaloide+von+peganiro+ilarroals+insbesondere+dea+Harmallns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeuner%26aufirst%3DA.%2BT.%2BH.%26atitle%3DOberdle%2520wirkung%2520der%2520alkaloide%2520von%2520peganiro%2520ilarroals%2520insbesondere%2520dea%2520Harmallns%26jtitle%3DArch.%2520Exp.%2520Pathol.%2520Phannakol.%26date%3D1895%26spage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19264</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lij1PF0LISMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">DNA binding properties of 9-substituted harmine derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.10.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bbrc.2005.10.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16288723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egs73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=1557-1563&author=R.+Caoauthor=W.+Pengauthor=H.+Chenauthor=Y.+Maauthor=X.+Liuauthor=X.+Houauthor=H.+Guanauthor=A.+Xu&title=DNA+binding+properties+of+9-substituted+harmine+derivatives&doi=10.1016%2Fj.bbrc.2005.10.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">DNA binding properties of 9-substituted harmine derivatives</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Chen, Hongsheng; Ma, Yan; Liu, Xiaodong; Hou, Xuerui; Guan, Huaji; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1557-1563</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The β-carboline alkaloids have been characterized as a group of potential antitumor agents.  The underlying mechanisms of harmine and its derivs. were investigated by DNA binding assay and Topoisomerase (Topo) inhibition assay.  Meanwhile, the DNA photocleavage potential of these compds. and their cytotoxicity were also examd. by DNA photocleavage assay and cytotoxicity assay in vitro.  Harmine and its derivs. exhibited remarkable DNA intercalation capacity and significant Topo I inhibition activity but no effect with Topo II.  Introducing an appropriate substituent into position-9 of β-carboline nucleus enhanced the affinity of the drug to DNA resulting in remarkable Topo I inhibition effects.  These results suggested that the ability of these compds. to act as intercalating agents and Topo I inhibitors was related to the antitumor activity.  Moreover, these data showing a correlation between cytotoxicity and Topo I inhibition or DNA binding capacity are very important as they strongly suggested that the Topo I-mediated DNA cleavage assay and DNA binding assay could be used as a guide to design and develop superior analogs for antitumor activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz2X-pwVBln7Vg90H21EOLACvtfcHk0lij1PF0LISMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egs73J&md5=ec4b1ac12a6ebbd3c0a17a65b11bc190</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.10.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.10.121%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DDNA%2520binding%2520properties%2520of%25209-substituted%2520harmine%2520derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26spage%3D1557%26epage%3D1563%26doi%3D10.1016%2Fj.bbrc.2005.10.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sobhani, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimi, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoudian, M.</span></span> <span> </span><span class="NLM_article-title">An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its β-carboline alkaloids</span>. <i>J. Pharm. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12042115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADC%252BD38zhs1antw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=19-23&author=A.+M.+Sobhaniauthor=S.-A.+Ebrahimiauthor=M.+Mahmoudian&title=An+in+vitro+evaluation+of+human+DNA+topoisomerase+I+inhibition+by+Peganum+harmala+L.+seeds+extract+and+its+%CE%B2-carboline+alkaloids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids</span></div><div class="casAuthors">Sobhani Armin Madadkar; Ebrahimi Sultan-Ahmad; Mahmoudian Massoud</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Peganum harmala L. (Zygophyllaceae) seeds extract is one of the main components of an ethnobotanical preparation used in the treatment of neoplasms in Iran.  Cytotoxic effects of P. harmala extract on cancerous cell-lines have been reported before. beta-carbolines like harmaline and harmine are the major alkaloids present in the seeds of the P. harmala.  Considering reports concerning DNA topoisomerase inhibition by other beta-carbolines like harmane, we have used DNA relaxation assays to investigate topoisomerase I inhibitory activity of P. harmala seeds extract and its beta-carboline alkaloids to further inspecting the mechanism of its cytotoxic activity.  METHODS:  Harmine and harmaline contents of the extract were determined using an HPTLC method.  DNA topoisomerase I enzyme needed for investigating inhibitory effect of the compounds using DNA relaxation assay, was partially purified from the human placenta.  DNA relaxation assay is based on the conversion of a supercoiled plasmid substrate to its relaxed form by the catalytic activity of the enzyme.  The supercoiled substrate and its relaxed product can be easily distinguished using agarose gel electrophoresis, since the relaxed topological isomers of DNA migrate more slowly than supercoiled species.  RESULTS:  Using HPTLC method, it was found that each gram of dried extract contained 55.5 and 79.0 mg of harmine and harmaline respectively.  In the DNA relaxation assay, order of potency was harmine > harmane > harmaline > extract.  The most active compound was harmine with IC50 value of 13.5 +/- 1.7 microg/ml.  CONCLUSIONS:  Our in vitro findings demonstrate that P. harmala seeds extract do inhibit human DNA topoisomerase I and based on the results of HPTLC analysis, it appears that the biological activity of the extract can be explained by its beta-carboline content.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTco1bQOg25AENHe_gFldTbfW6udTcc2eaptFOHMoElXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zhs1antw%253D%253D&md5=9a28f3bbbc901f48c665505be4e98b2a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobhani%26aufirst%3DA.%2BM.%26aulast%3DEbrahimi%26aufirst%3DS.-A.%26aulast%3DMahmoudian%26aufirst%3DM.%26atitle%3DAn%2520in%2520vitro%2520evaluation%2520of%2520human%2520DNA%2520topoisomerase%2520I%2520inhibition%2520by%2520Peganum%2520harmala%2520L.%2520seeds%2520extract%2520and%2520its%2520%25CE%25B2-carboline%2520alkaloids%26jtitle%3DJ.%2520Pharm.%2520Pharm.%2520Sci.%26date%3D2002%26volume%3D5%26spage%3D19%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine&doi=10.1016%2Fj.bbrc.2004.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0likYv9z87tzQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132%26doi%3D10.1016%2Fj.bbrc.2004.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-W.</span></span> <span> </span><span class="NLM_article-title">Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway</span>. <i>Hepatobiliary Pancreatic Dis. Int.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/S1499-3872(11)60102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2FS1499-3872%2811%2960102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22146623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1arsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=599-604&author=M.-R.+Caoauthor=Q.+Liauthor=Z.-L.+Liuauthor=H.-H.+Liuauthor=W.+Wangauthor=X.-L.+Liaoauthor=Y.-L.+Panauthor=J.-W.+Jiang&title=Harmine+induces+apoptosis+in+HepG2+cells+via+mitochondrial+signaling+pathway&doi=10.1016%2FS1499-3872%2811%2960102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway</span></div><div class="casAuthors">Cao, Ming-Rong; Li, Qiang; Liu, Zhi-Long; Liu, Hui-Hui; Wang, Wei; Liao, Xiao-Li; Pan, Yun-Long; Jiang, Jian-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Hepatobiliary & Pancreatic Diseases International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-604</span>CODEN:
                <span class="NLM_cas:coden">HPDIAJ</span>;
        ISSN:<span class="NLM_cas:issn">1499-3872</span>.
    
            (<span class="NLM_cas:orgname">First Affiliated Hospital, Zhejiang University School of Medicine</span>)
        </div><div class="casAbstract">BACKGROUND: Harmine has antitumor and antinociceptive effects, and inhibits human DNA topoisomerase.  However, no detailed data are available on the mechanisms of action of harmine in hepatocellular carcinoma.  This study aimed to investigate the effects of harmine on proliferation and apoptosis, and the underlying mechanisms in the human hepatocellular carcinoma cell line HepG2.  METHODS: The proliferation of HepG2 cells was detd. by the cell counting kit-8 (CCK-8) assay and the clone formation test.  The morphol. of HepG2 cells was examd. using fluorescence microscopy after Hoechst 33258 staining.  Annexin V/propidium iodide (PI) was used to analyze apoptosis and PI to analyze the cell cycle.  Western blotting was used to assess expression of the apoptosis-regulated genes Bcl-2, Bax, Bcl-xl, Mcl-1, caspase-3, and caspase-9.  Mitochondrial transmembrane potential (Ψm) was detd. using JC-1.  RESULTS: Harmine inhibited the proliferation of HepG2 cells in a dose-dependent manner.  Hoechst 33258 staining revealed nuclear fragmentation and chromosomal condensation, cell shrinkage, and attachment loss in HepG2 cells treated with harmine.  The percentage of the sub/G1 fraction was increased in a concn.-dependent manner, indicating apoptotic cell death.  PI staining showed that harmine changed the cell cycle distribution, by decreasing the proportion of cells in G0/G1 and increasing the proportion in S and G2/M.  Harmine induced apoptosis in a concn.-dependent manner, with rates of 20.0%, 32.7% and 64.9%, resp.  JC-1 revealed a decrease in Ψm.  Apoptosis of HepG2 cells was assocd. with caspase-3 and caspase-9 activation, down-regulation of Bcl-2, Mcl-1, and Bcl-xl, and no change in Bax.  CONCLUSIONS: Harmine had an anti-proliferative effect in HepG2 cells by inducing apoptosis.  Mitochondrial signal pathways were involved in the apoptosis.  The cancer-specific selectivity shown in this study suggested that harmine is a promising novel drug for human hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe5bUH_p6tALVg90H21EOLACvtfcHk0likYv9z87tzQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1arsA%253D%253D&md5=791b55a1d99c530a3ed3c67bc7d6a792</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS1499-3872%2811%2960102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1499-3872%252811%252960102-1%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DM.-R.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DH.-H.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DX.-L.%26aulast%3DPan%26aufirst%3DY.-L.%26aulast%3DJiang%26aufirst%3DJ.-W.%26atitle%3DHarmine%2520induces%2520apoptosis%2520in%2520HepG2%2520cells%2520via%2520mitochondrial%2520signaling%2520pathway%26jtitle%3DHepatobiliary%2520Pancreatic%2520Dis.%2520Int.%26date%3D2011%26volume%3D10%26spage%3D599%26epage%3D604%26doi%3D10.1016%2FS1499-3872%2811%2960102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taira, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiya, Y.</span></span> <span> </span><span class="NLM_article-title">Intercalation of six β-carboline derivatives into DNA</span>. <i>Eisei Kagaku</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1248/jhs1956.43.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1248%2Fjhs1956.43.83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1997&pages=83-91&author=Z.+Tairaauthor=S.+Kanzawaauthor=C.+Doharaauthor=S.+Ishidaauthor=M.+Matsumotoauthor=Y.+Sakiya&title=Intercalation+of+six+%CE%B2-carboline+derivatives+into+DNA&doi=10.1248%2Fjhs1956.43.83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1248%2Fjhs1956.43.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fjhs1956.43.83%26sid%3Dliteratum%253Aachs%26aulast%3DTaira%26aufirst%3DZ.%26aulast%3DKanzawa%26aufirst%3DS.%26aulast%3DDohara%26aufirst%3DC.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DSakiya%26aufirst%3DY.%26atitle%3DIntercalation%2520of%2520six%2520%25CE%25B2-carboline%2520derivatives%2520into%2520DNA%26jtitle%3DEisei%2520Kagaku%26date%3D1997%26volume%3D43%26spage%3D83%26epage%3D91%26doi%3D10.1248%2Fjhs1956.43.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdolazimi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegretti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalizi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annes, J. P.</span></span> <span> </span><span class="NLM_article-title">CC-401 promotes β-cell replication via pleiotropic consequences of DYRK1A/B inhibition</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">3143</span>– <span class="NLM_lpage">3157</span>, <span class="refDoi"> DOI: 10.1210/en.2018-00083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1210%2Fen.2018-00083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=29514186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCgu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=3143-3157&author=Y.+Abdolazimiauthor=Z.+Zhaoauthor=S.+Leeauthor=H.+Xuauthor=P.+Allegrettiauthor=T.+M.+Hortonauthor=B.+Yehauthor=H.+P.+Moellerauthor=R.+J.+Nicholsauthor=D.+McCutcheonauthor=A.+Shaliziauthor=M.+Smithauthor=N.+A.+Armstrongauthor=J.+P.+Annes&title=CC-401+promotes+%CE%B2-cell+replication+via+pleiotropic+consequences+of+DYRK1A%2FB+inhibition&doi=10.1210%2Fen.2018-00083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">CC-401 promotes β-cell replication via pleiotropic consequences of DYRK1A/B inhibition</span></div><div class="casAuthors">Abdolazimi, Yassan; Zhao, Zhengshan; Lee, Sooyeon; Xu, Haixia; Allegretti, Paul; Horton, Timothy M.; Yeh, Benjamin; Moeller, Hannah P.; Nichols, Robert J.; McCutcheon, David; Shalizi, Aryaman; Smith, Mark; Armstrong, Neali A.; Annes, Justin P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3143-3157</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pharmacol. expansion of endogenous β cells is a promising therapeutic strategy for diabetes.  To elucidate the mol. pathways that control β-cell growth we screened ∼2400 bioactive compds. for rat β-cell replication-modulating activity.  Numerous hit compds. impaired or promoted rat β-cell replication, including CC-401, an advanced clin. candidate previously characterized as a c-Jun N-terminal kinase inhibitor.  Surprisingly, CC-401 induced rodent (in vitro and in vivo) and human (in vitro) β-cell replication via dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) 1A and 1B inhibition.  In contrast to rat β cells, which were broadly growth responsive to compd. treatment, human β-cell replication was only consistently induced by DYRK1A/B inhibitors.  This effect was enhanced by simultaneous glycogen synthase kinase-3β (GSK-3β) or activin A receptor type II-like kinase/transforming growth factor-β (ALK5/TGF-β) inhibition.  Prior work emphasized DYRK1A/B inhibition-dependent activation of nuclear factor of activated T cells (NFAT) as the primary mechanism of human β-cell-replication induction.  However, inhibition of NFAT activity had limited effect on CC-401-induced β-cell replication.  Consequently, we investigated addnl. effects of CC-401-dependent DYRK1A/B inhibition.  Indeed, CC-401 inhibited DYRK1A-dependent phosphorylation/stabilization of the β-cell-replication inhibitor p27Kip1.  Addnl., CC-401 increased expression of numerous replication-promoting genes normally suppressed by the dimerization partner, RB-like, E2F and multivulval class B (DREAM) complex, which depends upon DYRK1A/B activity for integrity, including MYBL2 and FOXM1.  In summary, we present a compendium of compds. as a valuable resource for manipulating the signaling pathways that control β-cell replication and leverage a DYRK1A/B inhibitor (CC-401) to expand our understanding of the mol. pathways that control β-cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0bClqAWU1ZLVg90H21EOLACvtfcHk0lhW5RDePv9EZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCgu7rP&md5=35cb7f0245f44f2d8a66eae8a78b390e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1210%2Fen.2018-00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2018-00083%26sid%3Dliteratum%253Aachs%26aulast%3DAbdolazimi%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DAllegretti%26aufirst%3DP.%26aulast%3DHorton%26aufirst%3DT.%2BM.%26aulast%3DYeh%26aufirst%3DB.%26aulast%3DMoeller%26aufirst%3DH.%2BP.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DMcCutcheon%26aufirst%3DD.%26aulast%3DShalizi%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DN.%2BA.%26aulast%3DAnnes%26aufirst%3DJ.%2BP.%26atitle%3DCC-401%2520promotes%2520%25CE%25B2-cell%2520replication%2520via%2520pleiotropic%2520consequences%2520of%2520DYRK1A%252FB%2520inhibition%26jtitle%3DEndocrinology%26date%3D2018%26volume%3D159%26spage%3D3143%26epage%3D3157%26doi%3D10.1210%2Fen.2018-00083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man-Un Ung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.ejmech.2018.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30170319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ent7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=1005-1016&author=K.+Kumarauthor=P.+Man-Un+Ungauthor=P.+Wangauthor=H.+Wangauthor=H.+Liauthor=M.+K.+Andrewsauthor=A.+F.+Stewartauthor=A.+Schlessingerauthor=R.+J.+DeVita&title=Novel+selective+thiadiazine+DYRK1A+inhibitor+lead+scaffold+with+human+pancreatic+%CE%B2-cell+proliferation+activity&doi=10.1016%2Fj.ejmech.2018.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity</span></div><div class="casAuthors">Kumar, Kunal; Man-Un Ung, Peter; Wang, Peng; Wang, Hui; Li, Hailing; Andrews, Mary K.; Stewart, Andrew F.; Schlessinger, Avner; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) is an enzyme that has been implicated as an important drug target in various therapeutic areas, including neurol. disorders (Down syndrome, Alzheimer's disease), oncol., and diabetes (pancreatic β-cell expansion).  Current small mol. DYRK1A inhibitors are ATP-competitive inhibitors that bind to the kinase in an active conformation.  As a result, these inhibitors are promiscuous, resulting in pharmacol. side effects that limit their therapeutic applications.  None are in clin. trials at this time.  In order to identify a new DYRK1A inhibitor scaffold, we constructed a homol. model of DYRK1A in an inactive, DFG-out conformation.  Virtual screening of 2.2 million lead-like compds. from the ZINC database, followed by in vitro testing of selected 68 compds. revealed 8 hits representing 5 different chem. classes.  We chose to focus on one of the hits from the computational screen, thiadiazine 1 which was found to inhibit DYRK1A with IC50 of 9.41 μM (Kd = 7.3 μM).  Optimization of the hit compd. 1, using structure-activity relationship (SAR) anal. and in vitro testing led to the identification of potent thiadiazine analogs with significantly improved binding as compared to the initial hit (Kd = 71-185 nM).  Compd. 3-5 induced human β-cell proliferation at 5 μM while showing selectivity for DYRK1A over DYRK1B and DYRK2 at 10 μM.  This newly developed DYRK1A inhibitor scaffold with unique kinase selectivity profiles has potential to be further optimized as novel therapeutics for diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs8HXnn8ewabVg90H21EOLACvtfcHk0lhW5RDePv9EZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ent7vE&md5=026fe0a5ddf42ebeacdea9c5838b0565</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DMan-Un%2BUng%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DAndrews%26aufirst%3DM.%2BK.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DSchlessinger%26aufirst%3DA.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DNovel%2520selective%2520thiadiazine%2520DYRK1A%2520inhibitor%2520lead%2520scaffold%2520with%2520human%2520pancreatic%2520%25CE%25B2-cell%2520proliferation%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D1005%26epage%3D1016%26doi%3D10.1016%2Fj.ejmech.2018.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aamodt, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aramandla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. C.</span></span> <span> </span><span class="NLM_article-title">Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">E859</span>– <span class="NLM_lpage">E868</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00515.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1152%2Fajpendo.00515.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=27624103" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=E859-E868&author=K.+I.+Aamodtauthor=R.+Aramandlaauthor=J.+J.+Brownauthor=N.+Fiaschi-Taeschauthor=P.+Wangauthor=A.+F.+Stewartauthor=M.+Brissovaauthor=A.+C.+Powers&title=Development+of+a+reliable+automated+screening+system+to+identify+small+molecules+and+biologics+that+promote+human+%CE%B2-cell+regeneration&doi=10.1152%2Fajpendo.00515.2015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00515.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00515.2015%26sid%3Dliteratum%253Aachs%26aulast%3DAamodt%26aufirst%3DK.%2BI.%26aulast%3DAramandla%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DJ.%2BJ.%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DBrissova%26aufirst%3DM.%26aulast%3DPowers%26aufirst%3DA.%2BC.%26atitle%3DDevelopment%2520of%2520a%2520reliable%2520automated%2520screening%2520system%2520to%2520identify%2520small%2520molecules%2520and%2520biologics%2520that%2520promote%2520human%2520%25CE%25B2-cell%2520regeneration%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D311%26spage%3DE859%26epage%3DE868%26doi%3D10.1152%2Fajpendo.00515.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0ljlGmu3TYBFUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaway, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habegger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriever, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Cáceres, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabra, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembree, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irmler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabě de Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauvais-Jarvis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Tilve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfluger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarchi, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span> <span> </span><span class="NLM_article-title">Targeted estrogen delivery reverses the metabolic syndrome</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+Hrab%C4%9B+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Targeted+estrogen+delivery+reverses+the+metabolic+syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0ljlGmu3TYBFUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DHrab%25C4%259B%2Bde%2BAngelis%26aufirst%3DM.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520estrogen%2520delivery%2520reverses%2520the%2520metabolic%2520syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauvais-Jarvis, F.</span></span> <span> </span><span class="NLM_article-title">Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">10211</span>, <span class="refDoi"> DOI: 10.1038/srep10211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fsrep10211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=25970118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyhsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=10211&author=J.+P.+Tianoauthor=C.+R.+Tateauthor=B.+S.+Yangauthor=R.+DiMarchiauthor=F.+Mauvais-Jarvis&title=Effect+of+targeted+estrogen+delivery+using+glucagon-like+peptide-1+on+insulin+secretion%2C+insulin+sensitivity+and+glucose+homeostasis&doi=10.1038%2Fsrep10211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis</span></div><div class="casAuthors">Tiano, Joseph P.; Tate, Chandra R.; Yang, Bin S.; DiMarchi, Richard; Mauvais-Jarvis, Franck</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10211</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The female estrogen 17β-estradiol (E2) enhances pancreatic β-cell function via estrogen receptors (ERs).  However, the risk of hormone dependent cancer precludes the use of general estrogen therapy as a chronic treatment for diabetes.  To target E2 to β-cells without the undesirable effects of general estrogen therapy, we created fusion peptides combining active or inactive glucagon-like peptide-1 (GLP-1) and E2 in a single mol. (aGLP1-E2 and iGLP1-E2 resp.).  By combining the activities of GLP-1 and E2, we envisioned synergistic insulinotropic activities of these mols. on β-cells.  In cultured human islets and in C57BL/6 mice, both aGLP1 and aGLP1-E2 enhanced glucose-stimulated insulin secretion (GSIS) compared to vehicle and iGLP1-E2 without superior efficacy of aGLP1-E2 compared to GLP-1 alone.  However, aGLP1-E2 decreased fasting and fed blood glucose to a greater extent than aGLP1 and iGLP1-E2 alone.  Further, aGLP1-E2 exhibited improved insulin sensitivity compared to aGLP1 and iGLP1-E2 alone (HOMA-IR and insulin tolerance test).  In conclusion, targeted estrogen delivery to non-diabetic islets in the presence of GLP-1 does not enhance GSIS.  However, combining GLP-1 to estrogen delivers addnl. efficacy relative to GLP-1 alone on insulin sensitivity and glucose homeostasis in non-diabetic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra17oR2-_WP7Vg90H21EOLACvtfcHk0lhdkChWOBNksw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyhsrzK&md5=7141125efc709a1b572c8c74baaf8637</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsrep10211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep10211%26sid%3Dliteratum%253Aachs%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DTate%26aufirst%3DC.%2BR.%26aulast%3DYang%26aufirst%3DB.%2BS.%26aulast%3DDiMarchi%26aufirst%3DR.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26atitle%3DEffect%2520of%2520targeted%2520estrogen%2520delivery%2520using%2520glucagon-like%2520peptide-1%2520on%2520insulin%2520secretion%252C%2520insulin%2520sensitivity%2520and%2520glucose%2520homeostasis%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D10211%26doi%3D10.1038%2Fsrep10211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human β-cell proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7687</span>– <span class="NLM_lpage">7699</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSrsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7687-7699&author=K.+Kumarauthor=P.+Wangauthor=R.+Sanchezauthor=E.+A.+Swartzauthor=A.+F.+Stewartauthor=R.+J.+DeVita&title=Development+of+kinase-selective%2C+harmine-based+DYRK1A+inhibitors+that+induce+pancreatic+human+%CE%B2-cell+proliferation&doi=10.1021%2Facs.jmedchem.8b00658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation</span></div><div class="casAuthors">Kumar, Kunal; Wang, Peng; Sanchez, Roberto; Swartz, Ethan A.; Stewart, Andrew F.; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7687-7699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has been implicated as an important drug target in various therapeutic areas, including neurol. disorders and oncol.  DYRK1A has more recently been shown to be involved in pathways regulating human β-cell proliferation, thus making it a potential therapeutic target for both Type 1 and Type 2 diabetes.  Our group, using a high-throughput phenotypic screen identified harmine that is able to induce beta cell proliferation both in vitro and in vivo.  Since harmine has suboptimal kinase selectivity we sought to expand structure-activity relationships for harmine's DYRK1A activity, to enhance selectivity, while retaining human β-cell proliferation capability.  We carried out the optimization of the 1-position of harmine and synthesized 15 harmine analogs.  6 Compds. showed excellent DYRK1A inhibition with IC50 in the range of 49.5-264 nM.  Two compds., 2-2 and 2-8, exhibited excellent human β-cell proliferation at doses of 3-30 μM and compd. 2-2 showed improved kinase selectivity as compared to harmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFSDNEicChLVg90H21EOLACvtfcHk0lhdkChWOBNksw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSrsb7M&md5=e1b748db912ac5b0ef93b8729ad4b13e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00658%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DSwartz%26aufirst%3DE.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520kinase-selective%252C%2520harmine-based%2520DYRK1A%2520inhibitors%2520that%2520induce%2520pancreatic%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7687%26epage%3D7699%26doi%3D10.1021%2Facs.jmedchem.8b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0lhdkChWOBNksw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulyanova, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glicksman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, J. M. G.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2019</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.bmcl.2012.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22335895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlKmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2015-2019&author=G.+D.+Cunyauthor=N.+P.+Ulyanovaauthor=D.+Patnaikauthor=J.-F.+Liuauthor=X.+Linauthor=K.+Auerbachauthor=S.+S.+Rayauthor=J.+Xianauthor=M.+A.+Glicksmanauthor=R.+L.+Steinauthor=J.+M.+G.+Higgins&title=Structure-activity+relationship+study+of+beta-carboline+derivatives+as+haspin+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors</span></div><div class="casAuthors">Cuny, Gregory D.; Ulyanova, Natalia P.; Patnaik, Debasis; Liu, Ji-Feng; Lin, Xiangjie; Auerbach, Ken; Ray, Soumya S.; Xian, Jun; Glicksman, Marcie A.; Stein, Ross L.; Higgins, Jonathan M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2015-2019</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Haspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis that has emerged as a possible cancer therapeutic target.  High throughput screening of approx. 140,000 compds. identified the β-carbolines harmine and harmol as moderately potent haspin kinase inhibitors.  Based on information obtained from a structure-activity relationship study previously conducted for an acridine series of haspin inhibitors in conjunction with in silico docking using a recently disclosed crystal structure of the kinase, harmine analogs were designed that resulted in significantly increased haspin kinase inhibitory potency.  The harmine derivs. also demonstrated less activity towards DYRK2 compared to the acridine series.  In vitro mouse liver microsome stability and kinase profiling of a representative member of the harmine series (42, LDN-211898) are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDv6AjhnkUVrVg90H21EOLACvtfcHk0lj4vjFCN-8bTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlKmt7Y%253D&md5=b4d8195c003327228b5ab153fedc1c73</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DUlyanova%26aufirst%3DN.%2BP.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.-F.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DAuerbach%26aufirst%3DK.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DXian%26aufirst%3DJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DHiggins%26aufirst%3DJ.%2BM.%2BG.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520beta-carboline%2520derivatives%2520as%2520haspin%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2015%26epage%3D2019%26doi%3D10.1016%2Fj.bmcl.2012.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. S.</span></span> <span> </span><span class="NLM_article-title">Pd–C-induced catalytic transfer hydrogenation with triethylsilane</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6599</span>– <span class="NLM_lpage">6601</span>, <span class="refDoi"> DOI: 10.1021/jo0706123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0706123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFegsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6599-6601&author=P.+K.+Mandalauthor=J.+S.+McMurray&title=Pd%E2%80%93C-induced+catalytic+transfer+hydrogenation+with+triethylsilane&doi=10.1021%2Fjo0706123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-C-Induced Catalytic Transfer Hydrogenation with Triethylsilane</span></div><div class="casAuthors">Mandal, Pijus K.; McMurray, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6599-6601</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In situ generation of mol. hydrogen by addn. of triethylsilane to palladium-charcoal catalyst results in rapid and efficient redn. of multiple bonds, azides, imines, and nitro groups, as well as benzyl group and allyl group deprotection under mild, neutral conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfxyBSLp44bVg90H21EOLACvtfcHk0lj4vjFCN-8bTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFegsLg%253D&md5=d1f8e323daef824e892eafc43f941222</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo0706123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0706123%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DPd%25E2%2580%2593C-induced%2520catalytic%2520transfer%2520hydrogenation%2520with%2520triethylsilane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D6599%26epage%3D6601%26doi%3D10.1021%2Fjo0706123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. W. P.</span>; <span class="NLM_string-name">Swartz, E.A.</span>; <span class="NLM_string-name">Sanchez, R.</span>; <span class="NLM_string-name">Stewart, A.F.</span>; <span class="NLM_string-name">DeVita, R.J.</span></span>,unpublished</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kumar%2C+K.+W.+P.%3B+Swartz%2C+E.A.%3B+Sanchez%2C+R.%3B+Stewart%2C+A.F.%3B+DeVita%2C+R.J.%2Cunpublished"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%2BW.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Badura, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamowicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprouse, J.</span></span> <span> </span><span class="NLM_article-title">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.122846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1124%2Fjpet.107.122846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=17502429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=730-738&author=L.+Baduraauthor=T.+Swansonauthor=W.+Adamowiczauthor=J.+Adamsauthor=J.+Cianfrognaauthor=K.+Fisherauthor=J.+Hollandauthor=R.+Kleimanauthor=F.+Nelsonauthor=L.+Reynoldsauthor=K.+S.+Germainauthor=E.+Schaefferauthor=B.+Tateauthor=J.+Sprouse&title=An+inhibitor+of+casein+kinase+I%CE%B5+induces+phase+delays+in+circadian+rhythms+under+free-running+and+entrained+conditions&doi=10.1124%2Fjpet.107.122846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span></div><div class="casAuthors">Badura, Lori; Swanson, Terri; Adamowicz, Wendy; Adams, Jessica; Cianfrogna, Julie; Fisher, Katherine; Holland, Janice; Kleiman, Robin; Nelson, Frederick; Reynolds, Linda; St. Germain, Kristin; Schaeffer, Eric; Tate, Barbara; Sprouse, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Casein kinase Iε (CKIε) is an essential component of the biol. clock, phosphorylating PER proteins, and in doing so regulating their turnover and nuclear entry in oscillator cells of the suprachiasmatic nucleus (SCN).  Although hereditary decreases in PER phosphorylation have been well characterized, little is known about the consequences of acute enzyme inhibition by pharmacol. means.  A novel reagent, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), proved to be both a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 addnl. kinases) inhibitor of CKIε in isolated enzyme prepns.; in transfected whole cell assays, it caused a concn.-related redistribution of nuclear vs. cytosolic PER.  When tested in free-running animals, 50 mg/kg s.c. PF-670462 produced robust phase delays when dosed at circadian time (CT)9 (-1.97 ± 0.17 h).  Entrained rats dosed in normal light-dark (LD) and then released to const. darkness also experienced phase delays that were dose- and time of dosing-dependent.  PF-670462 yielded only phase delays across the circadian cycle with the most sensitive time at CT12 when PER levels are near their peak in the SCN.  Most importantly, these drug-induced phase delays persisted in animals entrained and maintained in LD throughout the entire expt.; re-entrainment to the prevailing LD required days in contrast to the rapid elimination of the drug (t1/2 = 0.46 ± 0.04 h).  Together, these results suggest that inhibition of CKIε yields a perturbation of oscillator function that forestalls light as a zeitgeber, and they demonstrate that pharmacol. tools such as PF-670462 may yield valuable insight into clock function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfqMEeisE8I7Vg90H21EOLACvtfcHk0lhG6x-c5jPJsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D&md5=ec355b6d0cee0f1ad9d37cad55f0936d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122846%26sid%3Dliteratum%253Aachs%26aulast%3DBadura%26aufirst%3DL.%26aulast%3DSwanson%26aufirst%3DT.%26aulast%3DAdamowicz%26aufirst%3DW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DK.%2BS.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DSprouse%26aufirst%3DJ.%26atitle%3DAn%2520inhibitor%2520of%2520casein%2520kinase%2520I%25CE%25B5%2520induces%2520phase%2520delays%2520in%2520circadian%2520rhythms%2520under%2520free-running%2520and%2520entrained%2520conditions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D730%26epage%3D738%26doi%3D10.1124%2Fjpet.107.122846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevsky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waltman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langan, P.</span></span> <span> </span><span class="NLM_article-title">Low- and room-temperature X-ray structures of protein kinase A ternary complexes shed new light on its activity</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1107/S0907444912014886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444912014886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22751671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=854-860&author=A.+Y.+Kovalevskyauthor=H.+Johnsonauthor=B.+L.+Hansonauthor=M.+J.+Waltmanauthor=S.+Z.+Fisherauthor=S.+Taylorauthor=P.+Langan&title=Low-+and+room-temperature+X-ray+structures+of+protein+kinase+A+ternary+complexes+shed+new+light+on+its+activity&doi=10.1107%2FS0907444912014886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Low- and room-temperature X-ray structures of protein kinase A ternary complexes shed new light on its activity</span></div><div class="casAuthors">Kovalevsky, Andrey Y.; Johnson, Hanna; Hanson, B. Leif; Waltman, Mary Jo; Fisher, S. Zoe; Taylor, Susan; Langan, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">854-860</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Post-translational protein phosphorylation by protein kinase A (PKA) is a ubiquitous signalling mechanism which regulates many cellular processes.  A low-temp. X-ray structure of the ternary complex of the PKA catalytic subunit (PKAc) with ATP and a 20-residue peptidic inhibitor (IP20) at the physiol. Mg2+ concn. of ∼0.5 mM (LT PKA-MgATP-IP20) revealed a single metal ion in the active site.  The lack of a second metal in LT PKA-MgATP-IP20 renders the β- and γ-phosphoryl groups of ATP very flexible, with high thermal B factors.  Thus, the second metal is crucial for tight positioning of the terminal phosphoryl group for transfer to a substrate, as demonstrated by comparison of the former structure with that of the LT PKA-Mg2ATP-IP20 complex obtained at high Mg2+ concn.  In addn. to its kinase activity, PKAc is also able to slowly catalyze the hydrolysis of ATP using a water mol. as a substrate.  It was found that ATP can be readily and completely hydrolyzed to ADP and a free phosphate ion in the crystals of the ternary complex PKA-Mg2ATP-IP20 by X-ray irradn. at room temp.  The cleavage of ATP may be aided by X-ray-generated free hydroxyl radicals, a very reactive chem. species, which move rapidly through the crystal at room temp.  The phosphate anion is clearly visible in the electron-d. maps; it remains in the active site but slides about 2 Å from its position in ATP towards Ala21 of IP20, which mimics the phosphorylation site.  The phosphate thus pushes the peptidic inhibitor away from the product ADP, while resulting in dramatic conformational changes of the terminal residues 24 and 25 of IP20.  X-ray structures of PKAc in complex with the nonhydrolysable ATP analog AMP-PNP at both room and low temp. demonstrated no temp. effects on the conformation and position of IP20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHHJMAvF9CVbVg90H21EOLACvtfcHk0lhG6x-c5jPJsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKntLo%253D&md5=ac54b7be35741645baf4e367f4276a0e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444912014886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912014886%26sid%3Dliteratum%253Aachs%26aulast%3DKovalevsky%26aufirst%3DA.%2BY.%26aulast%3DJohnson%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DB.%2BL.%26aulast%3DWaltman%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DS.%2BZ.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DLangan%26aufirst%3DP.%26atitle%3DLow-%2520and%2520room-temperature%2520X-ray%2520structures%2520of%2520protein%2520kinase%2520A%2520ternary%2520complexes%2520shed%2520new%2520light%2520on%2520its%2520activity%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D854%26epage%3D860%26doi%3D10.1107%2FS0907444912014886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N. R. W.</span></span> <span> </span><span class="NLM_article-title">The analysis of drug-induced tremor in mice</span>. <i>Br. J. Pharmacol. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1959.tb00255.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1111%2Fj.1476-5381.1959.tb00255.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=13792135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A280%3ADyaF3c7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1959&pages=350-354&author=A.+Ahmedauthor=N.+R.+W.+Taylor&title=The+analysis+of+drug-induced+tremor+in+mice&doi=10.1111%2Fj.1476-5381.1959.tb00255.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The analysis of drug-induced tremor in mice</span></div><div class="casAuthors">AHMED A; TAYLOR N R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology and chemotherapy</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">350-4</span>
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">An improved method of recording tremor in mice has been developed using a gramophone pick-up and a cathode ray oscillograph.  Permanent records are made on 35 mm. film from which it is possible to determine qualitative differences in the tremor caused by various drugs.  In addition, the severity of the tremor may be estimated quantitatively by a tremor index.  The rate and variations in the rhythm and amplitude and in the tremor index have been determined for Tremorine (1,4-dipyrrolidin-1'-ylbut-2-yne), harmine, harmaline, 3-amino-1,1,3-triphenylpropan-1-ol and lysergic acid diethylamide.  The incidence of side effects has also been noted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ54s5KS7l7ozslzEEsg76ufW6udTcc2eYFSjFNzCTSIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c7ht1Crtg%253D%253D&md5=a5ca7ef7d3e06730585ff5cd29a58722</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1959.tb00255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1959.tb00255.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DN.%2BR.%2BW.%26atitle%3DThe%2520analysis%2520of%2520drug-induced%2520tremor%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1959%26volume%3D14%26spage%3D350%26epage%3D354%26doi%3D10.1111%2Fj.1476-5381.1959.tb00255.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayukawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothstein, J. D.</span></span> <span> </span><span class="NLM_article-title">Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1168</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.neuropharm.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21034752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1168-1175&author=Y.+Liauthor=R.+Sattlerauthor=E.-J.+Yangauthor=A.+Nunesauthor=Y.+Ayukawaauthor=S.+Akhtarauthor=G.+Jiauthor=P.-W.+Zhangauthor=J.+D.+Rothstein&title=Harmine%2C+a+natural+beta-carboline+alkaloid%2C+upregulates+astroglial+glutamate+transporter+expression&doi=10.1016%2Fj.neuropharm.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression</span></div><div class="casAuthors">Li, Yun; Sattler, Rita; Yang, Eun-Ju; Nunes, Alice; Ayukawa, Yoko; Akhtar, Sadia; Ji, Grace; Zhang, Ping-Wu; Rothstein, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1168-1175</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutamate is the predominant excitatory amino acid neurotransmitter in the mammalian central nervous system (CNS).  Glutamate transporter EAAT2/GLT-1 is the physiol. dominant astroglial protein that inactivates synaptic glutamate.  Previous studies have shown that EAAT2 dysfunction leads to excessive extracellular glutamate and may contribute to various neurol. disorders including amyotrophic lateral sclerosis (ALS).  The recent discovery of the neuroprotective properties of ceftriaxone, a beta lactam antibiotic, suggested that increasing EAAT2/GLT-1 gene expression might be beneficial in ALS and other neurol./psychiatric disorders by augmenting astrocytic glutamate uptake.  Here we report our efforts to develop a new screening assay for identifying compds. that activate EAAT2 gene expression.  We generated fetal derived-human immortalized astroglial cells that are stably expressing a firefly luciferase reporter under the control of the human EAAT2 promoter.  When screening a library of 1040 FDA approved compds. and natural products, we identified harmine, a naturally occurring beta-carboline alkaloid, as one of the top hits for activating the EAAT2 promoter.  We further tested harmine in our in vitro cell culture systems and confirmed its ability to increase EAAT2/GLT1 gene expression and functional glutamate uptake activity.  We next tested its efficacy in both wild type animals and in an ALS animal model of disease and demonstrated that harmine effectively increased GLT-1 protein and glutamate transporter activity in vivo.  Our studies provide potential novel neurotherapeutics by modulating the activity of glutamate transporters via gene activation.  This article is part of a Special Issue entitled Trends in Neuropharmacol.: In Memory of Erminio Costa'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzo1F7uOuH9bVg90H21EOLACvtfcHk0lhG6x-c5jPJsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKitLw%253D&md5=1263b8e50c747350e60b999e176f7884</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSattler%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DE.-J.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DAyukawa%26aufirst%3DY.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.-W.%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DHarmine%252C%2520a%2520natural%2520beta-carboline%2520alkaloid%252C%2520upregulates%2520astroglial%2520glutamate%2520transporter%2520expression%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D1168%26epage%3D1175%26doi%3D10.1016%2Fj.neuropharm.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demirci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casinelli, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado-Gil, J. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rausell-Palamos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasavada, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.2337/db13-0333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb13-0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=24089510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=216-223&author=J.+C.+Alvarez-Perezauthor=S.+Ernstauthor=C.+Demirciauthor=G.+P.+Casinelliauthor=J.+M.+D.+Mellado-Gilauthor=F.+Rausell-Palamosauthor=R.+C.+Vasavadaauthor=A.+Garcia-Ocana&title=Hepatocyte+growth+factor%2Fc-Met+signaling+is+required+for+%CE%B2-cell+regeneration&doi=10.2337%2Fdb13-0333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration</span></div><div class="casAuthors">Alvarez-Perez, Juan Carlos; Ernst, Sara; Demirci, Cem; Casinelli, Gabriella P.; Mellado-Gil, Jose Manuel D.; Rausell-Palamos, Francisco; Vasavada, Rupangi C.; Garcia-Ocana, Adolfo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216-223</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) is a mitogen required for β-cell replication during pregnancy.  To det. whether HGF/c-Met signaling is required for β-cell regeneration, we characterized mice with pancreatic deletion of the HGF receptor, c-Met (PancMet KO mice), in two models of reduced β-cell mass and regeneration: multiple low-dose streptozotocin (MLDS) and partial pancreatectomy (Ppx).  We also analyzed whether HGF administration could accelerate β-cell regeneration in wild-type (WT) mice after Ppx.  Mouse islets obtained 7 days post-Ppx displayed significantly increased c-Met, suggesting a potential role for HGF/c-Met in β-cell proliferation in situations of reduced β-cell mass.  Indeed, adult PancMet KO mice displayed markedly reduced β-cell replication compared with WT mice 7 days post-Ppx.  Similarly, β-cell proliferation was decreased in PancMet KO mice in the MLDS mouse model.  The decrease in β-cell proliferation post-Ppx correlated with a striking decrease in D-cyclin levels.  Importantly, PancMet KO mice showed significantly diminished β-cell mass, decreased glucose tolerance, and impaired insulin secretion compared with WT mice 28 days post-Ppx.  Conversely, HGF administration in WT Ppx mice further accelerated β-cell regeneration.  These results indicate that HGF/c-Met signaling is crit. for β-cell proliferation in situations of diminished β-cell mass and suggest that activation of this pathway can enhance β-cell regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt81XkL5IvN7Vg90H21EOLACvtfcHk0lhLNlT3cWQekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKrtw%253D%253D&md5=5bba6716d3ef34fde1cdc1a0d569d0b7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0333%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DErnst%26aufirst%3DS.%26aulast%3DDemirci%26aufirst%3DC.%26aulast%3DCasinelli%26aufirst%3DG.%2BP.%26aulast%3DMellado-Gil%26aufirst%3DJ.%2BM.%2BD.%26aulast%3DRausell-Palamos%26aufirst%3DF.%26aulast%3DVasavada%26aufirst%3DR.%2BC.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-Met%2520signaling%2520is%2520required%2520for%2520%25CE%25B2-cell%2520regeneration%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D216%26epage%3D223%26doi%3D10.2337%2Fdb13-0333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
León, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahima, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffers, D. A.</span></span> <span> </span><span class="NLM_article-title">Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2337/diabetes.52.2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdiabetes.52.2.365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12540609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=365-371&author=D.+D.+De%0ALe%C3%B3nauthor=S.+Dengauthor=R.+Madaniauthor=R.+S.+Ahimaauthor=D.+J.+Druckerauthor=D.+A.+Stoffers&title=Role+of+endogenous+glucagon-like+peptide-1+in+islet+regeneration+after+partial+pancreatectomy&doi=10.2337%2Fdiabetes.52.2.365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy</span></div><div class="casAuthors">De Leon, Diva D.; Deng, Shaoping; Madani, Reza; Ahima, Rexford S.; Drucker, Daniel J.; Stoffers, Doris A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-371</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">A redn. in β-cell mass is an important causative factor in type 1 and type 2 diabetes.  Glucagon-like peptide-1 (GLP-1) and the long-acting agonist exendin 4 (Ex-4) expand β-cell mass by stimulating neogenesis and proliferation.  In the partial pancreatectomy (Ppx) model, exogenous Ex-4 promotes islet regeneration, leading to sustained improvement in glucose tolerance.  In this study, the authors investigate the potential role of endogenous GLP-1 in islet growth.  The authors examd. β-cell mass regeneration after 70% Ppx in mice receiving the GLP-1 antagonist Ex9-39 and in GLP-1R-/- mice.  In Ex9-39-treated sham-operated mice, persistent fasting hyperglycemia was obsd., but β-cell mass was not diminished.  In pancreatectomized mice, persistent glucose intolerance was noted, but this was not further exacerbated by Ex9-39.  Accordingly, β-cell mass recovery of Ppx mice was not impaired by Ex9-39.  In contrast, GLP-1R-/- CD1 mice showed worse glucose intolerance after Ppx compared with wild-type CD1 Ppx mice, and this correlated with a significant defect in β-cell mass regeneration.  The recovery of β-cell mass differed markedly in the BALB/c and CD1 control mice, indicating a significant role of genetic background in the regulation of β-cell mass.  These studies point to a role for endogenous GLP-1 in β-cell regeneration after Ppx in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorHP2L4qw57rVg90H21EOLACvtfcHk0lhLNlT3cWQekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFans74%253D&md5=c268594ec12721ec54e6811f7d571828</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.2.365%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLe%25C3%25B3n%26aufirst%3DD.%2BD.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DMadani%26aufirst%3DR.%26aulast%3DAhima%26aufirst%3DR.%2BS.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DStoffers%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520endogenous%2520glucagon-like%2520peptide-1%2520in%2520islet%2520regeneration%2520after%2520partial%2520pancreatectomy%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D365%26epage%3D371%26doi%3D10.2337%2Fdiabetes.52.2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Leon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimple, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamming, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrins, M. J.</span></span> <span> </span><span class="NLM_article-title">Age-dependent protection of insulin secretion in diet induced obese mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">17814</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36289-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fs41598-018-36289-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30546031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslKju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=17814&author=E.+R.+De%0ALeonauthor=J.+A.+Brinkmanauthor=R.+J.+Fenskeauthor=T.+Greggauthor=B.+A.+Schmidtauthor=D.+S.+Shermanauthor=N.+E.+Cummingsauthor=D.+C.+Peterauthor=M.+E.+Kimpleauthor=D.+W.+Lammingauthor=M.+J.+Merrins&title=Age-dependent+protection+of+insulin+secretion+in+diet+induced+obese+mice&doi=10.1038%2Fs41598-018-36289-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Age-Dependent Protection of Insulin Secretion in Diet Induced Obese Mice</span></div><div class="casAuthors">De Leon, Elizabeth R.; Brinkman, Jacqueline A.; Fenske, Rachel J.; Gregg, Trillian; Schmidt, Brian A.; Sherman, Dawn S.; Cummings, Nicole E.; Peter, Darby C.; Kimple, Michelle E.; Lamming, Dudley W.; Merrins, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17814</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Type 2 diabetes is an age-and-obesity assocd. disease driven by impairments in glucose homeostasis that ultimately result in defective insulin secretion from pancreatic β-cells.  To deconvolve the effects of age and obesity in an exptl. model of prediabetes, we fed young and aged mice either chow or a short-term high-fat/high-sucrose Western diet (WD) and examd. how wt., glucose tolerance, and β-cell function were affected.  Although WD induced a similar degree of wt. gain in young and aged mice, a high degree of heterogeneity was found exclusively in aged mice.  Wt. gain in WD-fed aged mice was well-correlated with glucose intolerance, fasting insulin, and in vivo glucose-stimulated insulin secretion, relationships that were not obsd. in young animals.  Although β-cell mass expansion in the WD-fed aged mice was only three-quarters of that obsd. in young mice, the islets from aged mice were resistant to the sharp WD-induced decline in ex vivo insulin secretion obsd. in young mice.  Our findings demonstrate that age is assocd. with the protection of islet function in diet-induced obese mice, and furthermore, that WD challenge exposes variability in the resilience of the insulin secretory pathway in aged mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7-1qc9KPErVg90H21EOLACvtfcHk0li628TkIBtACQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslKju7s%253D&md5=1a52e008ef17d4c50361dfe5c07f3b48</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36289-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36289-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeon%26aufirst%3DE.%2BR.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DFenske%26aufirst%3DR.%2BJ.%26aulast%3DGregg%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%2BA.%26aulast%3DSherman%26aufirst%3DD.%2BS.%26aulast%3DCummings%26aufirst%3DN.%2BE.%26aulast%3DPeter%26aufirst%3DD.%2BC.%26aulast%3DKimple%26aufirst%3DM.%2BE.%26aulast%3DLamming%26aufirst%3DD.%2BW.%26aulast%3DMerrins%26aufirst%3DM.%2BJ.%26atitle%3DAge-dependent%2520protection%2520of%2520insulin%2520secretion%2520in%2520diet%2520induced%2520obese%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D17814%26doi%3D10.1038%2Fs41598-018-36289-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talchai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accili, D.</span></span> <span> </span><span class="NLM_article-title">Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">1223</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cell.2012.07.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22980982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKrsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=1223-1234&author=C.+Talchaiauthor=S.+Xuanauthor=H.+V.+Linauthor=L.+Susselauthor=D.+Accili&title=Pancreatic+%CE%B2+cell+dedifferentiation+as+a+mechanism+of+diabetic+%CE%B2+cell+failure&doi=10.1016%2Fj.cell.2012.07.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic β Cell dedifferentiation as a mechanism of diabetic β cell failure</span></div><div class="casAuthors">Talchai, Chutima; Xuan, Shouhong; Lin, Hua V.; Sussel, Lori; Accili, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1223-1234</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetes is assocd. with β cell failure.  But it remains unclear whether the latter results from reduced β cell no. or function.  FoxO1 integrates β cell proliferation with adaptive β cell function.  We interrogated the contribution of these two processes to β cell dysfunction, using mice lacking FoxO1 in β cells.  FoxO1 ablation caused hyperglycemia with reduced β cell mass following physiol. stress, such as multiparity and aging.  Surprisingly, lineage-tracing expts. demonstrated that loss of β cell mass was due to β cell dedifferentiation, not death.  Dedifferentiated β cells reverted to progenitor-like cells expressing neurogenin 3, Oct4, Nanog, and L-Myc.  A subset of FoxO1-deficient β cells adopted the α cell fate, resulting in hyperglucagonemia.  Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes.  We propose that dedifferentiation trumps endocrine cell death in the natural history of β cell failure and suggest that treatment of β cell dysfunction should restore differentiation, rather than promoting β cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQ0PPawickLVg90H21EOLACvtfcHk0li628TkIBtACQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKrsbzI&md5=a6633771235960936013b269a8932815</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DTalchai%26aufirst%3DC.%26aulast%3DXuan%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DH.%2BV.%26aulast%3DSussel%26aufirst%3DL.%26aulast%3DAccili%26aufirst%3DD.%26atitle%3DPancreatic%2520%25CE%25B2%2520cell%2520dedifferentiation%2520as%2520a%2520mechanism%2520of%2520diabetic%2520%25CE%25B2%2520cell%2520failure%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D1223%26epage%3D1234%26doi%3D10.1016%2Fj.cell.2012.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cinti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim-Muller, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suleiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratner, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accili, D.</span></span> <span> </span><span class="NLM_article-title">Evidence of β-cell dedifferentiation in human type 2 diabetes</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1210/jc.2015-2860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1210%2Fjc.2015-2860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=26713822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCrtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=1044-1054&author=F.+Cintiauthor=R.+Bouchiauthor=J.+Y.+Kim-Mullerauthor=Y.+Ohmuraauthor=P.+R.+Sandovalauthor=M.+Masiniauthor=L.+Marselliauthor=M.+Suleimanauthor=L.+E.+Ratnerauthor=P.+Marchettiauthor=D.+Accili&title=Evidence+of+%CE%B2-cell+dedifferentiation+in+human+type+2+diabetes&doi=10.1210%2Fjc.2015-2860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of β-cell dedifferentiation in human type 2 diabetes</span></div><div class="casAuthors">Cinti, Francesca; Bouchi, Ryotaro; Kim-Muller, Ja Young; Ohmura, Yoshiaki; Sandoval, P. R.; Masini, Matilde; Marselli, Lorella; Suleiman, Mara; Ratner, Lloyd E.; Marchetti, Piero; Accili, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-1054</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1945-7197</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Diabetes is assocd. with a deficit of insulin-producing β-cells.  Animal studies show that β-cells become dedifferentiated in diabetes, reverting to a progenitor-like stage, and partly converting to other endocrine cell types.  Objective: To det. whether similar processes occur in human type 2 diabetes, we surveyed pancreatic islets from 15 diabetic and 15 nondiabetic organ donors.  Design: We scored dedifferentiation using markers of endocrine lineage, β-cell-specific transcription factors, and a newly identified endocrine progenitor cell marker, aldehyde dehydrogenase 1A3.  Results: By these criteria, dedifferentiated cells accounted for 31.9% of β-cells in type 2 diabetics vs 8.7% in controls, and for 16.8% vs 6.5% of all endocrine cells (P < .001).  The no. of aldehyde dehydrogenase 1A3-pos./hormone-neg. cells was 3-fold higher in diabetics compared with controls.  Moreover, β-cell-specific transcription factors were ectopically found in glucagon- and somatostatin-producing cells of diabetic subjects.  Conclusions: The data support the view that pancreatic β-cells become dedifferentiated and convert to α- and δ-"like" cells in human type 2 diabetes.  The findings should prompt a reassessment of goals in the prevention and treatment of β-cell dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoiaTHE04TK7Vg90H21EOLACvtfcHk0lhZgfcp9Br6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCrtL%252FK&md5=dee3ac8677607c299bc4c3d9a225554c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1210%2Fjc.2015-2860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2015-2860%26sid%3Dliteratum%253Aachs%26aulast%3DCinti%26aufirst%3DF.%26aulast%3DBouchi%26aufirst%3DR.%26aulast%3DKim-Muller%26aufirst%3DJ.%2BY.%26aulast%3DOhmura%26aufirst%3DY.%26aulast%3DSandoval%26aufirst%3DP.%2BR.%26aulast%3DMasini%26aufirst%3DM.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DSuleiman%26aufirst%3DM.%26aulast%3DRatner%26aufirst%3DL.%2BE.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DAccili%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520%25CE%25B2-cell%2520dedifferentiation%2520in%2520human%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2016%26volume%3D101%26spage%3D1044%26epage%3D1054%26doi%3D10.1210%2Fjc.2015-2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdigoto, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, K. C.</span></span> <span> </span><span class="NLM_article-title">β cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cmet.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=28190773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisF2is7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=727-738&author=J.+Ruiauthor=S.+Dengauthor=A.+Araziauthor=A.+L.+Perdigotoauthor=Z.+Liuauthor=K.+C.+Herold&title=%CE%B2+cells+that+resist+immunological+attack+develop+during+progression+of+autoimmune+diabetes+in+NOD+mice&doi=10.1016%2Fj.cmet.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice</span></div><div class="casAuthors">Rui, Jinxiu; Deng, Songyan; Arazi, Arnon; Perdigoto, Ana Luisa; Liu, Zongzhi; Herold, Kevan C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Type 1 diabetes (T1D) is a chronic autoimmune disease that involves immune-mediated destruction of β cells.  How β cells respond to immune attack is unknown.  We identified a population of β cells during the progression of T1D in non-obese diabetic (NOD) mice that survives immune attack.  This population develops from normal β cells confronted with islet infiltrates.  Pathways involving cell movement, growth and proliferation, immune responses, and cell death and survival are activated in these cells.  There is reduced expression of β cell identity genes and diabetes antigens and increased immune inhibitory markers and stemness genes.  This new subpopulation is resistant to killing when diabetes is pptd. with cyclophosphamide.  Human β cells show similar changes when cultured with immune cells.  These changes may account for the chronicity of the disease and the long-term survival of β cells in some patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr951jKBj2H-LVg90H21EOLACvtfcHk0lhdQumXmGwwAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisF2is7w%253D&md5=743d47adc2f8c0c531067a495c99a55b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DRui%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DArazi%26aufirst%3DA.%26aulast%3DPerdigoto%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHerold%26aufirst%3DK.%2BC.%26atitle%3D%25CE%25B2%2520cells%2520that%2520resist%2520immunological%2520attack%2520develop%2520during%2520progression%2520of%2520autoimmune%2520diabetes%2520in%2520NOD%2520mice%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D727%26epage%3D738%26doi%3D10.1016%2Fj.cmet.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakose, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackeifi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">652.e5</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.cmet.2018.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=30581122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2ht7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=638-652.e5&author=P.+Wangauthor=E.+Karakoseauthor=H.+Liuauthor=E.+Swartzauthor=C.+Ackeifiauthor=V.+Zlatanicauthor=J.+Wilsonauthor=B.+J.+Gonz%C3%A1lezauthor=A.+Benderauthor=K.+K.+Takaneauthor=L.+Yeauthor=G.+Harbauthor=F.+Pagliucaauthor=D.+Homannauthor=D.+Egliauthor=C.+Argmannauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=Combined+inhibition+of+DYRK1A%2C+SMAD%2C+and+trithorax+pathways+synergizes+to+induce+robust+replication+in+adult+human+beta+cells&doi=10.1016%2Fj.cmet.2018.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells</span></div><div class="casAuthors">Wang, Peng; Karakose, Esra; Liu, Hongtao; Swartz, Ethan; Ackeifi, Courtney; Zlatanic, Viktor; Wilson, Jessica; Gonzalez, Bryan J.; Bender, Aaron; Takane, Karen K.; Ye, Lillian; Harb, George; Pagliuca, Felicia; Homann, Dirk; Egli, Dieter; Argmann, Carmen; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-652.e5</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of dual-specificity tyrosine-regulated kinase 1A (DYRK1A) induce human beta cells to proliferate, generating a labeling index of 1.5%-3%.  Here, we demonstrate that combined pharmacol. inhibition of DYRK1A and transforming growth factor beta superfamily (TGFβSF)/SMAD signaling generates remarkable further synergistic increases in human beta cell proliferation (av. labeling index, 5%-8%, and as high as 15%-18%), and increases in both mouse and human beta cell nos.  This synergy reflects activation of cyclins and cdks by DYRK1A inhibition, accompanied by simultaneous redns. in key cell-cycle inhibitors (CDKN1C and CDKN1A).  The latter results from interference with the basal Trithorax- and SMAD-mediated transactivation of CDKN1C and CDKN1A.  Notably, combined DYRK1A and TGFβ inhibition allows preservation of beta cell differentiated function.  These beneficial effects extend from normal human beta cells and stem cell-derived human beta cells to those from people with type 2 diabetes, and occur both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTj3UaJV2-V7Vg90H21EOLACvtfcHk0lhdQumXmGwwAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2ht7jN&md5=99322b62913a95e1209524c958db8380</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKarakose%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSwartz%26aufirst%3DE.%26aulast%3DAckeifi%26aufirst%3DC.%26aulast%3DZlatanic%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DB.%2BJ.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DPagliuca%26aufirst%3DF.%26aulast%3DHomann%26aufirst%3DD.%26aulast%3DEgli%26aufirst%3DD.%26aulast%3DArgmann%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DCombined%2520inhibition%2520of%2520DYRK1A%252C%2520SMAD%252C%2520and%2520trithorax%2520pathways%2520synergizes%2520to%2520induce%2520robust%2520replication%2520in%2520adult%2520human%2520beta%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2019%26volume%3D29%26spage%3D638%26epage%3D652.e5%26doi%3D10.1016%2Fj.cmet.2018.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozar-Castellano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasavada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Lessons from the first comprehensive molecular characterization of cell cycle control in rodent insulinoma cell lines</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3056</span>– <span class="NLM_lpage">3068</span>, <span class="refDoi"> DOI: 10.2337/db08-0393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb08-0393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=18650366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsleis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=3056-3068&author=I.+Cozar-Castellanoauthor=G.+Harbauthor=K.+Selkauthor=K.+Takaneauthor=R.+Vasavadaauthor=B.+Sicariauthor=B.+Lawauthor=P.+Zhangauthor=D.+K.+Scottauthor=N.+Fiaschi-Taeschauthor=A.+F.+Stewart&title=Lessons+from+the+first+comprehensive+molecular+characterization+of+cell+cycle+control+in+rodent+insulinoma+cell+lines&doi=10.2337%2Fdb08-0393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the first comprehensive molecular characterization of cell cycle control in rodent insulinoma cell lines</span></div><div class="casAuthors">Cozar-Castellano, Irene; Harb, George; Selk, Karen; Takane, Karen; Vasavada, Rupangi; Sicari, Brian; Law, Brian; Zhang, Pili; Scott, Donald K.; Fiaschi-Taesch, Nathalie; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3056-3068</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-Rodent insulinoma cell lines may serve as a model for designing continuously replicating human β-cell lines and provide clues as to the central cell cycle regulatory mols. in the β-cell.  Research Design and Methods-We performed a comprehensive G1/S proteome anal. on the four most widely studied rodent insulinoma cell lines and defined their flow cytometric profiles and growth characteristics.  Results-(1) Despite their common T-antigen-derived origins, MIN6 and BTC3 cells display markedly different G1/S expression profiles; (2) despite their common radiation origins, RINm5F and INS1 cells display striking differences in cell cycle protein profiles; (3) phosphorylation of pRb is absent in INS1 and RINm5F cells; (4) cyclin D2 is absent in RINm5F and BTC3 cells and therefore apparently dispensable for their proliferation; (5) every cell cycle inhibitor is upregulated, presumably in a futile attempt to halt proliferation; (6) among the G1/S proteome members, seven are pro-proliferation mols.: cyclin-dependent kinase-1, -2, -4, and -6 and cyclins A, E, and D3; and (7) overexpression of the combination of these seven converts arrested proliferation rates in primary rat β-cells to those in insulinoma cells.  Unfortunately, this therapeutic overexpression appears to mildly attenuate β-cell differentiation and function.  Conclusions-These studies underscore the importance of characterizing the cell cycle at the protein level in rodent insulinoma cell lines.  They also emphasize the hazards of interpreting data from rodent insulinoma cell lines as modeling normal cell cycle progression.  Most importantly, they provide seven candidate targets for inducing proliferation in human β-cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlf9Hag2a0LVg90H21EOLACvtfcHk0lhtFTV1UIlERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsleis78%253D&md5=583e3b8dab223d6b31982d506b0dea2e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0393%26sid%3Dliteratum%253Aachs%26aulast%3DCozar-Castellano%26aufirst%3DI.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DSelk%26aufirst%3DK.%26aulast%3DTakane%26aufirst%3DK.%26aulast%3DVasavada%26aufirst%3DR.%26aulast%3DSicari%26aufirst%3DB.%26aulast%3DLaw%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DLessons%2520from%2520the%2520first%2520comprehensive%2520molecular%2520characterization%2520of%2520cell%2520cycle%2520control%2520in%2520rodent%2520insulinoma%2520cell%2520lines%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D3056%26epage%3D3068%26doi%3D10.2337%2Fdb08-0393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.,  III.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lélias, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.-M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhtFTV1UIlERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.-M.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eswaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0lhtFTV1UIlERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr. Sect., D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lj21f7E-AfXhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%2520Sect.%252C%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lj21f7E-AfXhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lj21f7E-AfXhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgtTNggfTCUZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgtTNggfTCUZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: building new software for automated crystallographic structure determination</span>. <i>Acta Crystallogr D Biol Crystallogr</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+building+new+software+for+automated+crystallographic+structure+determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lgtTNggfTCUZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520building%2520new%2520software%2520for%2520automated%2520crystallographic%2520structure%2520determination%26jtitle%3DActa%2520Crystallogr%2520D%2520Biol%2520Crystallogr%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span>; <span class="NLM_string-name">Blanc, E.</span>; <span class="NLM_string-name">Brandl, M.</span>; <span class="NLM_string-name">Flensburg, C.</span>; <span class="NLM_string-name">Keller, P.</span>; <span class="NLM_string-name">Paciorek, W.</span>; <span class="NLM_string-name">Roversi, P. S. A.</span>; <span class="NLM_string-name">Smart, O.S.</span>; <span class="NLM_string-name">Vonrhein, C.</span>; <span class="NLM_string-name">Womack, T.O.</span></span> <i>BUSTER version 2.10.3</i>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+S.+A.+Roversi&author=O.S.+Smart&author=C.+Vonrhein&author=T.O.+Womack&title=BUSTER+version+2.10.3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%2520version%25202.10.3%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1107/S0907444911056058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444911056058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=22505257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Gns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=368-380&author=O.+S.+Smartauthor=T.+O.+Womackauthor=C.+Flensburgauthor=P.+Kellerauthor=W.+Paciorekauthor=A.+Sharffauthor=C.+Vonrheinauthor=G.+Bricogne&title=Exploiting+structure+similarity+in+refinement%3A+automated+NCS+and+target-structure+restraints+in+BUSTER&doi=10.1107%2FS0907444911056058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER</span></div><div class="casAuthors">Smart, Oliver S.; Womack, Thomas O.; Flensburg, Claus; Keller, Peter; Paciorek, Wlodek; Sharff, Andrew; Vonrhein, Clemens; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-380</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Maximum-likelihood X-ray macromol. structure refinement in BUSTER has been extended with restraints facilitating the exploitation of structural similarity.  The similarity can be between two or more chains within the structure being refined, thus favoring NCS, or to a distinct 'target' structure that remains fixed during refinement.  The local structural similarity restraints (LSSR) approach considers all distances less than 5.5 Å between pairs of atoms in the chain to be restrained.  For each, the difference from the distance between the corresponding atoms in the related chain is found.  LSSR applies a restraint penalty on each difference.  A functional form that reaches a plateau for large differences is used to avoid the restraints distorting parts of the structure that are not similar.  Because LSSR are local, there is no need to sep. out domains.  Some restraint pruning is still necessary, but this has been automated.  LSSR have been available to academic users of BUSTER since 2009 with the easy-to-use and options.  The use of LSSR is illustrated in the re-refinement of PDB entries , where enables the correct ligand-binding structure to be found, and , where contributes to the location of an addnl. copy of the cyclic peptide ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu-qo0DGjn3bVg90H21EOLACvtfcHk0lh0tCIMXkAfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Gns78%253D&md5=bea89f86f489e8dbd00a9866a3d7dab9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444911056058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911056058%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DO.%2BS.%26aulast%3DWomack%26aufirst%3DT.%2BO.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DExploiting%2520structure%2520similarity%2520in%2520refinement%253A%2520automated%2520NCS%2520and%2520target-structure%2520restraints%2520in%2520BUSTER%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D368%26epage%3D380%26doi%3D10.1107%2FS0907444911056058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">Optimal description of a protein structure in terms of multiple groups undergoing TLS motion</span>. <i>Acta Crystallogr., D. Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1107/S0907444906005270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444906005270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=16552146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=439-450&author=J.+Painterauthor=E.+A.+Merritt&title=Optimal+description+of+a+protein+structure+in+terms+of+multiple+groups+undergoing+TLS+motion&doi=10.1107%2FS0907444906005270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Optimal description of a protein structure in terms of multiple groups undergoing TLS motion</span></div><div class="casAuthors">Painter, Jay; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-450</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A single protein crystal structure contains information about dynamic properties of the protein as well as providing a static view of one three-dimensional conformation.  This addnl. information is to be found in the distribution of obsd. electron d. about the mean position of each atom.  It is general practice to account for this by refining a sep. at. displacement parameter (ADP) for each at. center.  However, these same displacements are often described well by simpler models based on TLS (translation/libration/screw) rigid-body motion of large groups of atoms, for example interdomain hinge motion.  A procedure, TLSMD, has been developed that analyzes the distribution of ADPs in a previously refined protein crystal structure in order to generate optimal multi-group TLS descriptions of the constituent protein chains.  TLSMD is applicable to crystal structures at any resoln.  The models generated by TLSMD anal. can significantly improve the std. crystallog. residuals R and Rfree and can reveal intrinsic dynamic properties of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIR_NcneJBNbVg90H21EOLACvtfcHk0lh0tCIMXkAfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gkt74%253D&md5=6289483d19fb6dd64fe9b032e9c45005</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0907444906005270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906005270%26sid%3Dliteratum%253Aachs%26aulast%3DPainter%26aufirst%3DJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DOptimal%2520description%2520of%2520a%2520protein%2520structure%2520in%2520terms%2520of%2520multiple%2520groups%2520undergoing%2520TLS%2520motion%26jtitle%3DActa%2520Crystallogr.%252C%2520D.%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D439%26epage%3D450%26doi%3D10.1107%2FS0907444906005270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, E. A.</span></span> <span> </span><span class="NLM_article-title">TLSMD web server for the generation of multi-group TLS models</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1107/S0021889805038987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0021889805038987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=109-111&author=J.+Painterauthor=E.+A.+Merritt&title=TLSMD+web+server+for+the+generation+of+multi-group+TLS+models&doi=10.1107%2FS0021889805038987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">TLSMD web server for the generation of multi-group TLS models</span></div><div class="casAuthors">Painter, Jay; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-111</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The TLSMD web server exts. information about dynamic properties of a protein based on information derived from a single-crystal structure.  It does so by analyzing the spatial distribution of individual at. thermal parameters present in an input structural model.  The server partitions the protein structure into multiple, contiguous chain segments, each segment corresponding to one group in a multi-group description of the protein's overall dynamic motion.  For each polypeptide chain of the input protein, the anal. generates the optimal partition into two segments, three segments,... up to 20 segments.  Each such partition is optimal in the sense that it is the best approxn. of the overall spatial distribution of input thermal parameters in terms of N chain segments, each acting as a rigid group undergoing TLS (translation/libration/screw) motion.  This multi-group TLS model may be used as a starting point for further crystallog. refinement, or as the basis for analyzing inter-domain and other large-scale motions implied by the crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhkwf2sopjVrVg90H21EOLACvtfcHk0lh0tCIMXkAfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVyjsA%253D%253D&md5=5d16d5d6310baa5434064bdf0ec81e24</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889805038987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889805038987%26sid%3Dliteratum%253Aachs%26aulast%3DPainter%26aufirst%3DJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DTLSMD%2520web%2520server%2520for%2520the%2520generation%2520of%2520multi-group%2520TLS%2520models%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2006%26volume%3D39%26spage%3D109%26epage%3D111%26doi%3D10.1107%2FS0021889805038987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh0tCIMXkAfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lipYOFp-4dT5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roccisana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trucco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span> <span> </span><span class="NLM_article-title">Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1664</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.2337/diabetes.54.6.1664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdiabetes.54.6.1664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=15919787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1664-1675&author=P.+Raoauthor=J.+Roccisanaauthor=K.+K.+Takaneauthor=R.+Bottinoauthor=A.+Zhaoauthor=M.+Truccoauthor=A.+Garcia-Ocana&title=Gene+transfer+of+constitutively+active+Akt+markedly+improves+human+islet+transplant+outcomes+in+diabetic+severe+combined+immunodeficient+mice&doi=10.2337%2Fdiabetes.54.6.1664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice</span></div><div class="casAuthors">Rao, Poornima; Roccisana, Jennifer; Takane, Karen K.; Bottino, Rita; Zhao, Allan; Trucco, Massimo; Garcia-Ocana, Adolfo</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1664-1675</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Akt is an important intracellular mediator of β-cell growth and survival in rodents.  However, whether constitutive activation of Akt in human β-cells enhances the survival and function of transplanted islets is unknown.  In the current study, we examd. the efficacy of constitutive activation of Akt in improving human islet transplant outcomes using a marginal mass model in diabetic severe combined immunodeficient (SCID) mice.  Human islets transduced with adenoviruses encoding constitutively active Akt1 (Adv-CA-Akt) displayed increased total and phosphorylated Akt and Akt kinase activity compared with control islets.  Expression of CA-Akt in human islets induced a significant increase in β-cell replication and a significant decrease in β-cell death induced by serum and glucose deprivation or chronic hyperglycemia.  Two control groups of islets (1,500 uninfected or adenovirus LacZ [Adv-LacZ]-transduced human islet equiv. [IEQs]) transplanted under the kidney capsule of streptozotocin-induced diabetic SCID mice were insufficient to correct hyperglycemia.  Importantly and in marked contrast to these controls, 1,500 Adv-CA-Akt-transduced IEQs were capable of restoring euglycemia in diabetic SCID mice.  Moreover, blood glucose normalization persisted for at least 6 mo.  Human plasma insulin at day 54 after transplant was 10-fold higher in Adv-CA-Akt islet recipients (2.4±0.4 ng/mL) compared with those receiving Adv-LacZ islets (0.25±0.08 ng/mL) (P < 0.05).  In summary, expression of CA-Akt in human islets improves islet transplant outcomes in a subcapsular renal graft model in SCID mice.  Akt is an attractive target for future strategies aimed at reducing the no. of islets required for successful islet transplantation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgrV4aNbQA7Vg90H21EOLACvtfcHk0lipYOFp-4dT5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaitr0%253D&md5=40a87c83cfd090918b34fc20dd5ef1c2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.6.1664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.6.1664%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DP.%26aulast%3DRoccisana%26aufirst%3DJ.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DBottino%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DA.%26aulast%3DTrucco%26aufirst%3DM.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26atitle%3DGene%2520transfer%2520of%2520constitutively%2520active%2520Akt%2520markedly%2520improves%2520human%2520islet%2520transplant%2520outcomes%2520in%2520diabetic%2520severe%2520combined%2520immunodeficient%2520mice%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D1664%26epage%3D1675%26doi%3D10.2337%2Fdiabetes.54.6.1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiaschi-Taesch, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicari, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takane, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricordi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenyon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor enhances engraftment and function of non-human primate islets</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2745</span>– <span class="NLM_lpage">2754</span>, <span class="refDoi"> DOI: 10.2337/db07-1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.2337%2Fdb07-1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=18820214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1KntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2745-2754&author=N.+M.+Fiaschi-Taeschauthor=D.+M.+Bermanauthor=B.+M.+Sicariauthor=K.+K.+Takaneauthor=A.+Garcia-Ocanaauthor=C.+Ricordiauthor=N.+S.+Kenyonauthor=A.+F.+Stewart&title=Hepatocyte+growth+factor+enhances+engraftment+and+function+of+non-human+primate+islets&doi=10.2337%2Fdb07-1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets</span></div><div class="casAuthors">Fiaschi-Taesch, Nathalie M.; Berman, Dora M.; Sicari, Brian M.; Takane, Karen K.; Garcia-Ocana, Adolfo; Ricordi, Camillo; Kenyon, Norma S.; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2745-2754</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Adenoviral delivery of hepatocyte growth factor (HGF) to rodent islets improves islet graft survival and function, markedly reducing the no. of islets required to achieve glucose control.  Here, we asked whether these prior observations in rodent models extend to nonhuman primate (NHP) islets.  NHP islets were transduced with murine (Ad.mHGF) or human (Ad.hHGF) adenoviral HGF (Ad.HGF) at low multiplicity of infection and studied in vitro.  To study the function of Ad.HGF-transduced NHP islets in vivo, a renal subcapsular marginal mass islet transplant model was developed in streptozotocin-induced diabetic NOD-SCID mice.  Baseline glucose values were 454.7 mg/dL.  Transplant of 500 NHP islet equiv. (IE) had only a marginal effect on blood glucose (369.1 mg/dL).  In striking contrast, 500 NHP IE transduced with Ad.mHGF promptly and continuously cor. blood glucose (142.0 mg/dL) for the 6-wk duration of the expt.  Unilateral nephrectomy resulted in an immediate return of glucose to baseline diabetic levels.  Interestingly, adenoviral DNA, as well as mouse HGF (mHGF) mRNA derived from the adenovirus, were present for 42 days posttransplantation.  Surprisingly, transplant of 500 IE with Ad.hHGF, as compared with Ad.mHGF, resulted in only marginal correction of blood glucose, suggesting that human HGF is less efficient than mHGF in this system.  These studies demonstrate that mHGF markedly improves islet transplant outcomes in the highest preclin. species examd. to date.  HGF has promise as an agent that can improve islet mass and function in transplant models and likely in other models of types 1 and 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg9S7GJNO7JrVg90H21EOLACvtfcHk0lipYOFp-4dT5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1KntrY%253D&md5=db53465e117b4b3acdf8714d1aff91ab</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2337%2Fdb07-1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb07-1085%26sid%3Dliteratum%253Aachs%26aulast%3DFiaschi-Taesch%26aufirst%3DN.%2BM.%26aulast%3DBerman%26aufirst%3DD.%2BM.%26aulast%3DSicari%26aufirst%3DB.%2BM.%26aulast%3DTakane%26aufirst%3DK.%2BK.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DRicordi%26aufirst%3DC.%26aulast%3DKenyon%26aufirst%3DN.%2BS.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DHepatocyte%2520growth%2520factor%2520enhances%2520engraftment%2520and%2520function%2520of%2520non-human%2520primate%2520islets%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D2745%26epage%3D2754%26doi%3D10.2337%2Fdb07-1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0liP7LMXd03bpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0liP7LMXd03bpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liP7LMXd03bpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">Web servers and services for electrostatics calculations with APBS and PDB2PQR</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1002/jcc.21720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1002%2Fjcc.21720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=21425296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1488-1491&author=S.+Unniauthor=Y.+Huangauthor=R.+M.+Hansonauthor=M.+Tobiasauthor=S.+Krishnanauthor=W.+W.+Liauthor=J.+E.+Nielsenauthor=N.+A.+Baker&title=Web+servers+and+services+for+electrostatics+calculations+with+APBS+and+PDB2PQR&doi=10.1002%2Fjcc.21720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Web servers and services for electrostatics calculations with APBS and PDB2PQR</span></div><div class="casAuthors">Unni, Samir; Huang, Yong; Hanson, Robert M.; Tobias, Malcolm; Krishnan, Sriram; Li, Wilfred W.; Nielsen, Jens E.; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1488-1491</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">APBS and PDB2PQR are widely utilized free software packages for biomol. electrostatics calcns.  Using the Opal toolkit, we have developed a Web services framework for these software packages that enables the use of APBS and PDB2PQR by users who do not have local access to the necessary amt. of computational capabilities.  This not only increases accessibility of the software to a wider range of scientists, educators, and students but also increases the availability of electrostatics calcns. on portable computing platforms.  Users can access this new functionality in two ways.  First, an Opal-enabled version of APBS is provided in current distributions, available freely on the web.  Second, we have extended the PDB2PQR web server to provide an interface for the setup, execution, and visualization of electrostatic potentials as calcd. by APBS.  This web interface also uses the Opal framework which ensures the scalability needed to support the large APBS user community.  Both of these resources are available from the APBS/PDB2PQR website: . © 2011 Wiley Periodicals, Inc. J Comput Chem, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIIBjEkcmTaLVg90H21EOLACvtfcHk0lj3iwStqKdL0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsF2isb8%253D&md5=631ec77858bda82621dc10470a373e4f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21720%26sid%3Dliteratum%253Aachs%26aulast%3DUnni%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DHanson%26aufirst%3DR.%2BM.%26aulast%3DTobias%26aufirst%3DM.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%2BW.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DWeb%2520servers%2520and%2520services%2520for%2520electrostatics%2520calculations%2520with%2520APBS%2520and%2520PDB2PQR%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2011%26volume%3D32%26spage%3D1488%26epage%3D1491%26doi%3D10.1002%2Fjcc.21720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurrus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Star, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felberg, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohara, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konecny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head-Gordon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">Improvements to the APBS biomolecular solvation software suite</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1002/pro.3280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=10.1002%2Fpro.3280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=28836357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSkt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=112-128&author=E.+Jurrusauthor=D.+Engelauthor=K.+Starauthor=K.+Monsonauthor=J.+Brandiauthor=L.+E.+Felbergauthor=D.+H.+Brookesauthor=L.+Wilsonauthor=J.+Chenauthor=K.+Lilesauthor=M.+Chunauthor=P.+Liauthor=D.+W.+Goharaauthor=T.+Dolinskyauthor=R.+Konecnyauthor=D.+R.+Koesauthor=J.+E.+Nielsenauthor=T.+Head-Gordonauthor=W.+Gengauthor=R.+Krasnyauthor=G.+W.+Weiauthor=M.+J.+Holstauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=Improvements+to+the+APBS+biomolecular+solvation+software+suite&doi=10.1002%2Fpro.3280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Improvements to the APBS biomolecular solvation software suite</span></div><div class="casAuthors">Jurrus, Elizabeth; Engel, Dave; Star, Keith; Monson, Kyle; Brandi, Juan; Felberg, Lisa E.; Brookes, David H.; Wilson, Leighton; Chen, Jiahui; Liles, Karina; Chun, Minju; Li, Peter; Gohara, David W.; Dolinsky, Todd; Konecny, Robert; Koes, David R.; Nielsen, Jens Erik; Head-Gordon, Teresa; Geng, Weihua; Krasny, Robert; Wei, Guo-Wei; Holst, Michael J.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-128</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The Adaptive Poisson-Boltzmann Solver (APBS) software was developed to solve the equations of continuum electrostatics for large biomol. assemblages that have provided impact in the study of a broad range of chem., biol., and biomedical applications.  APBS addresses the three key technol. challenges for understanding solvation and electrostatics in biomedical applications: accurate and efficient models for biomol. solvation and electrostatics, robust and scalable software for applying those theories to biomol. systems, and mechanisms for sharing and analyzing biomol. electrostatics data in the scientific community.  To address new research applications and advancing computational capabilities, we have continually updated APBS and its suite of accompanying software since its release in 2001.  In this article, we discuss the models and capabilities that have recently been implemented within the APBS software package including a Poisson-Boltzmann anal. and a semi-anal. solver, an optimized boundary element solver, a geometry-based geometric flow solvation model, a graph theory-based algorithm for detg. pKa values, and an improved web-based visualization tool for viewing electrostatics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBO7hbYoyPZrVg90H21EOLACvtfcHk0lj3iwStqKdL0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSkt7vI&md5=99651d125e38f4a85d453fecf0f71652</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fpro.3280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3280%26sid%3Dliteratum%253Aachs%26aulast%3DJurrus%26aufirst%3DE.%26aulast%3DEngel%26aufirst%3DD.%26aulast%3DStar%26aufirst%3DK.%26aulast%3DMonson%26aufirst%3DK.%26aulast%3DBrandi%26aufirst%3DJ.%26aulast%3DFelberg%26aufirst%3DL.%2BE.%26aulast%3DBrookes%26aufirst%3DD.%2BH.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiles%26aufirst%3DK.%26aulast%3DChun%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DGohara%26aufirst%3DD.%2BW.%26aulast%3DDolinsky%26aufirst%3DT.%26aulast%3DKonecny%26aufirst%3DR.%26aulast%3DKoes%26aufirst%3DD.%2BR.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DHead-Gordon%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DW.%26aulast%3DKrasny%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DG.%2BW.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DImprovements%2520to%2520the%2520APBS%2520biomolecular%2520solvation%2520software%2520suite%26jtitle%3DProtein%2520Sci.%26date%3D2018%26volume%3D27%26spage%3D112%26epage%3D128%26doi%3D10.1002%2Fpro.3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR','PDB','3ANR'); return false;">PDB: 3ANR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY','PDB','6UWY'); return false;">PDB: 6UWY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52041"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01379?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01379</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figure S1: Docking of selected 9-<i>N</i>-substituted harmine analogs; Figure S2: effects of harmine analogs on human and rat β-cell proliferation; Figure S3: electron density of <b>2-2c</b> bound to DYRK1A; Figure S4: brain penetration determination of compound <b>2-2c</b> in male CD-1 mice; Table S1: data collection and refinement statistics; Table S2: kinome scan data of compounds <b>2-2c</b>, <b>I</b>, and harmine; Table S3: in vitro CNS off-target assay protocol; Table S4: individual and mean plasma concentrations (μM) of <b>2-2c</b>; Table S5: individual and mean brain concentrations (μM) of <b>2-2c</b>; Table S6: individual and mean concentration ratio of brain to plasma of <b>2-2c</b>; HPLC purity analysis; and NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_002.csv">CSV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of saline (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_003.mov">MOV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of harmine (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov">MOV</a>)</p></li><li><p class="inline">Video of 12 week-old C57BL6/N male mice that received ip injections of <b>2-2c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_005.mov">MOV</a>)</p></li><li><p class="inline">PDB file of <b>2-1c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_006.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-1k</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_007.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-1l</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_008.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-2c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_009.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-2f</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_010.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-3a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_011.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-3b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_012.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-5a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_013.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-5b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_014.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-6a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_015.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-7a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_016.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>2-8a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_017.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_001.pdf">jm9b01379_si_001.pdf (4.21 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_002.csv">jm9b01379_si_002.csv (1.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_003.mov">jm9b01379_si_003.mov (4.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_004.mov">jm9b01379_si_004.mov (6.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_005.mov">jm9b01379_si_005.mov (3.89 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_006.pdb">jm9b01379_si_006.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_007.pdb">jm9b01379_si_007.pdb (457.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_008.pdb">jm9b01379_si_008.pdb (458.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_009.pdb">jm9b01379_si_009.pdb (1.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_010.pdb">jm9b01379_si_010.pdb (457.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_011.pdb">jm9b01379_si_011.pdb (456.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_012.pdb">jm9b01379_si_012.pdb (456.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_013.pdb">jm9b01379_si_013.pdb (457.17 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_014.pdb">jm9b01379_si_014.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_015.pdb">jm9b01379_si_015.pdb (457.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_016.pdb">jm9b01379_si_016.pdb (457.47 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01379/suppl_file/jm9b01379_si_017.pdb">jm9b01379_si_017.pdb (457.87 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for the X-ray structures of compound <b>2-2c</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>) bound to DYRK1A are available from the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>). Authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01379%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01379" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679962d9291e3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
